1	Letters	NNS	O	letter	_	0	SENT_1	[p1l1688t82r1798b108],
2	to	TO	O	to	_	0	SENT_1	[p1l1814t86r1841b108],
3	the	DT	O	the	det	4	SENT_1	[p1l1857t81r1901b108],
4	Editor	NNP	O	Editor	prep_to	1	SENT_1	[p1l1915t81r2013b108],
5	1439	CD	DATE	1439	num	4	SENT_1	[p1l2034t81r2114b108],

1	16	CD	NUMBER	16	num	3	SENT_2	[p1l45t179r73b203],
2	Harrington	NNP	LOCATION	Harrington	nn	3	SENT_2	[p1l97t178r250b209],
3	DJ	NNP	LOCATION	DJ	dep	17	SENT_2	[p1l265t179r312b208],
4	,	,	O	,	_	0	SENT_2	[p1l265t179r312b208],
5	Underwood	NNP	PERSON	Underwood	nn	6	SENT_2	[p1l328t178r491b203],
6	S	NNP	O	S	appos	3	SENT_2	[p1l507t179r530b208],
7	,	,	O	,	_	0	SENT_2	[p1l507t179r530b208],
8	Morse	NNP	ORGANIZATION	Morse	nn	9	SENT_2	[p1l546t179r633b203],
9	C	NNP	ORGANIZATION	C	appos	3	SENT_2	[p1l648t179r677b208],
10	,	,	O	,	_	0	SENT_2	[p1l648t179r677b208],
11	Shearer	NNP	O	Shearer	nn	12	SENT_2	[p1l694t178r796b203],
12	MJ	NNP	O	MJ	appos	3	SENT_2	[p1l811t179r862b208],
13	,	,	O	,	_	0	SENT_2	[p1l811t179r862b208],
14	Tuddenham	NNP	PERSON	Tuddenham	appos	3	SENT_2	[p1l879t178r1044b203],
15	18	CD	NUMBER	18	num	17	SENT_2	[p1l1116t179r1143b203],
16	Tie	NN	O	tie	nn	17	SENT_2	[p1l1168t178r1210b203],
17	JK	NNP	ORGANIZATION	JK	_	0	SENT_2	[p1l1218t179r1265b208],
18	,	,	O	,	_	0	SENT_2	[p1l1218t179r1265b208],
19	Nicchitta	NNP	ORGANIZATION	Nicchitta	nn	20	SENT_2	[p1l1275t178r1400b203],
20	C	NNP	ORGANIZATION	C	appos	17	SENT_2	[p1l1408t179r1437b208],
21	,	,	O	,	_	0	SENT_2	[p1l1408t179r1437b208],
22	von	NNP	O	von	nn	24	SENT_2	[p1l1447t186r1497b203],
23	Heijne	NNP	O	Heijne	nn	24	SENT_2	[p1l1506t178r1593b209],
24	G	NNP	O	G	appos	17	SENT_2	[p1l1602t179r1634b208],
25	,	,	O	,	_	0	SENT_2	[p1l1602t179r1634b208],
26	Stafford	NNP	PERSON	Stafford	nn	27	SENT_2	[p1l1645t178r1754b203],
27	DW	NNP	O	DW	appos	17	SENT_2	[p1l1763t179r1827b203],
28	.	.	O	.	_	0	SENT_2	[p1l1763t179r1827b203],

1	Membrane	NN	O	membrane	nn	3	SENT_3	[p1l1837t178r1986b203],
2	topology	NN	O	topology	nn	3	SENT_3	[p1l1994t178r2114b209],
3	EG	NN	O	eg	_	0	SENT_3	[p1l97t219r151b248],
4	,	,	O	,	_	0	SENT_3	[p1l97t219r151b248],
5	Mumford	NNP	ORGANIZATION	Mumford	nn	6	SENT_3	[p1l165t219r297b243],
6	AD	NN	O	ad	appos	3	SENT_3	[p1l309t219r367b243],
7	.	.	O	.	_	0	SENT_3	[p1l309t219r367b243],

1	Pharmacodynamic	JJ	PERSON	pharmacodynamic	amod	2	SENT_4	[p1l380t219r635b250],
2	resistance	NN	O	resistance	nsubj	18	SENT_4	[p1l647t219r776b243],
3	to	TO	O	to	_	0	SENT_4	[p1l788t222r814b243],
4	warfarin	NN	O	warfarin	nn	5	SENT_4	[p1l827t219r942b243],
5	associ	NN	O	assocus	prep_to	2	SENT_4	[p1l954t219r1043b243],
6	-	:	O	-	_	0	SENT_4	[p1l954t219r1043b243],
7	mapping	NN	O	mapping	dep	2	SENT_4	[p1l1167t219r1287b250],
8	of	IN	O	of	_	0	SENT_4	[p1l1306t219r1336b243],
9	vitamin	NN	O	vitamin	nn	12	SENT_4	[p1l1350t219r1453b243],
10	K	NN	O	k	nn	12	SENT_4	[p1l1471t220r1497b243],
11	epoxide	NN	O	epoxide	nn	12	SENT_4	[p1l1515t219r1619b250],
12	reductase	NN	O	reductase	prep_of	7	SENT_4	[p1l1637t219r1764b243],
13	by	IN	O	by	prep	7	SENT_4	[p1l1782t219r1815b250],
14	in	IN	O	in	pcomp	13	SENT_4	[p1l1833t219r1858b243],
15	Vitro	NNP	O	Vitro	nn	16	SENT_4	[p1l1876t219r1940b243],
16	translation	NN	O	translation	pobj	14	SENT_4	[p1l1959t219r2114b250],
17	/	:	O	/	punct	7	SENT_4	[p1l1959t219r2114b250],
18	ated	VBN	O	ate	_	0	SENT_4	[p1l97t260r154b284],
19	with	IN	O	with	_	0	SENT_4	[p1l169t260r228b284],
20	a	DT	O	a	det	22	SENT_4	[p1l243t268r258b284],
21	Val66Met	NN	O	val66met	nn	22	SENT_4	[p1l273t260r409b284],
22	substitution	NN	O	substitution	prep_with	18	SENT_4	[p1l425t260r583b284],
23	in	IN	O	in	_	0	SENT_4	[p1l598t260r624b284],
24	vitamin	NN	O	vitamin	nn	25	SENT_4	[p1l638t260r741b284],
25	K	NN	O	k	prep_in	22	SENT_4	[p1l757t261r783b284],
26	epoxide	NN	O	epoxide	nn	28	SENT_4	[p1l798t260r901b291],
27	reductase	NN	O	reductase	nn	28	SENT_4	[p1l917t260r1043b284],
28	cotranslocation	NN	O	cotranslocation	dep	25	SENT_4	[p1l1168t260r1383b284],
29	.	.	O	.	_	0	SENT_4	[p1l1168t260r1383b284],

1	J	NNP	O	J	nn	3	SENT_5	[p1l1395t261r1413b284],
2	Biol	NNP	O	Biol	nn	3	SENT_5	[p1l1421t260r1476b284],
3	Chem	NNP	O	Chem	_	0	SENT_5	[p1l1487t260r1562b284],
4	2005	CD	DATE	2005	num	3	SENT_5	[p1l1573t261r1642b289],
5	;	:	O	;	_	0	SENT_5	[p1l1573t261r1642b289],
6	280	CD	NUMBER	280	dep	3	SENT_5	[p1l1654t261r1708b284],
7	:	:	O	:	_	0	SENT_5	[p1l1654t261r1708b284],
8	l6410	CD	MONEY	l6410	num	9	SENT_5	[p1l1724t260r1837b284],
9	£	NN	MONEY	£	dep	6	SENT_5	[p1l1724t260r1837b284],
10	.	.	O	.	_	0	SENT_5	[p1l1724t260r1837b284],

1	complex	NN	O	complex	nn	2	SENT_6	[p1l97t301r210b332],
2	subunit	NN	O	subunit	_	0	SENT_6	[p1l221t301r321b325],
3	1	CD	NUMBER	1	dep	2	SENT_6	[p1l335t302r353b325],
4	.	.	O	.	_	0	SENT_6	[p1l335t302r353b325],

1	Thromb	NNP	O	Thromb	nn	2	SENT_7	[p1l369t301r471b326],
2	Haemost	NNP	O	Haemost	_	0	SENT_7	[p1l482t302r601b326],
3	2005	CD	DATE	2005	num	5	SENT_7	[p1l611t302r681b331],
4	;	:	O	;	_	0	SENT_7	[p1l611t302r681b331],
5	93	CD	NUMBER	93	dep	2	SENT_7	[p1l693t302r731b326],
6	:	:	O	:	_	0	SENT_7	[p1l693t302r731b326],
7	23	CD	NUMBER	23	number	8	SENT_7	[p1l743t302r812b325],
8	—	CD	NUMBER	—	dep	2	SENT_7	[p1l743t302r812b325],
9	6	CD	NUMBER	6	dep	8	SENT_7	[p1l743t302r812b325],
10	.	.	O	.	_	0	SENT_7	[p1l743t302r812b325],

1	19	CD	NUMBER	19	num	3	SENT_8	[p1l1116t302r1143b325],
2	Goodstadt	NNP	ORGANIZATION	Goodstadt	nn	3	SENT_8	[p1l1168t301r1313b326],
3	L	NNP	ORGANIZATION	L	_	0	SENT_8	[p1l1324t302r1352b330],
4	,	,	O	,	_	0	SENT_8	[p1l1324t302r1352b330],
5	Ponting	NNP	O	Ponting	nn	6	SENT_8	[p1l1363t301r1470b332],
6	CP	NNP	O	CP	appos	3	SENT_8	[p1l1481t301r1529b326],
7	.	.	O	.	_	0	SENT_8	[p1l1481t301r1529b326],

1	Vitamin	NN	O	vitamin	nn	4	SENT_9	[p1l1541t301r1651b325],
2	K	NN	O	k	nn	4	SENT_9	[p1l1662t302r1688b325],
3	epoxide	NN	O	epoxide	nn	4	SENT_9	[p1l1699t301r1802b332],
4	reductase	NN	O	reductase	_	0	SENT_9	[p1l1814t301r1940b325],
5	:	:	O	:	_	0	SENT_9	[p1l1953t309r1956b325],
6	homology	NN	O	homology	dep	4	SENT_9	[p1l1969t301r2113b332],
7	,	,	O	,	_	0	SENT_9	[p1l1969t301r2113b332],
8	17	CD	NUMBER	17	num	10	SENT_9	[p1l45t342r72b367],
9	Wilrns	NN	O	wilrn	nn	10	SENT_9	[p1l96t342r183b367],
10	EB	NNP	O	EB	dep	4	SENT_9	[p1l196t343r245b372],
11	,	,	O	,	_	0	SENT_9	[p1l196t343r245b372],
12	Touw	NNP	LOCATION	Touw	nn	13	SENT_9	[p1l259t343r338b367],
13	DJ	NNP	LOCATION	DJ	dep	4	SENT_9	[p1l351t343r397b372],
14	,	,	O	,	_	0	SENT_9	[p1l351t343r397b372],
15	Conemans	NNP	O	Conemans	nn	16	SENT_9	[p1l411t342r554b367],
16	JM	NN	O	jm	conj_and	6	SENT_9	[p1l567t343r619b372],
17	,	,	O	,	_	0	SENT_9	[p1l567t343r619b372],
18	Veldkamp	NNP	PERSON	Veldkamp	nn	19	SENT_9	[p1l632t342r773b373],
19	R	NNP	PERSON	R	conj_and	6	SENT_9	[p1l786t343r817b372],
20	,	,	O	,	_	0	SENT_9	[p1l786t343r817b372],
21	Herrnans	NNP	O	Herrnans	nn	25	SENT_9	[p1l831t343r954b367],
22	M.	NNP	O	M.	nn	25	SENT_9	[p1l967t343r1005b367],
23	A	NNP	O	A	nn	25	SENT_9	[p1l1019t342r1043b366],
24	active	JJ	O	active	amod	25	SENT_9	[p1l1168t342r1245b367],
25	site	NN	O	site	conj_and	6	SENT_9	[p1l1262t342r1305b367],
26	and	CC	O	and	_	0	SENT_9	[p1l1322t342r1372b367],
27	catalytic	JJ	O	catalytic	amod	28	SENT_9	[p1l1388t342r1501b373],
28	mechanism	NN	O	mechanism	conj_and	6	SENT_9	[p1l1517t342r1675b367],
29	.	.	O	.	_	0	SENT_9	[p1l1517t342r1675b367],

1	Trends	NNS	O	trend	_	0	SENT_10	[p1l1696t342r1784b367],
2	Biochem	NNP	ORGANIZATION	Biochem	nn	3	SENT_10	[p1l1800t342r1913b367],
3	Sci	NNP	O	Sci	dep	1	SENT_10	[p1l1931t343r1972b367],
4	2004	CD	DATE	2004	num	6	SENT_10	[p1l1987t342r2057b372],
5	;	:	O	;	_	0	SENT_10	[p1l1987t342r2057b372],
6	29	CD	NUMBER	29	dep	1	SENT_10	[p1l2075t342r2112b367],
7	:	:	O	:	_	0	SENT_10	[p1l2075t342r2112b367],

1	new	JJ	O	new	amod	2	SENT_11	[p1l97t391r151b407],
2	VKORC1	NN	O	vkorc1	nsubj	5	SENT_11	[p1l164t383r299b407],
3	allelic	JJ	O	allelic	amod	5	SENT_11	[p1l316t383r391b407],
4	variant	JJ	O	variant	amod	5	SENT_11	[p1l404t383r501b407],
5	(	NN	O	(	_	0	SENT_11	[p1l514t383r695b414],
6	p.	NN	O	p.	nn	8	SENT_11	[p1l514t383r695b414],
7	Trp59Arg	NN	O	trp59arg	nn	8	SENT_11	[p1l514t383r695b414],
8	)	NN	O	)	dobj	5	SENT_11	[p1l514t383r695b414],
9	in	IN	O	in	_	0	SENT_11	[p1l709t383r734b407],
10	a	DT	O	a	det	11	SENT_11	[p1l748t391r763b407],
11	patient	NN	O	patient	prep_in	8	SENT_11	[p1l776t383r870b414],
12	with	IN	O	with	_	0	SENT_11	[p1l883t383r942b407],
13	partial	JJ	O	partial	amod	14	SENT_11	[p1l955t383r1043b414],
14	289	CD	NUMBER	289	prep_with	5	SENT_11	[p1l1168t384r1269b407],
15	—	CD	NUMBER	—	number	16	SENT_11	[p1l1168t384r1269b407],
16	92	CD	NUMBER	92	dep	14	SENT_11	[p1l1168t384r1269b407],
17	.	.	O	.	_	0	SENT_11	[p1l1168t384r1269b407],

1	resistance	NN	O	resistance	_	0	SENT_12	[p1l97t424r226b448],
2	to	TO	O	to	_	0	SENT_12	[p1l235t428r262b448],
3	acenocoumarol	NN	O	acenocoumarol	prep_to	1	SENT_12	[p1l271t424r479b448],
4	and	CC	O	and	_	0	SENT_12	[p1l488t424r537b448],
5	phenprocournon	NN	O	phenprocournon	prep_to	1	SENT_12	[p1l546t424r776b455],
6	.	.	O	.	_	0	SENT_12	[p1l546t424r776b455],

1	J	NN	O	j	nn	3	SENT_13	[p1l786t425r805b449],
2	T	NN	O	t	nn	3	SENT_13	[p1l813t425r835b448],
3	hromb	NN	O	hromb	_	0	SENT_13	[p1l832t424r916b449],
4	Haemost	NNP	O	Haemost	dep	3	SENT_13	[p1l924t425r1044b449],
5	2008	CD	DATE	2008	num	4	SENT_13	[p1l97t465r167b494],
6	;	:	O	;	_	0	SENT_13	[p1l97t465r167b494],
7	6	CD	NUMBER	6	num	9	SENT_13	[p1l179t465r200b489],
8	:	:	O	:	_	0	SENT_13	[p1l179t465r200b489],
9	1224-6	CD	NUMBER	1224-6	dep	3	SENT_13	[p1l216t465r314b489],
10	.	.	O	.	_	0	SENT_13	[p1l216t465r314b489],

1	The	DT	O	the	det	4	SENT_14	[p1l49t645r166b703],
2	common	JJ	O	common	amod	4	SENT_14	[p1l187t663r462b703],
3	gene	NN	O	gene	nn	4	SENT_14	[p1l486t663r640b720],
4	variants	NNS	O	variant	nsubj	8	SENT_14	[p1l660t650r913b703],
5	of	IN	O	of	_	0	SENT_14	[p1l936t645r1000b703],
6	CYP2	NN	O	cyp2	nn	7	SENT_14	[p1l1023t649r1190b703],
7	C19	NN	O	c19	prep_of	4	SENT_14	[p1l1201t649r1326b703],
8	affect	VBP	O	affect	_	0	SENT_14	[p1l1348t645r1529b703],
9	pharmacokinetics	NNS	O	pharmacokinetic	dobj	8	SENT_14	[p1l1550t645r2112b720],
10	and	CC	O	and	_	0	SENT_14	[p1l50t728r163b785],
11	pharmacodynamics	NNS	O	pharmacodynamic	dobj	8	SENT_14	[p1l190t728r809b802],
12	in	IN	O	in	_	0	SENT_14	[p1l836t732r888b784],
13	an	DT	O	a	det	15	SENT_14	[p1l913t745r985b785],
14	active	JJ	O	active	amod	15	SENT_14	[p1l1010t732r1198b785],
15	metabolite	NN	O	metabolite	prep_in	8	SENT_14	[p1l1223t728r1565b785],
16	of	IN	O	of	_	0	SENT_14	[p1l1587t727r1651b785],
17	clopidogrel	NN	O	clopidogrel	prep_of	15	SENT_14	[p1l1672t728r2029b802],
18	in	IN	O	in	_	0	SENT_14	[p1l2058t732r2110b784],
19	healthy	JJ	O	healthy	amod	20	SENT_14	[p1l52t810r287b885],
20	subjects	NNS	O	subject	prep_in	17	SENT_14	[p1l316t810r576b885],

1	K.	NNP	LOCATION	K.	nn	2	SENT_15	[p1l50t941r83b967],
2	UMEMURA	NNP	LOCATION	UMEMURA	_	0	SENT_15	[p1l107t941r364b973],
3	,	,	O	,	_	0	SENT_15	[p1l107t941r364b973],
4	*	CD	NUMBER	*	num	6	SENT_15	[p1l107t941r364b973],
5	T.	NNP	O	T.	nn	6	SENT_15	[p1l385t941r418b967],
6	FURUTAT	NNP	O	FURUTAT	conj_and	2	SENT_15	[p1l442t941r629b975],
7	and	CC	O	and	_	0	SENT_15	[p1l649t939r705b968],
8	K.	NNP	PERSON	K.	nn	9	SENT_15	[p1l723t941r755b967],
9	KONDO	NNP	PERSON	KONDO	conj_and	2	SENT_15	[p1l779t940r958b968],
10	*	CD	NUMBER	*	num	12	SENT_15	[p1l779t940r958b968],
11	*	NNP	O	*	nn	12	SENT_15	[p1l50t989r235b1021],
12	Department	NNP	O	Department	dep	2	SENT_15	[p1l50t989r235b1021],
13	of	IN	O	of	_	0	SENT_15	[p1l247t988r278b1014],
14	Pharmacology	NNP	O	Pharmacology	prep_of	12	SENT_15	[p1l287t988r496b1021],
15	;	:	O	;	_	0	SENT_15	[p1l287t988r496b1021],
16	and	CC	O	and	_	0	SENT_15	[p1l509t988r563b1014],
17	’	JJ	O	’	amod	18	SENT_15	[p1l575t989r686b1020],
18	rCenter	NN	O	rcenter	prep_of	12	SENT_15	[p1l575t989r686b1020],
19	for	IN	O	for	_	0	SENT_15	[p1l698t988r738b1014],
20	Clinical	JJ	ORGANIZATION	clinical	amod	21	SENT_15	[p1l749t988r856b1014],
21	Research	NN	ORGANIZATION	research	prep_for	18	SENT_15	[p1l869t988r1000b1018],
22	,	,	O	,	_	0	SENT_15	[p1l869t988r1000b1018],
23	Hamamatsu	NNP	ORGANIZATION	Hamamatsu	nn	25	SENT_15	[p1l1016t990r1185b1014],
24	University	NNP	ORGANIZATION	University	nn	25	SENT_15	[p1l1199t990r1342b1021],
25	School	NNP	ORGANIZATION	School	appos	21	SENT_15	[p1l1353t988r1449b1014],
26	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l1461t988r1491b1014],
27	Medicine	NNP	ORGANIZATION	Medicine	prep_of	25	SENT_15	[p1l1500t988r1639b1018],
28	,	,	O	,	_	0	SENT_15	[p1l1500t988r1639b1018],
29	Hamamatsu	NNP	ORGANIZATION	Hamamatsu	nn	31	SENT_15	[p1l1656t990r1831b1018],
30	,	,	O	,	_	0	SENT_15	[p1l1656t990r1831b1018],
31	Japan	NNP	LOCATION	Japan	dep	12	SENT_15	[p1l1845t990r1927b1021],

1	To	TO	O	to	aux	2	SENT_16	[p1l48t1131r83b1155],
2	cite	VB	O	cite	dep	7	SENT_16	[p1l94t1131r144b1155],
3	this	DT	O	this	det	4	SENT_16	[p1l153t1129r205b1155],
4	article	NN	O	article	dobj	2	SENT_16	[p1l215t1129r310b1155],
5	:	:	O	:	_	0	SENT_16	[p1l215t1129r310b1155],
6	Umemura	NNP	PERSON	Umemura	nn	7	SENT_16	[p1l323t1131r462b1155],
7	K	NNP	PERSON	K	_	0	SENT_16	[p1l473t1131r497b1159],
8	,	,	O	,	_	0	SENT_16	[p1l473t1131r497b1159],
9	Furuta	NNP	PERSON	Furuta	nn	10	SENT_16	[p1l511t1131r600b1155],
10	T	NN	O	t	appos	7	SENT_16	[p1l608t1131r633b1159],
11	,	,	O	,	_	0	SENT_16	[p1l608t1131r633b1159],
12	Kondo	NNP	PERSON	Kondo	nn	14	SENT_16	[p1l646t1129r737b1155],
13	K.	NNP	O	K.	nn	14	SENT_16	[p1l748t1131r772b1155],
14	The	NNP	O	The	appos	7	SENT_16	[p1l784t1129r836b1155],
15	common	JJ	O	common	amod	17	SENT_16	[p1l846t1137r968b1155],
16	gene	NN	O	gene	nn	17	SENT_16	[p1l979t1137r1047b1162],
17	variants	NNS	O	variant	nsubj	20	SENT_16	[p1l1056t1131r1165b1155],
18	of	IN	O	of	_	0	SENT_16	[p1l1175t1129r1204b1155],
19	CYPZC19	NN	O	cypzc19	prep_of	17	SENT_16	[p1l1213t1131r1349b1155],
20	affect	VBP	O	affect	rcmod	14	SENT_16	[p1l1359t1129r1439b1155],
21	pharmacokinetics	NNS	O	pharmacokinetic	dobj	20	SENT_16	[p1l1449t1129r1692b1163],
22	and	CC	O	and	_	0	SENT_16	[p1l1702t1129r1752b1155],
23	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	21	SENT_16	[p1l1765t1129r2035b1163],
24	in	IN	O	in	_	0	SENT_16	[p1l2046t1131r2068b1155],
25	an	DT	O	a	det	27	SENT_16	[p1l2079t1137r2111b1155],
26	active	JJ	O	active	amod	27	SENT_16	[p1l49t1177r129b1201],
27	metabolite	NN	O	metabolite	prep_in	20	SENT_16	[p1l144t1175r291b1201],
28	of	IN	O	of	_	0	SENT_16	[p1l304t1175r333b1201],
29	clopidogrel	NN	O	clopidogrel	prep_of	27	SENT_16	[p1l345t1175r497b1209],
30	in	IN	O	in	_	0	SENT_16	[p1l512t1177r533b1201],
31	healthy	JJ	O	healthy	amod	32	SENT_16	[p1l549t1175r651b1208],
32	subjects	NNS	O	subject	prep_in	29	SENT_16	[p1l663t1175r780b1208],
33	.	.	O	.	_	0	SENT_16	[p1l663t1175r780b1208],

1	J	NNP	O	J	nn	3	SENT_17	[p1l794t1177r806b1201],
2	Thromb	NNP	O	Thromb	nn	3	SENT_17	[p1l821t1175r929b1201],
3	Haemost	NNP	O	Haemost	_	0	SENT_17	[p1l942t1177r1068b1201],
4	2008	CD	DATE	2008	num	3	SENT_17	[p1l1079t1177r1159b1205],
5	;	:	O	;	_	0	SENT_17	[p1l1079t1177r1159b1205],
6	6	CD	NUMBER	6	num	8	SENT_17	[p1l1173t1177r1197b1201],
7	:	:	O	:	_	0	SENT_17	[p1l1173t1177r1197b1201],
8	1439-41	CD	NUMBER	1439-41	dep	3	SENT_17	[p1l1213t1177r1344b1201],
9	.	.	O	.	_	0	SENT_17	[p1l1213t1177r1344b1201],

1	Clopidogrel	NNP	O	Clopidogrel	nsubjpass	12	SENT_18	[p1l10t1439r414b1518],
2	is	VBZ	O	be	cop	5	SENT_18	[p1l447t1439r496b1502],
3	a	DT	O	a	det	5	SENT_18	[p1l532t1460r570b1502],
4	thienopyridine	NN	O	thienopyridine	nn	5	SENT_18	[p1l604t1439r1100b1518],
5	derivative	NN	O	derivative	_	0	SENT_18	[p1l1134t1439r1466b1502],
6	with	IN	O	with	_	0	SENT_18	[p1l1499t1439r1650b1502],
7	ADPantagonistic	JJ	MISC	adpantagonistic	amod	8	SENT_18	[p1l1682t1439r2150b1518, p1l9t1546r186b1608],
8	activity	NN	O	activity	prep_with	5	SENT_18	[p1l210t1546r458b1625],
9	and	CC	O	and	_	0	SENT_18	[p1l484t1546r611b1609],
10	is	VBZ	O	be	auxpass	12	SENT_18	[p1l634t1546r683b1608],
11	widely	RB	O	widely	advmod	12	SENT_18	[p1l707t1546r928b1625],
12	used	VBN	O	use	conj_and	5	SENT_18	[p1l950t1546r1104b1609],
13	for	IN	O	for	_	0	SENT_18	[p1l1129t1546r1228b1609],
14	the	DT	O	the	det	15	SENT_18	[p1l1252t1546r1356b1608],
15	prevention	NN	O	prevention	prep_for	12	SENT_18	[p1l1379t1546r1745b1625],
16	of	IN	O	of	_	0	SENT_18	[p1l1771t1546r1847b1609],
17	ischemic	JJ	O	ischemic	amod	18	SENT_18	[p1l1862t1546r2151b1608],
18	events	NNS	O	event	prep_of	15	SENT_18	[p1l9t1662r218b1716],
19	in	IN	O	in	_	0	SENT_18	[p1l243t1654r307b1715],
20	patients	NNS	O	patient	prep_in	12	SENT_18	[p1l330t1654r597b1733],
21	who	WP	O	who	nsubj	23	SENT_18	[p1l621t1654r766b1716],
22	have	VBP	O	have	aux	23	SENT_18	[p1l792t1654r950b1716],
23	suffered	VBN	O	suffer	rcmod	20	SENT_18	[p1l977t1654r1246b1716],
24	a	DT	O	a	det	25	SENT_18	[p1l1271t1674r1308b1716],
25	stroke	NN	O	stroke	dobj	23	SENT_18	[p1l1334t1654r1560b1729],
26	,	,	O	,	_	0	SENT_18	[p1l1334t1654r1560b1729],
27	non-ST-segment	JJ	O	non-st-segment	amod	30	SENT_18	[p1l1587t1655r2151b1733],
28	elevation	NN	O	elevation	nn	30	SENT_18	[p1l9t1761r316b1823],
29	myocardial	JJ	O	myocardial	amod	30	SENT_18	[p1l342t1760r727b1839],
30	infarction	NN	O	infarction	conj_and	25	SENT_18	[p1l754t1761r1087b1823],
31	and	CC	O	and	_	0	SENT_18	[p1l1116t1760r1242b1823],
32	peripheral	JJ	O	peripheral	amod	35	SENT_18	[p1l1269t1761r1616b1840],
33	arterial	JJ	O	arterial	amod	35	SENT_18	[p1l1645t1761r1887b1823],
34	disease	NN	O	disease	nn	35	SENT_18	[p1l1915t1760r2150b1823],
35	[	NN	O	[	conj_and	25	SENT_18	[p1l12t1868r167b1945],
36	1,2	CD	NUMBER	1,2	num	37	SENT_18	[p1l12t1868r167b1945],
37	]	NN	O	]	dep	35	SENT_18	[p1l12t1868r167b1945],
38	.	.	O	.	_	0	SENT_18	[p1l12t1868r167b1945],

1	However	RB	O	however	advmod	4	SENT_19	[p1l196t1870r524b1942],
2	,	,	O	,	_	0	SENT_19	[p1l196t1870r524b1942],
3	there	EX	O	there	expl	4	SENT_19	[p1l551t1867r720b1929],
4	are	VBP	O	be	_	0	SENT_19	[p1l746t1887r849b1930],
5	a	DT	O	a	det	7	SENT_19	[p1l875t1887r913b1930],
6	substantial	JJ	O	substantial	amod	7	SENT_19	[p1l939t1867r1305b1930],
7	number	NN	O	number	nsubj	4	SENT_19	[p1l1329t1867r1596b1929],
8	of	IN	O	of	_	0	SENT_19	[p1l1621t1867r1698b1930],
9	patients	NNS	O	patient	prep_of	7	SENT_19	[p1l1711t1867r1979b1946],
10	who	WP	O	who	nsubj	13	SENT_19	[p1l2003t1867r2149b1930],
11	do	VBP	O	do	aux	13	SENT_19	[p1l10t1974r95b2036],
12	not	RB	O	not	neg	13	SENT_19	[p1l128t1982r243b2036],
13	respond	VB	O	respond	rcmod	9	SENT_19	[p1l274t1974r548b2053],
14	to	TO	O	to	_	0	SENT_19	[p1l579t1983r646b2036],
15	clopidoglrel	NN	O	clopidoglrel	prep_to	13	SENT_19	[p1l679t1974r1081b2053],
16	despite	IN	O	despite	_	0	SENT_19	[p1l1113t1974r1347b2053],
17	a	DT	O	a	det	20	SENT_19	[p1l1380t1994r1418b2036],
18	standardized	JJ	O	standardized	amod	20	SENT_19	[p1l1451t1974r1885b2036],
19	dosage	NN	O	dosage	nn	20	SENT_19	[p1l1917t1974r2150b2053],
20	regimen	NN	O	regimen	prep_despite	13	SENT_19	[p1l9t2081r298b2160],
21	.	.	O	.	_	0	SENT_19	[p1l9t2081r298b2160],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_20	[p1l327t2081r731b2160],
2	resistance	NN	O	resistance	nsubj	4	SENT_20	[p1l754t2081r1081b2144],
3	is	VBZ	O	be	cop	4	SENT_20	[p1l1103t2081r1153b2143],
4	one	CD	NUMBER	one	_	0	SENT_20	[p1l1178t2101r1298b2144],
5	of	IN	O	of	_	0	SENT_20	[p1l1324t2081r1399b2144],
6	the	DT	O	the	det	8	SENT_20	[p1l1414t2081r1518b2143],
7	major	JJ	O	major	amod	8	SENT_20	[p1l1539t2081r1744b2160],
8	concerns	NNS	O	concern	prep_of	4	SENT_20	[p1l1766t2101r2064b2144],
9	in	IN	O	in	_	0	SENT_20	[p1l2087t2081r2151b2143],
10	the	DT	O	the	det	11	SENT_20	[p1l9t2189r113b2251],
11	management	NN	O	management	prep_in	8	SENT_20	[p1l135t2197r577b2268],
12	of	IN	O	of	_	0	SENT_20	[p1l600t2189r676b2251],
13	high-risk	JJ	O	high-risk	amod	15	SENT_20	[p1l690t2189r992b2268],
14	vascular	JJ	O	vascular	amod	15	SENT_20	[p1l1013t2189r1296b2251],
15	patients	NNS	O	patient	prep_of	11	SENT_20	[p1l1316t2189r1602b2268],
16	,	,	O	,	_	0	SENT_20	[p1l1316t2189r1602b2268],
17	especially	RB	O	especially	advmod	15	SENT_20	[p1l1627t2189r1950b2268],
18	those	DT	O	those	dep	15	SENT_20	[p1l1972t2189r2150b2251],
19	who	WP	O	who	nsubj	21	SENT_20	[p1l8t2295r154b2358],
20	have	VBP	O	have	aux	21	SENT_20	[p1l181t2295r340b2358],
21	experienced	VBN	O	experience	rcmod	4	SENT_20	[p1l366t2295r765b2374],
22	acute	JJ	O	acute	amod	24	SENT_20	[p1l793t2304r971b2358],
23	coronary	JJ	O	coronary	amod	24	SENT_20	[p1l997t2316r1307b2374],
24	syndromes	NNS	O	syndrome	dobj	21	SENT_20	[p1l1334t2295r1716b2374],
25	.	.	O	.	_	0	SENT_20	[p1l1334t2295r1716b2374],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	5	SENT_21	[p1l1747t2295r2151b2374],
2	is	VBZ	O	be	cop	5	SENT_21	[p1l9t2402r58b2464],
3	an	DT	O	a	det	5	SENT_21	[p1l110t2422r192b2465],
4	inactive	JJ	O	inactive	amod	5	SENT_21	[p1l242t2402r503b2465],
5	prodrug	NN	O	prodrug	_	0	SENT_21	[p1l553t2402r833b2481],
6	requiring	VBG	O	require	partmod	5	SENT_21	[p1l882t2402r1193b2481],
7	several	JJ	O	several	amod	9	SENT_21	[p1l1244t2402r1473b2465],
8	biotransforrnation	NN	O	biotransforrnation	nn	9	SENT_21	[p1l1523t2402r2151b2465],
9	steps	NNS	O	step	dobj	6	SENT_21	[p1l11t2519r192b2589],
10	,	,	O	,	_	0	SENT_21	[p1l11t2519r192b2589],
11	mediated	VBN	O	mediate	partmod	9	SENT_21	[p1l221t2510r535b2572],
12	mainly	RB	O	mainly	advmod	11	SENT_21	[p1l561t2510r796b2589],
13	by	IN	O	by	_	0	SENT_21	[p1l823t2510r907b2589],
14	cytochrome	NN	O	cytochrome	nn	16	SENT_21	[p1l934t2510r1336b2589],
15	P-450	NN	MISC	p-450	nn	16	SENT_21	[p1l1364t2511r1558b2572],
16	isoforms	NNS	O	isoform	agent	11	SENT_21	[p1l1586t2510r1880b2572],
17	(	CD	NUMBER	(	num	19	SENT_21	[p1l1909t2510r2147b2589],
18	CYP	NN	O	cyp	nn	19	SENT_21	[p1l1909t2510r2147b2589],
19	)	NN	O	)	dep	16	SENT_21	[p1l1909t2510r2147b2589],
20	,	,	O	,	_	0	SENT_21	[p1l1909t2510r2147b2589],
21	in	IN	O	in	mark	24	SENT_21	[p1l9t2617r73b2678],
22	order	NN	O	order	dep	24	SENT_21	[p1l107t2616r290b2679],
23	to	TO	O	to	aux	24	SENT_21	[p1l322t2625r389b2679],
24	generate	VB	O	generate	purpcl	11	SENT_21	[p1l424t2626r708b2696],
25	an	DT	O	a	det	27	SENT_21	[p1l742t2637r824b2679],
26	active	JJ	O	active	amod	27	SENT_21	[p1l857t2617r1052b2679],
27	metabolite	NN	O	metabolite	dobj	24	SENT_21	[p1l1083t2616r1444b2679],
28	with	IN	O	with	_	0	SENT_21	[p1l1476t2616r1626b2679],
29	a	DT	O	a	det	31	SENT_21	[p1l1660t2637r1698b2679],
30	thiol	NN	O	thiol	nn	31	SENT_21	[p1l1730t2617r1885b2679],
31	moiety	NN	O	moiety	prep_with	24	SENT_21	[p1l1916t2617r2151b2695],
32	that	WDT	O	that	nsubj	33	SENT_21	[p1l9t2723r146b2786],
33	binds	VBZ	O	bind	rcmod	31	SENT_21	[p1l164t2723r347b2785],
34	irreversibly	RB	O	irreversibly	advmod	33	SENT_21	[p1l366t2723r746b2802],
35	to	TO	O	to	_	0	SENT_21	[p1l764t2732r831b2786],
36	the	DT	O	the	det	40	SENT_21	[p1l852t2723r956b2785],
37	platelet	NN	O	platelet	nn	40	SENT_21	[p1l974t2723r1223b2802],
38	ADP	NN	O	adp	nn	40	SENT_21	[p1l1240t2723r1420b2785],
39	receptor	NN	O	receptor	nn	40	SENT_21	[p1l1438t2732r1719b2802],
40	P2Y12	NN	O	p2y12	prep_to	33	SENT_21	[p1l1737t2725r1969b2785],
41	[	CD	NUMBER	[	number	42	SENT_21	[p1l1991t2724r2146b2801],
42	3,4	CD	NUMBER	3,4	num	43	SENT_21	[p1l1991t2724r2146b2801],
43	]	NN	O	]	dep	40	SENT_21	[p1l1991t2724r2146b2801],
44	.	.	O	.	_	0	SENT_21	[p1l1991t2724r2146b2801],

1	The	DT	O	the	det	2	SENT_22	[p1l9t2830r141b2892],
2	conversion	NN	O	conversion	nsubjpass	11	SENT_22	[p1l162t2830r533b2892],
3	of	IN	O	of	_	0	SENT_22	[p1l554t2830r630b2892],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_22	[p1l643t2830r1024b2909],
5	to	TO	O	to	_	0	SENT_22	[p1l1045t2838r1112b2892],
6	the	DT	O	the	det	8	SENT_22	[p1l1135t2830r1239b2892],
7	active	JJ	O	active	amod	8	SENT_22	[p1l1261t2830r1455b2892],
8	metabolite	NN	O	metabolite	prep_to	4	SENT_22	[p1l1475t2830r1836b2892],
9	has	VBZ	O	have	aux	11	SENT_22	[p1l1858t2830r1970b2892],
10	been	VBN	O	be	auxpass	11	SENT_22	[p1l1992t2830r2150b2892],
11	reported	VBN	O	report	_	0	SENT_22	[p1l9t2937r299b3016],
12	to	TO	O	to	aux	18	SENT_22	[p1l335t2946r402b3000],
13	be	VB	O	be	cop	18	SENT_22	[p1l441t2937r518b2999],
14	a	DT	O	a	det	18	SENT_22	[p1l556t2957r594b3000],
15	two-step	JJ	O	two-step	amod	18	SENT_22	[p1l630t2946r938b3016],
16	,	,	O	,	_	0	SENT_22	[p1l630t2946r938b3016],
17	CYP-dependent	JJ	O	cyp-dependent	amod	18	SENT_22	[p1l979t2937r1529b3016],
18	process	NN	O	process	xcomp	11	SENT_22	[p1l1563t2957r1830b3016],
19	.	.	O	.	_	0	SENT_22	[p1l1563t2957r1830b3016],

1	In	IN	O	in	_	0	SENT_23	[p1l1872t2940r1944b2999],
2	these	DT	O	these	det	3	SENT_23	[p1l1981t2937r2150b2999],
3	steps	NNS	O	step	prep_in	16	SENT_23	[p1l11t3053r192b3124],
4	,	,	O	,	_	0	SENT_23	[p1l11t3053r192b3124],
5	CYP2Cl9	NN	O	cyp2cl9	conj_and	3	SENT_23	[p1l218t3046r584b3120],
6	,	,	O	,	_	0	SENT_23	[p1l218t3046r584b3120],
7	1A2	NN	O	1a2	conj_and	3	SENT_23	[p1l617t3045r768b3120],
8	,	,	O	,	_	0	SENT_23	[p1l617t3045r768b3120],
9	2B6	NN	O	2b6	conj_and	3	SENT_23	[p1l794t3046r944b3120],
10	,	,	O	,	_	0	SENT_23	[p1l794t3046r944b3120],
11	2C9	NN	O	2c9	conj_and	3	SENT_23	[p1l970t3046r1105b3107],
12	and	CC	O	and	_	0	SENT_23	[p1l1130t3045r1256b3107],
13	3A4/5	NN	O	3a4/5	conj_and	3	SENT_23	[p1l1281t3045r1484b3124],
14	may	MD	O	may	aux	16	SENT_23	[p1l1506t3065r1655b3124],
15	be	VB	O	be	auxpass	16	SENT_23	[p1l1676t3045r1754b3107],
16	involved	VBN	O	involve	_	0	SENT_23	[p1l1775t3045r2066b3107],
17	in	IN	O	in	_	0	SENT_23	[p1l2086t3045r2151b3106],
18	the	DT	O	the	det	19	SENT_23	[p1l9t3151r113b3214],
19	activation	NN	O	activation	prep_in	16	SENT_23	[p1l166t3152r504b3214],
20	of	IN	O	of	_	0	SENT_23	[p1l557t3152r633b3214],
21	clopidogrel	NN	O	clopidogrel	prep_of	19	SENT_23	[p1l677t3151r1058b3231],
22	[	CD	NUMBER	[	num	21	SENT_23	[p1l1112t3153r1267b3230],
23	5,6	CD	NUMBER	5,6	num	24	SENT_23	[p1l1112t3153r1267b3230],
24	]	NN	O	]	nsubjpass	16	SENT_23	[p1l1112t3153r1267b3230],
25	.	.	O	.	_	0	SENT_23	[p1l1112t3153r1267b3230],

1	Kim	NNP	PERSON	Kim	nsubj	8	SENT_24	[p1l1325t3152r1479b3213],
2	et	FW	O	et	nn	4	SENT_24	[p1l1531t3164r1591b3214],
3	al.	FW	O	al.	nn	4	SENT_24	[p1l1620t3152r1696b3214],
4	[	FW	O	[	dep	1	SENT_24	[p1l1755t3153r1830b3230],
5	7	CD	NUMBER	7	num	6	SENT_24	[p1l1755t3153r1830b3230],
6	]	NN	O	]	npadvmod	7	SENT_24	[p1l1755t3153r1830b3230],
7	recently	RB	DATE	recently	advmod	4	SENT_24	[p1l1885t3152r2151b3230],
8	reported	VBD	O	report	_	0	SENT_24	[p1l9t3258r299b3337],
9	that	IN	O	that	complm	13	SENT_24	[p1l328t3258r464b3321],
10	the	DT	O	the	det	12	SENT_24	[p1l491t3258r595b3320],
11	CYP2Cl9	NN	O	cyp2cl9	nn	12	SENT_24	[p1l625t3259r971b3321],
12	polymorphism	NN	O	polymorphism	nsubj	20	SENT_24	[p1l1000t3258r1502b3337],
13	affects	VBZ	O	affect	ccomp	8	SENT_24	[p1l1531t3258r1746b3321],
14	the	DT	O	the	det	16	SENT_24	[p1l1776t3258r1880b3320],
15	plasma	NN	O	plasma	nn	16	SENT_24	[p1l1906t3258r2151b3337],
16	levels	NNS	O	level	dobj	13	SENT_24	[p1l9t3366r189b3428],
17	of	IN	O	of	_	0	SENT_24	[p1l245t3366r321b3428],
18	clopidogrel	NN	O	clopidogrel	prep_of	16	SENT_24	[p1l365t3366r746b3445],
19	and	CC	O	and	_	0	SENT_24	[p1l800t3366r928b3428],
20	modulates	VBZ	O	modulate	ccomp	8	SENT_24	[p1l979t3366r1333b3428],
21	its	PRP$	O	its	poss	23	SENT_24	[p1l1386t3366r1462b3428],
22	antiplatelet	JJ	O	antiplatelet	amod	23	SENT_24	[p1l1517t3366r1896b3445],
23	effect	NN	O	effect	dobj	20	SENT_24	[p1l1948t3366r2146b3428],
24	.	.	O	.	_	0	SENT_24	[p1l1948t3366r2146b3428],

1	However	RB	O	however	advmod	6	SENT_25	[p1l10t3475r338b3548],
2	,	,	O	,	_	0	SENT_25	[p1l10t3475r338b3548],
3	they	PRP	O	they	nsubj	6	SENT_25	[p1l369t3472r514b3551],
4	did	VBD	O	do	aux	6	SENT_25	[p1l542t3472r650b3535],
5	not	RB	O	not	neg	6	SENT_25	[p1l678t3481r793b3535],
6	measure	VB	O	measure	_	0	SENT_25	[p1l819t3493r1103b3535],
7	the	DT	O	the	det	8	SENT_25	[p1l1131t3472r1235b3535],
8	metabolite	NN	O	metabolite	dobj	6	SENT_25	[p1l1262t3472r1623b3535],
9	of	IN	O	of	_	0	SENT_25	[p1l1653t3473r1730b3535],
10	clopidogrel	NN	O	clopidogrel	prep_of	8	SENT_25	[p1l1749t3472r2146b3552],
11	.	.	O	.	_	0	SENT_25	[p1l1749t3472r2146b3552],

1	Therefore	RB	O	therefore	advmod	5	SENT_26	[p1l9t3579r362b3654],
2	,	,	O	,	_	0	SENT_26	[p1l9t3579r362b3654],
3	it	PRP	O	it	nsubj	5	SENT_26	[p1l396t3579r442b3641],
4	remains	VBZ	O	remain	cop	5	SENT_26	[p1l473t3579r740b3642],
5	unresolved	JJ	O	unresolved	_	0	SENT_26	[p1l772t3579r1142b3642],
6	whether	IN	O	whether	complm	18	SENT_26	[p1l1172t3579r1448b3642],
7	the	DT	O	the	det	9	SENT_26	[p1l1478t3579r1581b3641],
8	plasma	NN	O	plasma	nn	9	SENT_26	[p1l1612t3579r1857b3658],
9	concentration	NN	O	concentration	nsubjpass	18	SENT_26	[p1l1887t3599r2150b3642, p1l9t3686r242b3748],
10	of	IN	O	of	_	0	SENT_26	[p1l270t3686r345b3748],
11	the	DT	O	the	det	13	SENT_26	[p1l364t3686r468b3748],
12	active	JJ	O	active	amod	13	SENT_26	[p1l496t3686r690b3748],
13	metabolite	NN	O	metabolite	prep_of	9	SENT_26	[p1l715t3686r1076b3748],
14	of	IN	O	of	_	0	SENT_26	[p1l1105t3686r1181b3748],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_26	[p1l1199t3686r1579b3765],
16	may	MD	O	may	aux	18	SENT_26	[p1l1605t3706r1753b3765],
17	be	VB	O	be	auxpass	18	SENT_26	[p1l1779t3686r1857b3748],
18	affected	VBN	O	affect	ccomp	5	SENT_26	[p1l1885t3686r2150b3748],

1	Correspondence	NN	O	correspondence	_	0	SENT_27	[p2l10t134r516b201],
2	:	:	O	:	_	0	SENT_27	[p2l10t134r516b201],
3	Kazuo	NNP	PERSON	Kazuo	nn	4	SENT_27	[p2l564t136r764b187],
4	Umemura	NNP	PERSON	Umemura	dep	1	SENT_27	[p2l810t136r1133b197],
5	,	,	O	,	_	0	SENT_27	[p2l810t136r1133b197],
6	Department	NNP	ORGANIZATION	Department	appos	1	SENT_27	[p2l1180t136r1546b201],
7	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l1591t134r1657b187],
8	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_of	6	SENT_27	[p2l1694t134r2149b201],
9	,	,	O	,	_	0	SENT_27	[p2l1694t134r2149b201],
10	Hamamatsu	NNP	ORGANIZATION	Hamamatsu	nn	12	SENT_27	[p2l9t228r381b279],
11	University	NNP	ORGANIZATION	University	nn	12	SENT_27	[p2l430t227r745b293],
12	School	NNP	ORGANIZATION	School	appos	1	SENT_27	[p2l796t226r999b279],
13	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l1049t226r1115b279],
14	Medicine	NNP	ORGANIZATION	Medicine	prep_of	12	SENT_27	[p2l1158t226r1452b290],
15	,	,	O	,	_	0	SENT_27	[p2l1158t226r1452b290],
16	1-20-1	CD	NUMBER	1-20-1	appos	1	SENT_27	[p2l1511t228r1709b290],
17	,	,	O	,	_	0	SENT_27	[p2l1511t228r1709b290],
18	Handayama	NN	LOCATION	handayama	appos	1	SENT_27	[p2l1761t226r2149b293],
19	,	,	O	,	_	0	SENT_27	[p2l1761t226r2149b293],
20	Higashi-ku	NN	O	higashi-ku	appos	1	SENT_27	[p2l9t318r360b385],
21	,	,	O	,	_	0	SENT_27	[p2l9t318r360b385],
22	Hamamatsu	NNP	LOCATION	Hamamatsu	appos	1	SENT_27	[p2l390t320r762b371],
23	431-3192	CD	NUMBER	431-3192	num	22	SENT_27	[p2l787t319r1075b381],
24	,	,	O	,	_	0	SENT_27	[p2l787t319r1075b381],
25	Japan	NNP	LOCATION	Japan	appos	1	SENT_27	[p2l1104t320r1298b385],
26	.	.	O	.	_	0	SENT_27	[p2l1104t320r1298b385],

1	Tel.	NNP	O	Tel.	_	0	SENT_28	[p2l9t410r258b477],
2	/	:	O	/	punct	3	SENT_28	[p2l9t410r258b477],
3	fax	NN	O	fax	dep	1	SENT_28	[p2l9t410r258b477],
4	:	:	O	:	_	0	SENT_28	[p2l9t410r258b477],
5	+81 53 435 2269	CD	NUMBER	+81 53 435 2269	dep	3	SENT_28	[p2l681t412r836b463],[p2l301t412r421b463],
6	.	.	O	.	_	0	SENT_28	[p2l681t412r836b463],

1	E-mail	NN	O	e-mail	_	0	SENT_29	[p2l10t502r226b555],
2	:	:	O	:	_	0	SENT_29	[p2l10t502r226b555],
3	umemura@hama-med.ac.jp	NN	O	umemura@hama-med.ac.jp	dep	1	SENT_29	[p2l256t502r1100b569],

1	DOI	NNP	O	DOI	_	0	SENT_30	[p2l9t700r162b752],
2	:	:	O	:	_	0	SENT_30	[p2l9t700r162b752],
3	10.1111	CD	NUMBER	10.1111	dep	1	SENT_30	[p2l200t699r1210b766],
4	/	:	O	/	punct	3	SENT_30	[p2l200t699r1210b766],
5	j.1538-7836	CD	DURATION	j.1538-7836	num	6	SENT_30	[p2l200t699r1210b766],
6	.2008.03050	CD	NUMBER	.2008.03050	dep	3	SENT_30	[p2l200t699r1210b766],
7	.	.	O	.	_	0	SENT_30	[p2l200t699r1210b766],

1	X	NN	O	x	_	0	SENT_31	[p2l200t699r1210b766],

1	Received	VBN	O	receive	_	0	SENT_32	[p2l11t896r270b948],
2	14	CD	DATE	14	dobj	1	SENT_32	[p2l300t897r360b947],
3	May	NNP	DATE	May	tmod	1	SENT_32	[p2l384t897r519b962],
4	2008	CD	DATE	2008	num	3	SENT_32	[p2l542t897r692b959],
5	,	,	O	,	_	0	SENT_32	[p2l542t897r692b959],
6	accepted	VBN	O	accept	partmod	1	SENT_32	[p2l719t896r967b962],
7	22	CD	DATE	22	dobj	6	SENT_32	[p2l991t897r1057b947],
8	May	NNP	DATE	May	tmod	6	SENT_32	[p2l1081t897r1217b962],
9	2008	CD	DATE	2008	num	8	SENT_32	[p2l1240t897r1389b948],
10	.	.	O	.	_	0	SENT_32	[p2l1240t897r1389b948],

1	©	RB	O	©	advmod	2	SENT_33	[p2l10t1113r61b1163],
2	2008	CD	DATE	2008	_	0	SENT_33	[p2l90t1112r227b1163],
3	International	NNP	ORGANIZATION	International	nn	4	SENT_33	[p2l256t1111r653b1163],
4	Society	NNP	ORGANIZATION	Society	dep	2	SENT_33	[p2l683t1111r898b1176],
5	on	IN	O	on	_	0	SENT_33	[p2l925t1128r1000b1163],
6	Thrombosis	NNP	O	Thrombosis	prep_on	4	SENT_33	[p2l1027t1110r1388b1163],
7	and	CC	O	and	_	0	SENT_33	[p2l1417t1110r1527b1163],
8	Haemostasis	NNP	PERSON	Haemostasis	prep_on	4	SENT_33	[p2l1555t1111r1935b1163],
9	by	IN	O	by	_	0	SENT_33	[p2l7t1207r91b1285],
10	the	DT	O	the	det	13	SENT_33	[p2l112t1207r215b1269],
11	CYP	NN	O	cyp	nn	13	SENT_33	[p2l238t1208r406b1269],
12	2Cl9	NN	O	2cl9	nn	13	SENT_33	[p2l427t1208r603b1269],
13	polymorphism	NN	O	polymorphism	prep_by	4	SENT_33	[p2l624t1207r1141b1285],
14	.	.	O	.	_	0	SENT_33	[p2l624t1207r1141b1285],

1	In	IN	O	in	_	0	SENT_34	[p2l1168t1210r1240b1268],
2	this	DT	O	this	det	3	SENT_34	[p2l1262t1207r1380b1269],
3	study	NN	O	study	prep_in	6	SENT_34	[p2l1404t1207r1605b1285],
4	,	,	O	,	_	0	SENT_34	[p2l1404t1207r1605b1285],
5	we	PRP	O	we	nsubj	6	SENT_34	[p2l1628t1227r1721b1269],
6	investigated	VBD	O	investigate	_	0	SENT_34	[p2l1742t1207r2145b1285],
7	whether	IN	O	whether	complm	13	SENT_34	[p2l6t1313r280b1374],
8	the	DT	O	the	det	9	SENT_34	[p2l329t1313r432b1374],
9	polymorphism	NN	O	polymorphism	nsubj	13	SENT_34	[p2l480t1313r982b1391],
10	of	IN	O	of	_	0	SENT_34	[p2l1032t1313r1108b1374],
11	CYP2Cl9	NN	O	cyp2cl9	prep_of	9	SENT_34	[p2l1149t1314r1495b1375],
12	would	MD	O	would	aux	13	SENT_34	[p2l1544t1313r1757b1374],
13	affect	VB	O	affect	ccomp	6	SENT_34	[p2l1807t1313r1993b1374],
14	the	DT	O	the	det	15	SENT_34	[p2l2041t1313r2145b1374],
15	formation	NN	O	formation	dobj	13	SENT_34	[p2l7t1419r351b1481],
16	of	IN	O	of	_	0	SENT_34	[p2l385t1419r461b1481],
17	the	DT	O	the	det	19	SENT_34	[p2l486t1419r590b1481],
18	active	JJ	O	active	amod	19	SENT_34	[p2l624t1419r818b1481],
19	metabolite	NN	O	metabolite	prep_of	15	SENT_34	[p2l850t1419r1210b1481],
20	and	CC	O	and	_	0	SENT_34	[p2l1245t1419r1371b1481],
21	hence	RB	O	hence	advmod	24	SENT_34	[p2l1404t1419r1596b1481],
22	the	DT	O	the	det	24	SENT_34	[p2l1630t1419r1733b1481],
23	antiplatelet	JJ	O	antiplatelet	amod	24	SENT_34	[p2l1768t1419r2146b1497],
24	effects	NNS	O	effect	dobj	13	SENT_34	[p2l7t1526r218b1587],
25	in	IN	O	in	_	0	SENT_34	[p2l246t1526r310b1586],
26	healthy	JJ	O	healthy	amod	27	SENT_34	[p2l337t1526r588b1604],
27	subjects	NNS	O	subject	prep_in	24	SENT_34	[p2l617t1526r896b1604],
28	.	.	O	.	_	0	SENT_34	[p2l617t1526r896b1604],

1	Written	VBN	O	write	csubjpass	5	SENT_35	[p2l91t1632r356b1693],
2	informed	JJ	O	informed	amod	3	SENT_35	[p2l433t1631r746b1693],
3	consent	NN	O	consent	dobj	1	SENT_35	[p2l824t1640r1084b1693],
4	was	VBD	O	be	auxpass	5	SENT_35	[p2l1161t1652r1289b1693],
5	obtained	VBN	O	obtain	_	0	SENT_35	[p2l1370t1631r1667b1693],
6	from	IN	O	from	_	0	SENT_35	[p2l1746t1632r1914b1693],
7	each	DT	O	each	det	8	SENT_35	[p2l1992t1631r2146b1693],
8	subject	NN	O	subject	prep_from	5	SENT_35	[p2l9t1737r258b1815],
9	.	.	O	.	_	0	SENT_35	[p2l9t1737r258b1815],

1	The	DT	O	the	det	2	SENT_36	[p2l311t1737r443b1799],
2	protocol	NN	O	protocol	nsubjpass	4	SENT_36	[p2l490t1737r780b1815],
3	was	VBD	O	be	auxpass	4	SENT_36	[p2l827t1757r955b1799],
4	approved	VBN	O	approve	_	0	SENT_36	[p2l1005t1737r1327b1815],
5	by	IN	O	by	_	0	SENT_36	[p2l1375t1737r1459b1815],
6	the	DT	O	the	det	10	SENT_36	[p2l1506t1737r1610b1799],
7	Human	JJ	ORGANIZATION	human	amod	10	SENT_36	[p2l1658t1740r1921b1799],
8	Institutional	JJ	ORGANIZATION	institutional	amod	10	SENT_36	[p2l1970t1737r2144b1799, p2l7t1843r274b1904],
9	Review	NNP	ORGANIZATION	Review	nn	10	SENT_36	[p2l312t1843r562b1904],
10	Board	NNP	ORGANIZATION	Board	agent	4	SENT_36	[p2l600t1843r811b1904],
11	of	IN	ORGANIZATION	of	_	0	SENT_36	[p2l850t1843r925b1904],
12	Hamamatsu	NNP	ORGANIZATION	Hamamatsu	nn	14	SENT_36	[p2l954t1845r1378b1904],
13	University	NNP	ORGANIZATION	University	nn	14	SENT_36	[p2l1415t1843r1770b1921],
14	School	NNP	ORGANIZATION	School	prep_of	10	SENT_36	[p2l1809t1843r2039b1905],
15	of	IN	ORGANIZATION	of	_	0	SENT_36	[p2l2078t1843r2154b1904],
16	Medicine	NNP	ORGANIZATION	Medicine	prep_of	14	SENT_36	[p2l8t1949r340b2025],
17	,	,	O	,	_	0	SENT_36	[p2l8t1949r340b2025],
18	Hamamatsu	NNP	ORGANIZATION	Hamamatsu	nn	20	SENT_36	[p2l381t1952r821b2025],
19	,	,	O	,	_	0	SENT_36	[p2l381t1952r821b2025],
20	Japan	NNP	LOCATION	Japan	appos	16	SENT_36	[p2l861t1952r1080b2029],
21	.	.	O	.	_	0	SENT_36	[p2l861t1952r1080b2029],

1	Three	CD	NUMBER	three	num	3	SENT_37	[p2l1123t1950r1320b2012],
2	hundred	CD	NUMBER	hundred	num	3	SENT_37	[p2l1357t1949r1643b2012],
3	milligrams	NNS	O	milligram	nsubjpass	14	SENT_37	[p2l1679t1950r2038b2029],
4	of	IN	O	of	_	0	SENT_37	[p2l2078t1950r2154b2012],
5	clopidogrel	NN	O	clopidogrel	nn	7	SENT_37	[p2l7t2056r387b2134],
6	(	CD	NUMBER	(	num	7	SENT_37	[p2l426t2056r972b2134],
7	Sanoﬁ-Aventis	NNP	O	Sanoﬁ-Aventis	prep_of	3	SENT_37	[p2l426t2056r972b2134],
8	,	,	O	,	_	0	SENT_37	[p2l426t2056r972b2134],
9	Tokyo	NNP	LOCATION	Tokyo	appos	7	SENT_37	[p2l1013t2056r1258b2134],
10	,	,	O	,	_	0	SENT_37	[p2l1013t2056r1258b2134],
11	Japan	NNP	LOCATION	Japan	nn	12	SENT_37	[p2l1298t2056r1527b2134],
12	)	NN	O	)	appos	9	SENT_37	[p2l1298t2056r1527b2134],
13	was	VBD	O	be	auxpass	14	SENT_37	[p2l1566t2076r1693b2118],
14	given	VBN	O	give	_	0	SENT_37	[p2l1733t2056r1911b2134],
15	orally	RB	O	orally	advmod	14	SENT_37	[p2l1951t2056r2145b2134],
16	to	TO	O	to	_	0	SENT_37	[p2l7t2170r74b2223],
17	47	CD	NUMBER	47	num	18	SENT_37	[p2l122t2163r200b2224],
18	subjects	NNS	O	subject	prep_to	14	SENT_37	[p2l250t2162r529b2240],
19	.	.	O	.	_	0	SENT_37	[p2l250t2162r529b2240],

1	Venous	JJ	O	venous	amod	3	SENT_38	[p2l579t2164r836b2223],
2	blood	NN	O	blood	nn	3	SENT_38	[p2l883t2162r1081b2223],
3	samples	NNS	O	sample	nsubjpass	14	SENT_38	[p2l1129t2162r1394b2240],
4	for	IN	O	for	_	0	SENT_38	[p2l1441t2162r1541b2223],
5	determining	VBG	O	determine	prepc_for	3	SENT_38	[p2l1587t2162r1995b2240],
6	the	DT	O	the	det	8	SENT_38	[p2l2041t2162r2144b2223],
7	plasma	NN	O	plasma	nn	8	SENT_38	[p2l6t2268r250b2346],
8	concentrations	NNS	O	concentration	dobj	5	SENT_38	[p2l334t2268r834b2330],
9	of	IN	O	of	_	0	SENT_38	[p2l922t2268r998b2330],
10	the	DT	O	the	det	12	SENT_38	[p2l1075t2268r1178b2330],
11	active	JJ	O	active	amod	12	SENT_38	[p2l1264t2268r1458b2330],
12	metabolite	NN	O	metabolite	prep_of	8	SENT_38	[p2l1542t2268r1903b2330],
13	were	VBD	O	be	auxpass	14	SENT_38	[p2l1986t2288r2145b2330],
14	obtained	VBN	O	obtain	conj_and	14	SENT_38	[p2l9t2375r306b2436],
15	before	IN	O	before	_	0	SENT_38	[p2l359t2375r573b2436],
16	and	CC	O	and	_	0	SENT_38	[p2l627t2375r753b2436],
17	at	IN	O	at	_	0	SENT_38	[p2l807t2383r872b2436],
18	0.25	CD	NUMBER	0.25	prep_before	14	SENT_38	[p2l924t2376r1081b2449],
19	,	,	O	,	_	0	SENT_38	[p2l924t2376r1081b2449],
20	0.5	CD	NUMBER	0.5	conj_and	18	SENT_38	[p2l1137t2377r1253b2449],
21	,	,	O	,	_	0	SENT_38	[p2l1137t2377r1253b2449],
22	1	CD	NUMBER	1	prep_before	14	SENT_38	[p2l1317t2376r1366b2449],
23	,	,	O	,	_	0	SENT_38	[p2l1317t2376r1366b2449],
24	2	CD	NUMBER	2	prep_before	14	SENT_38	[p2l1422t2376r1478b2449],
25	,	,	O	,	_	0	SENT_38	[p2l1422t2376r1478b2449],
26	4	CD	NUMBER	4	conj_and	18	SENT_38	[p2l1533t2376r1589b2449],
27	,	,	O	,	_	0	SENT_38	[p2l1533t2376r1589b2449],
28	and	CC	NUMBER	and	_	0	SENT_38	[p2l1646t2375r1773b2436],
29	8	CD	NUMBER	8	num	30	SENT_38	[p2l1828t2377r1861b2436],
30	h	NN	O	h	conj_and	18	SENT_38	[p2l1894t2375r1938b2435],
31	after	IN	O	after	_	0	SENT_38	[p2l1990t2375r2146b2436],
32	dosing	NN	O	dosing	prep_after	14	SENT_38	[p2l8t2480r247b2560],
33	.	.	O	.	_	0	SENT_38	[p2l8t2480r247b2560],

1	The	DT	O	the	det	3	SENT_39	[p2l298t2480r430b2543],
2	plasma	NN	O	plasma	nn	3	SENT_39	[p2l475t2481r719b2560],
3	concentration	NN	O	concentration	nsubjpass	9	SENT_39	[p2l764t2481r1234b2543],
4	of	IN	O	of	_	0	SENT_39	[p2l1282t2481r1357b2543],
5	the	DT	O	the	det	7	SENT_39	[p2l1395t2480r1498b2543],
6	active	JJ	O	active	amod	7	SENT_39	[p2l1545t2481r1740b2543],
7	metabolite	NN	O	metabolite	prep_of	3	SENT_39	[p2l1784t2480r2145b2543],
8	was	VBD	O	be	auxpass	9	SENT_39	[p2l6t2607r134b2649],
9	determined	VBN	O	determine	_	0	SENT_39	[p2l204t2587r586b2649],
10	using	VBG	O	use	xcomp	9	SENT_39	[p2l654t2587r835b2665],
11	validated	VBN	O	validate	dep	10	SENT_39	[p2l902t2587r1214b2649],
12	liquid	JJ	O	liquid	amod	16	SENT_39	[p2l1283t2587r1478b2665],
13	chromatographytandem	NN	O	chromatographytandem	nn	16	SENT_39	[p2l1546t2587r2144b2665, p2l7t2693r264b2754],
14	mass	NN	O	mass	nn	16	SENT_39	[p2l310t2713r478b2754],
15	spectrometry	NN	O	spectrometry	nn	16	SENT_39	[p2l528t2701r971b2771],
16	methods	NNS	O	method	dobj	11	SENT_39	[p2l1017t2693r1309b2754],
17	with	IN	O	with	_	0	SENT_39	[p2l1356t2693r1507b2754],
18	a	DT	O	a	det	20	SENT_39	[p2l1554t2713r1592b2754],
19	lower	JJR	O	lower	amod	20	SENT_39	[p2l1639t2693r1828b2754],
20	limit	NN	O	limit	prep_with	11	SENT_39	[p2l1874t2693r2030b2754],
21	of	IN	O	of	_	0	SENT_39	[p2l2079t2693r2154b2754],
22	quantitation	NN	O	quantitation	prep_of	20	SENT_39	[p2l8t2800r429b2878],
23	of	IN	O	of	_	0	SENT_39	[p2l480t2800r556b2862],
24	0.5	CD	NUMBER	0.5	num	26	SENT_39	[p2l597t2802r693b2862],
25	ng	NN	O	ng	nn	26	SENT_39	[p2l725t2820r810b2879],
26	mL	NN	O	ml	prep_of	22	SENT_39	[p2l838t2783r1045b2875],
27	'	''	O	'	_	0	SENT_39	[p2l838t2783r1045b2875],
28	1	CD	NUMBER	1	dep	20	SENT_39	[p2l838t2783r1045b2875],
29	,	,	O	,	_	0	SENT_39	[p2l838t2783r1045b2875],
30	as	IN	O	as	mark	32	SENT_39	[p2l1098t2820r1166b2862],
31	previously	RB	DATE	previously	advmod	32	SENT_39	[p2l1214t2800r1566b2879],
32	described	VBN	O	describe	dep	28	SENT_39	[p2l1615t2799r1934b2862],
33	[	CD	NUMBER	[	number	34	SENT_39	[p2l1986t2801r2140b2878],
34	6,8	CD	NUMBER	6,8	num	35	SENT_39	[p2l1986t2801r2140b2878],
35	]	NN	O	]	dobj	32	SENT_39	[p2l1986t2801r2140b2878],
36	.	.	O	.	_	0	SENT_39	[p2l1986t2801r2140b2878],

1	The	DT	O	the	det	2	SENT_40	[p2l7t2906r139b2968],
2	area	NN	O	area	nsubjpass	26	SENT_40	[p2l214t2926r358b2968],
3	under	IN	O	under	prep	2	SENT_40	[p2l431t2906r630b2968],
4	the	DT	O	the	det	6	SENT_40	[p2l703t2906r806b2968],
5	plasma	NN	O	plasma	nn	6	SENT_40	[p2l879t2906r1123b2984],
6	concentration	NN	O	concentration	dep	12	SENT_40	[p2l1197t2906r1857b2968],
7	—	CD	NUMBER	—	num	9	SENT_40	[p2l1197t2906r1857b2968],
8	time	NN	O	time	nn	9	SENT_40	[p2l1197t2906r1857b2968],
9	curves	NNS	O	curve	dep	6	SENT_40	[p2l1931t2926r2144b2968],
10	(	CD	NUMBER	(	num	11	SENT_40	[p2l9t3012r246b3090],
11	AUC	NN	O	auc	dep	12	SENT_40	[p2l9t3012r246b3090],
12	)	CD	NUMBER	)	dep	3	SENT_40	[p2l9t3012r246b3090],
13	from	IN	O	from	_	0	SENT_40	[p2l294t3012r463b3073],
14	o	NN	O	o	prep_from	12	SENT_40	[p2l510t3014r547b3074],
15	to	TO	O	to	_	0	SENT_40	[p2l596t3020r663b3073],
16	8	CD	NUMBER	8	num	17	SENT_40	[p2l715t3014r748b3073],
17	h	NN	O	h	prep_to	14	SENT_40	[p2l781t3012r824b3073],
18	and	CC	O	and	_	0	SENT_40	[p2l872t3012r999b3073],
19	the	DT	O	the	det	24	SENT_40	[p2l1047t3012r1150b3073],
20	peak	NN	O	peak	nn	24	SENT_40	[p2l1197t3012r1362b3090],
21	concentration	NN	O	concentration	nn	24	SENT_40	[p2l1409t3012r1880b3073],
22	(	CD	NUMBER	(	num	24	SENT_40	[p2l1928t3012r2144b3090],
23	Cmax	NN	O	cmax	nn	24	SENT_40	[p2l1928t3012r2144b3090],
24	)	NN	O	)	prep_to	14	SENT_40	[p2l1928t3012r2144b3090],
25	were	VBD	O	be	auxpass	26	SENT_40	[p2l6t3138r164b3180],
26	derived	VBN	O	derive	_	0	SENT_40	[p2l217t3118r465b3180],
27	using	VBG	O	use	xcomp	26	SENT_40	[p2l515t3118r696b3196],
28	non-compartmental	JJ	O	non-compartmental	amod	29	SENT_40	[p2l746t3118r1428b3196],
29	methods	NNS	O	method	dobj	27	SENT_40	[p2l1479t3118r1770b3180],
30	from	IN	O	from	_	0	SENT_40	[p2l1823t3118r1991b3180],
31	the	DT	O	the	det	35	SENT_40	[p2l2042t3118r2145b3180],
32	concentration	NN	O	concentration	nn	35	SENT_40	[p2l7t3225r652b3286],
33	—	CD	NUMBER	—	num	35	SENT_40	[p2l7t3225r652b3286],
34	time	NN	O	time	nn	35	SENT_40	[p2l7t3225r652b3286],
35	data	NNS	O	datum	prep_from	27	SENT_40	[p2l687t3225r853b3286],
36	.	.	O	.	_	0	SENT_40	[p2l687t3225r853b3286],

1	AUC	NN	O	auc	nn	2	SENT_41	[p2l891t3225r1079b3286],
2	values	NNS	O	value	nsubjpass	4	SENT_41	[p2l1113t3225r1323b3286],
3	were	VBD	O	be	auxpass	4	SENT_41	[p2l1356t3245r1515b3286],
4	calculated	VBN	O	calculate	_	0	SENT_41	[p2l1549t3225r1890b3286],
5	by	IN	O	by	_	0	SENT_41	[p2l1924t3225r2008b3303],
6	the	DT	O	the	det	9	SENT_41	[p2l2042t3225r2145b3286],
7	linear	JJ	O	linear	amod	9	SENT_41	[p2l7t3331r198b3393],
8	trapezoidal	NN	O	trapezoidal	nn	9	SENT_41	[p2l265t3330r646b3410],
9	method	NN	O	method	agent	4	SENT_41	[p2l712t3330r991b3393],
10	.	.	O	.	_	0	SENT_41	[p2l712t3330r991b3393],

1	Venous	JJ	O	venous	amod	3	SENT_42	[p2l1062t3333r1319b3393],
2	blood	NN	O	blood	nn	3	SENT_42	[p2l1387t3330r1585b3393],
3	samples	NNS	O	sample	nsubjpass	5	SENT_42	[p2l1655t3331r1920b3410],
4	were	VBD	O	be	auxpass	5	SENT_42	[p2l1987t3351r2145b3393],
5	taken	VBN	O	take	_	0	SENT_42	[p2l7t3437r196b3499],
6	into	IN	O	into	_	0	SENT_42	[p2l231t3437r364b3499],
7	1	CD	NUMBER	1	prep_into	5	SENT_42	[p2l409t3437r465b3515],
8	/	:	O	/	punct	14	SENT_42	[p2l409t3437r465b3515],
9	10th	JJ	ORDINAL	10th	amod	10	SENT_42	[p2l476t3437r618b3499],
10	volume	NN	O	volume	dep	14	SENT_42	[p2l651t3437r904b3499],
11	3.2	CD	PERCENT	3.2	num	14	SENT_42	[p2l942t3438r1115b3500],
12	%	NN	PERCENT	%	nn	14	SENT_42	[p2l942t3438r1115b3500],
13	trisodium	NN	O	trisodium	nn	14	SENT_42	[p2l1157t3437r1486b3499],
14	citrate	NN	O	citrate	conj_and	14	SENT_42	[p2l1521t3437r1733b3499],
15	before	IN	O	before	_	0	SENT_42	[p2l1768t3437r1982b3499],
16	and	CC	O	and	_	0	SENT_42	[p2l2019t3437r2146b3499],
17	at	IN	O	at	_	0	SENT_42	[p2l8t3551r73b3604],
18	1	CD	NUMBER	1	prep_before	14	SENT_42	[p2l128t3545r176b3617],
19	,	,	O	,	_	0	SENT_42	[p2l128t3545r176b3617],
20	4	CD	NUMBER	4	prep_into	5	SENT_42	[p2l227t3544r284b3617],
21	,	,	O	,	_	0	SENT_42	[p2l227t3544r284b3617],
22	6	CD	NUMBER	6	prep_into	5	SENT_42	[p2l337t3545r373b3604],
23	and	CC	O	and	_	0	SENT_42	[p2l423t3543r549b3604],
24	24	CD	NUMBER	24	num	25	SENT_42	[p2l598t3544r677b3604],
25	h	NN	O	h	prep_into	5	SENT_42	[p2l707t3543r750b3604],
26	after	IN	O	after	_	0	SENT_42	[p2l798t3543r954b3604],
27	dosing	NN	O	dosing	prep_after	5	SENT_42	[p2l1002t3543r1226b3621],
28	for	IN	O	for	_	0	SENT_42	[p2l1273t3543r1374b3604],
29	the	DT	O	the	det	30	SENT_42	[p2l1421t3543r1524b3604],
30	measurement	NN	O	measurement	prep_for	27	SENT_42	[p2l1571t3551r2028b3604],
31	of	IN	O	of	_	0	SENT_42	[p2l2078t3543r2153b3604],
32	inhibition	NN	O	inhibition	prep_of	30	SENT_42	[p2l7t3649r338b3712],
33	of	IN	O	of	_	0	SENT_42	[p2l380t3650r456b3712],
34	platelet	NN	O	platelet	nn	35	SENT_42	[p2l486t3650r735b3729],
35	aggregation	NN	O	aggregation	prep_of	32	SENT_42	[p2l775t3650r1176b3729],
36	to	TO	O	to	_	0	SENT_42	[p2l1216t3658r1283b3712],
37	ADP	NN	O	adp	prep_to	5	SENT_42	[p2l1324t3650r1519b3712],
38	.	.	O	.	_	0	SENT_42	[p2l1324t3650r1519b3712],

1	Platelet	NN	O	platelet	nn	2	SENT_43	[p2l1563t3650r1815b3712],
2	aggregation	NN	O	aggregation	_	0	SENT_43	[p2l1855t3670r2144b3729, p3l7t20r142b82],

1	was	VBD	O	be	auxpass	2	SENT_44	[p3l190t40r318b82],
2	determined	VBN	O	determine	_	0	SENT_44	[p3l368t20r750b82],
3	in	IN	O	in	_	0	SENT_44	[p3l799t20r864b81],
4	response	NN	O	response	prep_in	2	SENT_44	[p3l912t40r1206b98],
5	to	TO	O	to	_	0	SENT_44	[p3l1255t28r1323b82],
6	20	CD	NUMBER	20	num	8	SENT_44	[p3l1374t22r1451b82],
7	HM	NNS	O	hm	nn	8	SENT_44	[p3l1485t40r1583b98],
8	ADP	NN	O	adp	prep_to	4	SENT_44	[p3l1633t20r1813b81],
9	by	IN	O	by	_	0	SENT_44	[p3l1862t20r1946b98],
10	light	JJ	O	light	amod	12	SENT_44	[p3l1994t20r2146b98],
11	transmittance	JJ	O	transmittance	amod	12	SENT_44	[p3l7t126r473b187],
12	aggregometry	NN	O	aggregometry	agent	2	SENT_44	[p3l506t134r975b204],
13	using	VBG	O	use	partmod	12	SENT_44	[p3l1006t126r1186b204],
14	an	DT	O	a	det	16	SENT_44	[p3l1219t146r1301b187],
15	MCM	NN	O	mcm	nn	16	SENT_44	[p3l1333t127r1551b188],
16	hematracer	NN	O	hematracer	dobj	13	SENT_44	[p3l1585t126r1969b187],
17	313M	NN	O	313m	nn	21	SENT_44	[p3l2003t128r2144b187, p3l8t234r85b293],
18	(	CD	NUMBER	(	num	21	SENT_44	[p3l143t232r319b310],
19	SSR	NNP	ORGANIZATION	SSR	nn	21	SENT_44	[p3l143t232r319b310],
20	Engineering	NNP	ORGANIZATION	Engineering	nn	21	SENT_44	[p3l374t232r782b310],
21	Co.	NNP	ORGANIZATION	Co.	dep	16	SENT_44	[p3l837t233r953b294],
22	.	.	O	.	_	0	SENT_44	[p3l837t233r953b294],

1	LTD.	NNP	O	LTD.	_	0	SENT_45	[p3l1014t234r1225b306],
2	,	,	O	,	_	0	SENT_45	[p3l1014t234r1225b306],
3	Tokyo	NNP	LOCATION	Tokyo	nn	5	SENT_45	[p3l1282t232r1527b310],
4	,	,	O	,	_	0	SENT_45	[p3l1282t232r1527b310],
5	Japan	NNP	LOCATION	Japan	appos	1	SENT_45	[p3l1584t233r1830b310],
6	)	CD	NUMBER	)	num	5	SENT_45	[p3l1584t233r1830b310],
7	.	.	O	.	_	0	SENT_45	[p3l1584t233r1830b310],

1	Venous	JJ	O	venous	amod	3	SENT_46	[p3l1887t234r2144b294],
2	blood	NN	O	blood	nn	3	SENT_46	[p3l7t339r205b400],
3	samples	NNS	O	sample	nsubj	9	SENT_46	[p3l239t339r504b417],
4	for	IN	O	for	_	0	SENT_46	[p3l538t339r638b400],
5	determining	VBG	O	determine	prepc_for	3	SENT_46	[p3l670t339r1079b417],
6	platelet	NN	O	platelet	nn	8	SENT_46	[p3l1110t339r1359b417],
7	reactivity	NN	O	reactivity	nn	8	SENT_46	[p3l1390t339r1705b417],
8	index	NN	O	index	dobj	5	SENT_46	[p3l1735t339r1920b400],
9	(	VBD	O	(	_	0	SENT_46	[p3l1954t339r2144b417],
10	PRI	NNP	ORGANIZATION	PRI	nsubjpass	13	SENT_46	[p3l1954t339r2144b417],
11	)	CD	NUMBER	)	num	10	SENT_46	[p3l1954t339r2144b417],
12	were	VBD	O	be	auxpass	13	SENT_46	[p3l6t465r164b507],
13	obtained	VBN	O	obtain	conj_and	13	SENT_46	[p3l206t444r503b507],
14	before	IN	O	before	_	0	SENT_46	[p3l543t444r756b507],
15	and	CC	O	and	_	0	SENT_46	[p3l797t444r924b507],
16	at	IN	O	at	_	0	SENT_46	[p3l965t454r1029b507],
17	1	CD	NUMBER	1	prep_at	13	SENT_46	[p3l1077t446r1125b520],
18	,	,	O	,	_	0	SENT_46	[p3l1077t446r1125b520],
19	4	CD	NUMBER	4	prep_at	13	SENT_46	[p3l1167t446r1224b520],
20	,	,	O	,	_	0	SENT_46	[p3l1167t446r1224b520],
21	6	CD	NUMBER	6	prep_at	13	SENT_46	[p3l1269t446r1305b507],
22	and	CC	O	and	_	0	SENT_46	[p3l1346t444r1473b507],
23	24	CD	NUMBER	24	num	24	SENT_46	[p3l1513t446r1592b506],
24	h	NN	O	h	prep_at	13	SENT_46	[p3l1622t445r1665b506],
25	after	IN	O	after	_	0	SENT_46	[p3l1706t445r1861b507],
26	dosing	NN	O	dosing	prep_after	13	SENT_46	[p3l1900t444r2140b524],
27	.	.	O	.	_	0	SENT_46	[p3l1900t444r2140b524],

1	To	TO	O	to	aux	2	SENT_47	[p3l7t554r103b613],
2	determine	VB	O	determine	purpcl	16	SENT_47	[p3l178t551r515b613],
3	the	DT	O	the	det	8	SENT_47	[p3l588t551r691b613],
4	vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	8	SENT_47	[p3l764t551r1529b613],
5	phosphoprotein	NN	O	phosphoprotein	nn	8	SENT_47	[p3l1601t551r2145b629],
6	(	CD	NUMBER	(	num	8	SENT_47	[p3l9t657r272b735],
7	VASP	NN	ORGANIZATION	vasp	nn	8	SENT_47	[p3l9t657r272b735],
8	)	NN	O	)	nsubj	10	SENT_47	[p3l9t657r272b735],
9	phosphorylation	NN	O	phosphorylation	nn	10	SENT_47	[p3l335t657r901b735],
10	state	NN	O	state	xcomp	2	SENT_47	[p3l965t666r1118b718],
11	of	IN	O	of	_	0	SENT_47	[p3l1183t657r1259b718],
12	whole	JJ	O	whole	amod	13	SENT_47	[p3l1311t657r1514b719],
13	blood	NN	O	blood	prep_of	10	SENT_47	[p3l1577t657r1792b731],
14	,	,	O	,	_	0	SENT_47	[p3l1577t657r1792b731],
15	we	PRP	O	we	nsubj	16	SENT_47	[p3l1856t677r1948b719],
16	performed	VBD	O	perform	_	0	SENT_47	[p3l2010t677r2144b735, p3l7t763r254b826],
17	a	DT	O	a	det	22	SENT_47	[p3l296t784r334b826],
18	dual	JJ	O	dual	amod	22	SENT_47	[p3l375t763r523b826],
19	color	NN	O	color	nn	22	SENT_47	[p3l564t764r738b826],
20	ﬂow	NN	O	ﬂow	nn	22	SENT_47	[p3l778t764r925b826],
21	cytometric	JJ	O	cytometric	amod	22	SENT_47	[p3l965t764r1325b842],
22	assay	NN	O	assay	dobj	16	SENT_47	[p3l1367t784r1547b842],
23	(	CD	NUMBER	(	num	25	SENT_47	[p3l1588t764r1865b843],
24	Platelet	NN	O	platelet	nn	25	SENT_47	[p3l1588t764r1865b843],
25	VASPFCM	NN	O	vaspfcm	dep	22	SENT_47	[p3l1904t764r2143b826, p3l9t871r218b945],
26	;	:	O	;	_	0	SENT_47	[p3l1904t764r2143b826, p3l9t871r218b945],
27	Biocytex	NNP	PERSON	Biocytex	nn	31	SENT_47	[p3l263t870r574b948],
28	,	,	O	,	_	0	SENT_47	[p3l263t870r574b948],
29	Marseille	NNP	LOCATION	Marseille	appos	31	SENT_47	[p3l617t870r948b945],
30	,	,	O	,	_	0	SENT_47	[p3l617t870r948b945],
31	France	NNP	LOCATION	France	dep	22	SENT_47	[p3l992t871r1253b948],
32	)	CD	NUMBER	)	num	31	SENT_47	[p3l992t871r1253b948],
33	[	CD	NUMBER	[	number	34	SENT_47	[p3l1297t872r1391b948],
34	9	CD	NUMBER	9	num	35	SENT_47	[p3l1297t872r1391b948],
35	]	NN	O	]	dep	31	SENT_47	[p3l1297t872r1391b948],
36	.	.	O	.	_	0	SENT_47	[p3l1297t872r1391b948],

1	1440	CD	NUMBER	1440	num	2	SENT_48	[p3l48t1023r127b1050],
2	Letters	NNS	O	letter	_	0	SENT_48	[p3l148t1024r258b1050],
3	to	TO	O	to	_	0	SENT_48	[p3l273t1028r301b1050],
4	the	DT	O	the	det	5	SENT_48	[p3l317t1023r361b1050],
5	Editor	NNP	O	Editor	prep_to	2	SENT_48	[p3l375t1023r473b1050],

1	Table	NNP	O	Table	_	0	SENT_49	[p3l46t1123r121b1147],
2	1	CD	NUMBER	1	num	3	SENT_49	[p3l134t1123r147b1146],
3	Cum	NN	O	cum	dep	1	SENT_49	[p3l161t1123r225b1152],
4	and	CC	O	and	_	0	SENT_49	[p3l235t1122r286b1147],
5	AUC	NN	O	auc	nn	6	SENT_49	[p3l296t1122r370b1147],
6	values	NNS	O	value	dep	1	SENT_49	[p3l381t1122r464b1147],
7	for	IN	O	for	_	0	SENT_49	[p3l475t1122r514b1147],
8	the	DT	O	the	det	10	SENT_49	[p3l525t1122r565b1147],
9	active	JJ	O	active	amod	10	SENT_49	[p3l577t1122r654b1147],
10	metabolite	NN	O	metabolite	prep_for	3	SENT_49	[p3l664t1122r806b1147],
11	of	IN	O	of	_	0	SENT_49	[p3l818t1122r848b1147],
12	clopidogrel	NN	O	clopidogrel	prep_of	10	SENT_49	[p3l855t1122r1005b1153],
13	as	IN	O	as	mark	43	SENT_49	[p3l1017t1130r1043b1147],
14	a	DT	O	a	det	15	SENT_49	[p3l1054t1130r1069b1147],
15	funcition	NN	O	funcition	dep	43	SENT_49	[p3l1080t1122r1201b1147],
16	of	IN	O	of	_	0	SENT_49	[p3l1212t1122r1242b1147],
17	CYP2C19	NN	O	cyp2c19	prep_of	15	SENT_49	[p3l1250t1123r1386b1147],
18	pharrnacogenomic	JJ	O	pharrnacogenomic	amod	24	SENT_49	[p3l1397t1122r1648b1153],
19	status	NN	O	status	nn	24	SENT_49	[p3l1659t1126r1735b1147],
20	CYP2Cl9	NN	O	cyp2cl9	nn	24	SENT_49	[p3l47t1186r188b1210],
21	Cmax	NN	O	cmax	nn	24	SENT_49	[p3l468t1187r533b1216],
22	(	CD	NUMBER	(	num	24	SENT_49	[p3l547t1186r591b1217],
23	ng	NN	O	ng	nn	24	SENT_49	[p3l547t1186r591b1217],
24	mL	NN	O	ml	dep	15	SENT_49	[p3l603t1179r689b1217],
25	"	''	O	"	punct	15	SENT_49	[p3l603t1179r689b1217],
26	1	CD	NUMBER	1	number	27	SENT_49	[p3l603t1179r689b1217],
27	)	CD	NUMBER	)	num	28	SENT_49	[p3l603t1179r689b1217],
28	Ratio	NN	O	ratio	dep	15	SENT_49	[p3l919t1186r996b1210],
29	(	CD	PERCENT	(	number	30	SENT_49	[p3l1010t1186r1083b1217],
30	95	CD	PERCENT	95	dep	31	SENT_49	[p3l1010t1186r1083b1217],
31	%	NN	PERCENT	%	dep	28	SENT_49	[p3l1010t1186r1083b1217],
32	CI	NN	O	ci	nn	34	SENT_49	[p3l1098t1186r1143b1217],
33	)	CD	NUMBER	)	num	34	SENT_49	[p3l1098t1186r1143b1217],
34	AUC	NN	O	auc	dep	28	SENT_49	[p3l1386t1186r1462b1210],
35	(	CD	NUMBER	(	num	36	SENT_49	[p3l1475t1186r1544b1217],
36	ng	NN	O	ng	dep	28	SENT_49	[p3l1475t1186r1544b1217],
37	‘	CD	NUMBER	‘	num	39	SENT_49	[p3l1475t1186r1544b1217],
38	h	NN	O	h	nn	39	SENT_49	[p3l1475t1186r1544b1217],
39	mL	NN	O	ml	dep	36	SENT_49	[p3l1556t1180r1643b1217],
40	'	''	O	'	_	0	SENT_49	[p3l1556t1180r1643b1217],
41	1	CD	NUMBER	1	number	42	SENT_49	[p3l1556t1180r1643b1217],
42	)	CD	NUMBER	)	num	43	SENT_49	[p3l1556t1180r1643b1217],
43	Ratio	NN	O	ratio	dep	12	SENT_49	[p3l1873t1186r1950b1210],
44	(	CD	PERCENT	(	number	45	SENT_49	[p3l1964t1186r2037b1217],
45	95	CD	PERCENT	95	dep	46	SENT_49	[p3l1964t1186r2037b1217],
46	%	NN	PERCENT	%	dep	43	SENT_49	[p3l1964t1186r2037b1217],
47	CI	NN	O	ci	nn	50	SENT_49	[p3l2052t1186r2097b1217],
48	)	CD	NUMBER	)	num	50	SENT_49	[p3l2052t1186r2097b1217],
49	EM	NN	O	em	nn	50	SENT_49	[p3l47t1266r99b1289],
50	(	NN	O	(	dep	10	SENT_49	[p3l113t1265r139b1296],
51	n	NN	O	n	dep	50	SENT_49	[p3l113t1265r139b1296],
52	=	JJ	O	=	amod	53	SENT_49	[p3l157t1274r177b1281],
53	18	CD	NUMBER	18	rcmod	51	SENT_49	[p3l198t1265r237b1296],
54	)	CD	NUMBER	)	number	55	SENT_49	[p3l198t1265r237b1296],
55	39.0	CD	NUMBER	39.0	dep	53	SENT_49	[p3l467t1265r523b1289],
56	:	:	O	:	_	0	SENT_49	[p3l541t1276r562b1287],
57	:	:	O	:	_	0	SENT_49	[p3l541t1276r562b1287],
58	15.0	CD	NUMBER	15.0	num	59	SENT_49	[p3l583t1265r637b1289],
59	IM/EM	NN	O	im/em	dep	10	SENT_49	[p3l918t1265r1027b1296],
60	58.3	CD	NUMBER	58.3	dep	59	SENT_49	[p3l1388t1266r1442b1289],
61	:	:	O	:	_	0	SENT_49	[p3l1462t1276r1482b1287],
62	:	:	O	:	_	0	SENT_49	[p3l1462t1276r1482b1287],
63	21.0	CD	NUMBER	21.0	num	64	SENT_49	[p3l1500t1265r1557b1289],
64	IM/EM	NN	O	im/em	dep	3	SENT_49	[p3l1872t1265r1981b1296],

1	IM	NN	O	im	nn	3	SENT_50	[p3l47t1391r90b1414],
2	(	NN	O	(	nn	3	SENT_50	[p3l104t1390r129b1421],
3	n	NN	O	n	_	0	SENT_50	[p3l104t1390r129b1421],
4	=	JJ	O	=	amod	5	SENT_50	[p3l148t1399r168b1406],
5	20	CD	NUMBER	20	rcmod	3	SENT_50	[p3l186t1390r228b1421],
6	)	CD	NUMBER	)	number	7	SENT_50	[p3l186t1390r228b1421],
7	26.3	CD	NUMBER	26.3	dep	5	SENT_50	[p3l466t1391r522b1414],
8	:	:	O	:	_	0	SENT_50	[p3l541t1402r562b1412],
9	:	:	O	:	_	0	SENT_50	[p3l541t1402r562b1412],
10	11.0	CD	NUMBER	11.0	dep	3	SENT_50	[p3l583t1391r637b1415],
11	41.5	CD	NUMBER	41.5	dep	10	SENT_50	[p3l1386t1390r1443b1414],
12	:	:	O	:	_	0	SENT_50	[p3l1462t1402r1482b1412],
13	:	:	O	:	_	0	SENT_50	[p3l1462t1402r1482b1412],
14	15.8	CD	NUMBER	15.8	dep	3	SENT_50	[p3l1504t1391r1556b1414],

1	PM/EM	NN	O	pm/em	nn	2	SENT_51	[p3l918t1439r1035b1470],
2	PM/EM	NN	O	pm/em	_	0	SENT_51	[p3l1871t1439r1988b1470],

1	PM	NN	O	pm	nsubj	46	SENT_52	[p3l46t1515r97b1538],
2	(	CD	NUMBER	(	num	3	SENT_52	[p3l111t1514r136b1545],
3	n	NN	O	n	dep	1	SENT_52	[p3l111t1514r136b1545],
4	=	JJ	O	=	amod	6	SENT_52	[p3l155t1523r175b1530],
5	9	CD	NUMBER	9	tmod	4	SENT_52	[p3l193t1514r219b1545],
6	)	NN	O	)	dep	1	SENT_52	[p3l193t1514r219b1545],
7	23.7	CD	NUMBER	23.7	amod	6	SENT_52	[p3l466t1514r523b1539],
8	:	:	O	:	_	0	SENT_52	[p3l542t1525r562b1537],
9	:	:	O	:	_	0	SENT_52	[p3l542t1525r562b1537],
10	5.9	CD	NUMBER	5.9	number	11	SENT_52	[p3l581t1514r620b1539],
11	0.61	CD	NUMBER	0.61	num	12	SENT_52	[p3l918t1514r972b1539],
12	(	NN	O	(	dep	6	SENT_52	[p3l988t1507r1155b1545],
13	0.45	CD	NUMBER	0.45	num	14	SENT_52	[p3l988t1507r1155b1545],
14	—	CD	NUMBER	—	dep	12	SENT_52	[p3l988t1507r1155b1545],
15	0.82	CD	NUMBER	0.82	num	16	SENT_52	[p3l988t1507r1155b1545],
16	)	NN	O	)	dep	12	SENT_52	[p3l988t1507r1155b1545],
17	1	CD	NUMBER	1	number	18	SENT_52	[p3l988t1507r1155b1545],
18	33.0	CD	NUMBER	33.0	dep	16	SENT_52	[p3l1388t1514r1443b1539],
19	:	:	O	:	_	0	SENT_52	[p3l1462t1525r1482b1537],
20	:	:	O	:	_	0	SENT_52	[p3l1462t1525r1482b1537],
21	5.9	CD	NUMBER	5.9	number	22	SENT_52	[p3l1502t1514r1540b1539],
22	0.57	CD	NUMBER	0.57	dep	16	SENT_52	[p3l1872t1514r1928b1539],
23	(	NN	O	(	dep	22	SENT_52	[p3l1942t1507r2108b1545],
24	0.43	CD	NUMBER	0.43	num	23	SENT_52	[p3l1942t1507r2108b1545],
25	—	CD	NUMBER	—	number	26	SENT_52	[p3l1942t1507r2108b1545],
26	0.83	CD	NUMBER	0.83	dep	22	SENT_52	[p3l1942t1507r2108b1545],
27	)	NN	O	)	nn	29	SENT_52	[p3l1942t1507r2108b1545],
28	T	NN	O	t	nn	29	SENT_52	[p3l1942t1507r2108b1545],
29	EM	NN	O	em	dep	26	SENT_52	[p3l47t1583r108b1611],
30	,	,	O	,	_	0	SENT_52	[p3l47t1583r108b1611],
31	extensive	JJ	O	extensive	amod	32	SENT_52	[p3l121t1582r247b1606],
32	metabolizer	NN	O	metabolizer	appos	22	SENT_52	[p3l259t1582r431b1611],
33	;	:	O	;	_	0	SENT_52	[p3l259t1582r431b1611],
34	IM	NNP	O	IM	dep	32	SENT_52	[p3l445t1583r496b1611],
35	,	,	O	,	_	0	SENT_52	[p3l445t1583r496b1611],
36	intermediate	JJ	O	intermediate	amod	38	SENT_52	[p3l509t1582r685b1606],
37	metabolizerg	NN	O	metabolizerg	nn	38	SENT_52	[p3l696t1582r868b1611],
38	PM	NN	O	pm	appos	12	SENT_52	[p3l882t1583r941b1611],
39	,	,	O	,	_	0	SENT_52	[p3l882t1583r941b1611],
40	poor	JJ	O	poor	amod	41	SENT_52	[p3l954t1590r1021b1613],
41	metabolizer	NN	O	metabolizer	appos	38	SENT_52	[p3l1032t1582r1204b1611],
42	;	:	O	;	_	0	SENT_52	[p3l1032t1582r1204b1611],
43	Cmx	NNP	O	Cmx	dep	6	SENT_52	[p3l1219t1583r1293b1612],
44	,	,	O	,	_	0	SENT_52	[p3l1219t1583r1293b1612],
45	maximum	NN	O	maximum	appos	43	SENT_52	[p3l1306t1582r1447b1606],
46	observed	VBD	O	observe	_	0	SENT_52	[p3l1460t1582r1584b1606],
47	concentration	NN	O	concentration	dobj	46	SENT_52	[p3l1595t1582r1797b1611],
48	;	:	O	;	_	0	SENT_52	[p3l1595t1582r1797b1611],
49	AUC	NN	O	auc	dep	47	SENT_52	[p3l1810t1582r1893b1611],
50	,	,	O	,	_	0	SENT_52	[p3l1810t1582r1893b1611],
51	area	NN	O	area	appos	49	SENT_52	[p3l1907t1590r1966b1606],
52	under	IN	O	under	_	0	SENT_52	[p3l1977t1582r2058b1606],
53	the	DT	O	the	det	55	SENT_52	[p3l2071t1582r2113b1606],
54	concentration-time	JJ	O	concentration-time	amod	55	SENT_52	[p3l46t1622r313b1646],
55	curve	NN	O	curve	prep_under	46	SENT_52	[p3l325t1629r408b1646],
56	.	.	O	.	_	0	SENT_52	[p3l325t1629r408b1646],

1	*	NN	O	*	nn	2	SENT_53	[p3l424t1622r461b1646],
2	P	NN	O	p	_	0	SENT_53	[p3l424t1622r461b1646],
3	<	JJR	O	<	dep	2	SENT_53	[p3l479t1626r497b1642],
4	0.05	CD	NUMBER	0.05	dep	3	SENT_53	[p3l516t1622r581b1651],
5	,	,	O	,	_	0	SENT_53	[p3l516t1622r581b1651],
6	difference	NN	O	difference	appos	4	SENT_53	[p3l595t1621r730b1646],
7	between	IN	O	between	_	0	SENT_53	[p3l742t1622r856b1646],
8	IMs	NNS	O	im	prep_between	6	SENT_53	[p3l868t1622r925b1646],
9	and	CC	O	and	_	0	SENT_53	[p3l938t1622r989b1646],
10	EMS	NN	ORGANIZATION	em	conj_and	8	SENT_53	[p3l1002t1622r1076b1651],
11	;	:	O	;	_	0	SENT_53	[p3l1002t1622r1076b1651],
12	TP	NN	O	tp	dep	13	SENT_53	[p3l1090t1615r1123b1646],
13	<	JJR	O	<	dep	6	SENT_53	[p3l1142t1626r1160b1642],
14	0.05	CD	NUMBER	0.05	dep	13	SENT_53	[p3l1179t1622r1244b1651],
15	,	,	O	,	_	0	SENT_53	[p3l1179t1622r1244b1651],
16	difference	NN	O	difference	dep	2	SENT_53	[p3l1258t1621r1392b1646],
17	between	IN	O	between	_	0	SENT_53	[p3l1405t1621r1519b1646],
18	PMs	NNS	O	pm	prep_between	16	SENT_53	[p3l1531t1622r1595b1646],
19	and	CC	O	and	_	0	SENT_53	[p3l1608t1622r1659b1646],
20	EMs	NNS	O	em	prep_between	16	SENT_53	[p3l1672t1622r1745b1646],
21	.	.	O	.	_	0	SENT_53	[p3l1672t1622r1745b1646],

1	The	DT	O	the	det	2	SENT_54	[p3l94t1812r225b1873],
2	subjects	NNS	O	subject	nsubjpass	4	SENT_54	[p3l290t1812r553b1890],
3	were	VBD	O	be	auxpass	4	SENT_54	[p3l615t1832r774b1873],
4	classiﬁed	VBN	O	classiﬁed	_	0	SENT_54	[p3l837t1812r1137b1873],
5	into	IN	O	into	_	0	SENT_54	[p3l1199t1812r1332b1873],
6	the	DT	O	the	det	10	SENT_54	[p3l1397t1812r1501b1873],
7	three	CD	NUMBER	three	num	10	SENT_54	[p3l1564t1812r1732b1873],
8	CYP2C19	NN	O	cyp2c19	nn	10	SENT_54	[p3l1798t1813r2142b1873],
9	genotype	NN	O	genotype	nn	10	SENT_54	[p3l9t1926r317b1996],
10	groups	NNS	O	group	prep_into	4	SENT_54	[p3l371t1938r602b1996],
11	as	IN	O	as	mark	12	SENT_54	[p3l657t1938r723b1979],
12	follows	VBZ	O	follow	advcl	4	SENT_54	[p3l777t1918r1037b1979],
13	:	:	O	:	_	0	SENT_54	[p3l777t1918r1037b1979],
14	extensive	JJ	O	extensive	amod	15	SENT_54	[p3l1094t1918r1400b1979],
15	metabolizers	NNS	O	metabolizer	nsubj	16	SENT_54	[p3l1451t1917r1880b1979],
16	(	VBP	O	(	conj_and	4	SENT_54	[p3l1934t1918r2141b1996],
17	EMs	NNS	O	em	dobj	16	SENT_54	[p3l1934t1918r2141b1996],
18	;	:	O	;	_	0	SENT_54	[p3l1934t1918r2141b1996],
19	C	NN	O	c	nn	21	SENT_54	[p3l13t2026r69b2085],
20	YP2C19	NN	O	yp2c19	nn	21	SENT_54	[p3l80t2023r430b2085],
21	*	NN	O	*	dep	34	SENT_54	[p3l80t2023r430b2085],
22	1	CD	NUMBER	1	dep	21	SENT_54	[p3l80t2023r430b2085],
23	/	:	O	/	punct	21	SENT_54	[p3l440t2023r464b2101],
24	*	CD	NUMBER	*	dep	21	SENT_54	[p3l471t2023r562b2097],
25	1	CD	NUMBER	1	dep	24	SENT_54	[p3l471t2023r562b2097],
26	,	,	O	,	_	0	SENT_54	[p3l471t2023r562b2097],
27	n	NN	O	n	nsubj	34	SENT_54	[p3l591t2045r629b2084],
28	=	JJ	O	=	amod	27	SENT_54	[p3l675t2046r725b2064],
29	18	CD	NUMBER	18	num	30	SENT_54	[p3l779t2023r893b2101],
30	)	NN	O	)	tmod	28	SENT_54	[p3l779t2023r893b2101],
31	,	,	O	,	_	0	SENT_54	[p3l779t2023r893b2101],
32	intermediate	JJ	O	intermediate	amod	33	SENT_54	[p3l921t2023r1345b2085],
33	metabolizers	NNS	O	metabolizer	appos	30	SENT_54	[p3l1370t2023r1799b2085],
34	(	VBP	O	(	conj_and	4	SENT_54	[p3l1827t2024r2009b2101],
35	IMs	NNS	O	im	nn	52	SENT_54	[p3l1827t2024r2009b2101],
36	;	:	O	;	_	0	SENT_54	[p3l1827t2024r2009b2101],
37	*	CD	NUMBER	*	number	38	SENT_54	[p3l2043t2023r2109b2084],
38	1	CD	NUMBER	1	dep	35	SENT_54	[p3l2043t2023r2109b2084],
39	/	:	O	/	punct	44	SENT_54	[p3l2119t2023r2143b2101],
40	*	CD	NUMBER	*	number	44	SENT_54	[p3l13t2129r87b2190],
41	2	CD	NUMBER	2	number	44	SENT_54	[p3l13t2129r87b2190],
42	or	CC	O	or	_	0	SENT_54	[p3l121t2149r194b2190],
43	*	CD	NUMBER	*	dep	38	SENT_54	[p3l229t2129r295b2189],
44	1	CD	NUMBER	1	dep	38	SENT_54	[p3l229t2129r295b2189],
45	/	:	O	/	punct	44	SENT_54	[p3l305t2129r428b2207],
46	*	CD	NUMBER	*	number	47	SENT_54	[p3l305t2129r428b2207],
47	3	CD	NUMBER	3	num	38	SENT_54	[p3l305t2129r428b2207],
48	,	,	O	,	_	0	SENT_54	[p3l305t2129r428b2207],
49	n	NN	O	n	appos	38	SENT_54	[p3l462t2150r500b2190],
50	=	JJ	O	=	amod	52	SENT_54	[p3l546t2152r597b2170],
51	20	CD	NUMBER	20	tmod	50	SENT_54	[p3l643t2129r765b2207],
52	)	NN	O	)	dobj	34	SENT_54	[p3l643t2129r765b2207],
53	,	,	O	,	_	0	SENT_54	[p3l643t2129r765b2207],
54	and	CC	O	and	_	0	SENT_54	[p3l800t2129r927b2190],
55	poor	JJ	O	poor	amod	56	SENT_54	[p3l958t2149r1123b2207],
56	metabolizers	NNS	O	metabolizer	nsubj	57	SENT_54	[p3l1152t2129r1582b2190],
57	(	VBP	O	(	conj_and	4	SENT_54	[p3l1616t2129r1817b2207],
58	PMs	NNS	O	pm	nn	76	SENT_54	[p3l1616t2129r1817b2207],
59	;	:	O	;	_	0	SENT_54	[p3l1616t2129r1817b2207],
60	*	NN	O	*	dep	58	SENT_54	[p3l1857t2129r2038b2207],
61	2	CD	NUMBER	2	num	60	SENT_54	[p3l1857t2129r2038b2207],
62	/	:	O	/	punct	64	SENT_54	[p3l1857t2129r2038b2207],
63	’‘	CD	NUMBER	’‘	num	64	SENT_54	[p3l1857t2129r2038b2207],
64	‘	NN	O	‘	dep	60	SENT_54	[p3l1857t2129r2038b2207],
65	2	CD	NUMBER	2	dep	64	SENT_54	[p3l1857t2129r2038b2207],
66	or	CC	O	or	_	0	SENT_54	[p3l2072t2149r2144b2190],
67	*	CD	NUMBER	*	dep	64	SENT_54	[p3l13t2236r211b2314],
68	2	CD	NUMBER	2	dep	65	SENT_54	[p3l13t2236r211b2314],
69	/	:	O	/	punct	64	SENT_54	[p3l13t2236r211b2314],
70	*	CD	NUMBER	*	number	71	SENT_54	[p3l13t2236r211b2314],
71	3	CD	NUMBER	3	num	60	SENT_54	[p3l13t2236r211b2314],
72	,	,	O	,	_	0	SENT_54	[p3l13t2236r211b2314],
73	n	NN	O	n	appos	60	SENT_54	[p3l269t2257r308b2297],
74	=	JJ	O	=	amod	76	SENT_54	[p3l354t2258r404b2276],
75	9	CD	NUMBER	9	tmod	74	SENT_54	[p3l450t2236r530b2313],
76	)	NN	O	)	dobj	57	SENT_54	[p3l450t2236r530b2313],
77	.	.	O	.	_	0	SENT_54	[p3l450t2236r530b2313],

1	The	DT	O	the	det	3	SENT_55	[p3l590t2236r721b2297],
2	mean	NN	O	mean	nn	3	SENT_55	[p3l776t2256r963b2297],
3	AUC	NN	O	auc	nsubj	10	SENT_55	[p3l1017t2236r1205b2297],
4	and	CC	O	and	_	0	SENT_55	[p3l1262t2235r1388b2297],
5	Cmax	NN	O	cmax	nsubj	10	SENT_55	[p3l1449t2238r1611b2310],
6	of	IN	O	of	_	0	SENT_55	[p3l1667t2236r1743b2297],
7	the	DT	O	the	det	9	SENT_55	[p3l1790t2235r1892b2297],
8	active	JJ	O	active	amod	9	SENT_55	[p3l1950t2236r2143b2297],
9	metabolite	NN	O	metabolite	prep_of	3	SENT_55	[p3l7t2342r367b2403],
10	differed	VBD	O	differ	_	0	SENT_55	[p3l394t2342r654b2403],
11	signiﬁcantly	RB	O	signiﬁcantly	dep	12	SENT_55	[p3l682t2342r1087b2420],
12	(	CD	NUMBER	(	num	13	SENT_55	[p3l1114t2342r1193b2420],
13	P	NN	O	p	npadvmod	14	SENT_55	[p3l1114t2342r1193b2420],
14	<	JJR	O	<	acomp	10	SENT_55	[p3l1238t2353r1285b2393],
15	0.05	CD	NUMBER	0.05	num	16	SENT_55	[p3l1332t2342r1496b2420],
16	)	NN	O	)	dobj	10	SENT_55	[p3l1332t2342r1496b2420],
17	between	IN	O	between	_	0	SENT_55	[p3l1523t2342r1800b2403],
18	EMs	NNS	O	em	prep_between	16	SENT_55	[p3l1827t2344r1989b2403],
19	and	CC	O	and	_	0	SENT_55	[p3l2018t2342r2144b2403],
20	IMs	NNS	O	im	conj_and	18	SENT_55	[p3l9t2450r167b2522],
21	,	,	O	,	_	0	SENT_55	[p3l9t2450r167b2522],
22	as	RB	O	as	_	0	SENT_55	[p3l197t2468r264b2509],
23	well	RB	O	well	_	0	SENT_55	[p3l288t2448r423b2509],
24	as	IN	O	as	_	0	SENT_55	[p3l449t2468r516b2509],
25	EMs	NNS	O	em	conj_and	16	SENT_55	[p3l543t2450r705b2509],
26	and	CC	O	and	_	0	SENT_55	[p3l732t2447r859b2509],
27	PMs	NNS	O	pm	conj_and	25	SENT_55	[p3l883t2450r1042b2509],
28	(	CD	NUMBER	(	num	29	SENT_55	[p3l1070t2447r1287b2526],
29	Table	NNP	O	Table	dep	25	SENT_55	[p3l1070t2447r1287b2526],
30	1	CD	NUMBER	1	num	29	SENT_55	[p3l1326t2448r1398b2525],
31	)	CD	NUMBER	)	tmod	10	SENT_55	[p3l1326t2448r1398b2525],
32	.	.	O	.	_	0	SENT_55	[p3l1326t2448r1398b2525],

1	Maximum	NNP	O	Maximum	nn	2	SENT_56	[p3l1428t2448r1789b2509],
2	inhibition	NN	O	inhibition	nsubjpass	8	SENT_56	[p3l1813t2447r2144b2509],
3	of	IN	O	of	_	0	SENT_56	[p3l10t2553r86b2615],
4	ADP-induced	JJ	O	adp-induced	amod	6	SENT_56	[p3l99t2553r574b2615],
5	platelet	NN	O	platelet	nn	6	SENT_56	[p3l595t2553r844b2631],
6	aggregation	NN	O	aggregation	prep_of	2	SENT_56	[p3l868t2553r1268b2631],
7	was	VBD	O	be	auxpass	8	SENT_56	[p3l1289t2573r1418b2615],
8	observed	VBN	O	observe	_	0	SENT_56	[p3l1442t2553r1744b2615],
9	at	IN	O	at	_	0	SENT_56	[p3l1768t2562r1832b2615],
10	6	CD	NUMBER	6	num	11	SENT_56	[p3l1856t2555r1891b2615],
11	h	NN	O	h	prep_at	8	SENT_56	[p3l1922t2553r1966b2614],
12	after	IN	O	after	_	0	SENT_56	[p3l1990t2553r2145b2615],
13	the	DT	O	the	det	14	SENT_56	[p3l9t2660r112b2721],
14	dosing	NN	O	dosing	prep_after	8	SENT_56	[p3l136t2660r375b2738],
15	.	.	O	.	_	0	SENT_56	[p3l136t2660r375b2738],

1	The	DT	O	the	det	2	SENT_57	[p3l403t2660r535b2721],
2	time	NN	O	time	nsubj	13	SENT_57	[p3l559t2660r706b2721],
3	to	TO	O	to	aux	4	SENT_57	[p3l730t2668r796b2721],
4	reach	VB	O	reach	infmod	2	SENT_57	[p3l821t2660r1005b2721],
5	the	DT	O	the	det	7	SENT_57	[p3l1028t2660r1131b2721],
6	maximal	JJ	O	maximal	amod	7	SENT_57	[p3l1153t2660r1450b2721],
7	response	NN	O	response	dobj	4	SENT_57	[p3l1473t2680r1766b2738],
8	in	IN	O	in	_	0	SENT_57	[p3l1789t2660r1854b2720],
9	the	DT	O	the	det	10	SENT_57	[p3l1876t2660r1979b2721],
10	IMs	NNS	O	im	prep_in	4	SENT_57	[p3l2004t2662r2143b2721],
11	and	CC	O	and	_	0	SENT_57	[p3l10t2765r136b2827],
12	PMs	NNS	O	pm	prep_in	4	SENT_57	[p3l157t2768r316b2827],
13	tended	VBD	O	tend	_	0	SENT_57	[p3l339t2765r567b2827],
14	to	TO	O	to	aux	16	SENT_57	[p3l589t2774r656b2827],
15	be	VB	O	be	auxpass	16	SENT_57	[p3l679t2765r757b2827],
16	delayed	VBN	O	delay	xcomp	13	SENT_57	[p3l779t2765r1037b2843],
17	compared	VBN	O	compare	_	0	SENT_57	[p3l1058t2765r1398b2844],
18	with	IN	O	with	prepc_compared_with	16	SENT_57	[p3l1420t2765r1569b2827],
19	that	DT	O	that	pobj	16	SENT_57	[p3l1591t2765r1726b2827],
20	in	IN	O	in	_	0	SENT_57	[p3l1747t2766r1812b2826],
21	the	DT	O	the	det	22	SENT_57	[p3l1833t2765r1936b2827],
22	EMs	NNS	O	em	prep_in	19	SENT_57	[p3l1960t2768r2139b2827],
23	.	.	O	.	_	0	SENT_57	[p3l1960t2768r2139b2827],

1	At	IN	O	at	_	0	SENT_58	[p3l8t2871r97b2932],
2	4	CD	NUMBER	4	num	3	SENT_58	[p3l118t2873r156b2932],
3	h	NN	O	h	prep_at	16	SENT_58	[p3l186t2871r230b2932],
4	after	IN	O	after	_	0	SENT_58	[p3l252t2871r408b2933],
5	the	DT	O	the	det	6	SENT_58	[p3l429t2871r532b2933],
6	dosing	NN	O	dosing	prep_after	3	SENT_58	[p3l555t2871r796b2949],
7	,	,	O	,	_	0	SENT_58	[p3l555t2871r796b2949],
8	the	DT	O	the	det	9	SENT_58	[p3l821t2871r924b2933],
9	inhibition	NN	O	inhibition	nsubj	16	SENT_58	[p3l945t2871r1276b2933],
10	of	IN	O	of	_	0	SENT_58	[p3l1300t2871r1376b2933],
11	platelet	NN	O	platelet	nn	12	SENT_58	[p3l1388t2871r1636b2949],
12	aggregation	NN	O	aggregation	prep_of	9	SENT_58	[p3l1659t2871r2059b2949],
13	in	IN	O	in	_	0	SENT_58	[p3l2079t2871r2144b2932],
14	the	DT	O	the	det	15	SENT_58	[p3l9t2977r112b3038],
15	PMs	NNS	O	pm	prep_in	12	SENT_58	[p3l176t2979r335b3038],
16	tended	VBD	O	tend	_	0	SENT_58	[p3l400t2977r627b3038],
17	to	TO	O	to	aux	19	SENT_58	[p3l691t2986r758b3038],
18	be	VB	O	be	cop	19	SENT_58	[p3l823t2977r900b3038],
19	weaker	JJR	O	weaker	xcomp	16	SENT_58	[p3l963t2977r1206b3038],
20	than	IN	O	than	mark	25	SENT_58	[p3l1270t2977r1423b3038],
21	that	DT	O	that	nsubj	25	SENT_58	[p3l1487t2977r1622b3038],
22	in	IN	O	in	_	0	SENT_58	[p3l1684t2977r1749b3038],
23	the	DT	O	the	det	24	SENT_58	[p3l1812t2977r1915b3038],
24	EMs	NNS	O	em	prep_in	21	SENT_58	[p3l1980t2979r2143b3038],
25	(	VBP	O	(	ccomp	19	SENT_58	[p3l10t3084r90b3162],
26	P	NN	O	p	dobj	25	SENT_58	[p3l10t3084r90b3162],
27	=	JJ	O	=	advmod	25	SENT_58	[p3l132t3106r183b3124],
28	0.082	CD	NUMBER	0.082	num	29	SENT_58	[p3l228t3084r450b3161],
29	)	NN	O	)	dep	27	SENT_58	[p3l228t3084r450b3161],
30	.	.	O	.	_	0	SENT_58	[p3l228t3084r450b3161],

1	The	DT	O	the	det	3	SENT_59	[p3l492t3083r623b3145],
2	lower	JJR	O	lower	amod	3	SENT_59	[p3l662t3084r850b3145],
3	response	NN	O	response	nsubjpass	10	SENT_59	[p3l887t3104r1180b3162],
4	to	TO	O	to	_	0	SENT_59	[p3l1219t3092r1286b3145],
5	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_59	[p3l1324t3083r1704b3162],
6	in	IN	O	in	_	0	SENT_59	[p3l1742t3084r1806b3144],
7	the	DT	O	the	det	8	SENT_59	[p3l1844t3083r1947b3145],
8	PMs	NNS	O	pm	prep_in	5	SENT_59	[p3l1984t3086r2143b3145],
9	was	VBD	O	be	auxpass	10	SENT_59	[p3l8t3210r136b3251],
10	observed	VBN	O	observe	_	0	SENT_59	[p3l164t3190r466b3251],
11	in	IN	O	in	_	0	SENT_59	[p3l491t3190r556b3250],
12	the	DT	O	the	det	13	SENT_59	[p3l582t3190r685b3251],
13	PRI	NNP	ORGANIZATION	PRI	prep_in	10	SENT_59	[p3l711t3192r851b3250],
14	as	RB	O	as	advmod	15	SENT_59	[p3l880t3210r947b3251],
15	well	RB	O	well	advmod	10	SENT_59	[p3l972t3190r1123b3251],
16	.	.	O	.	_	0	SENT_59	[p3l972t3190r1123b3251],

1	In	IN	O	in	_	0	SENT_60	[p3l1154t3192r1227b3250],
2	the	DT	O	the	det	3	SENT_60	[p3l1253t3190r1357b3251],
3	PMs	NNS	O	pm	prep_in	20	SENT_60	[p3l1382t3192r1541b3251],
4	and	CC	O	and	_	0	SENT_60	[p3l1569t3190r1696b3251],
5	the	DT	O	the	det	6	SENT_60	[p3l1722t3190r1825b3251],
6	IMs	NNS	O	im	prep_in	20	SENT_60	[p3l1852t3192r2010b3264],
7	,	,	O	,	_	0	SENT_60	[p3l1852t3192r2010b3264],
8	the	DT	O	the	det	9	SENT_60	[p3l2040t3190r2143b3251],
9	PRI	NNP	ORGANIZATION	PRI	nsubj	20	SENT_60	[p3l8t3298r149b3356],
10	at	IN	O	at	_	0	SENT_60	[p3l185t3304r250b3357],
11	4	CD	NUMBER	4	num	12	SENT_60	[p3l284t3297r322b3356],
12	h	NN	O	h	prep_at	9	SENT_60	[p3l352t3295r396b3356],
13	after	IN	O	after	_	0	SENT_60	[p3l431t3296r587b3357],
14	the	DT	O	the	det	15	SENT_60	[p3l621t3296r724b3357],
15	dosing	NN	O	dosing	prep_after	12	SENT_60	[p3l760t3295r984b3374],
16	was	VBD	O	be	cop	20	SENT_60	[p3l1016t3316r1145b3357],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_60	[p3l1182t3296r1588b3374],
18	(	CD	NUMBER	(	num	19	SENT_60	[p3l1624t3296r1703b3374],
19	P	NN	O	p	npadvmod	20	SENT_60	[p3l1624t3296r1703b3374],
20	<	JJR	O	<	_	0	SENT_60	[p3l1748t3307r1795b3347],
21	0.01	CD	NUMBER	0.01	nsubj	34	SENT_60	[p3l1842t3297r1973b3357],
22	and	CC	O	and	_	0	SENT_60	[p3l2017t3295r2143b3357],
23	P	NN	O	p	conj_and	21	SENT_60	[p3l9t3405r64b3462],
24	<	JJR	O	<	amod	23	SENT_60	[p3l108t3413r155b3453],
25	0.05	CD	NUMBER	0.05	num	26	SENT_60	[p3l202t3401r367b3479],
26	)	CD	NUMBER	)	npadvmod	27	SENT_60	[p3l202t3401r367b3479],
27	higher	JJR	O	higher	advmod	23	SENT_60	[p3l387t3401r601b3479],
28	compared	VBN	O	compare	_	0	SENT_60	[p3l619t3401r959b3479],
29	with	IN	O	with	prepc_compared_with	23	SENT_60	[p3l977t3401r1128b3463],
30	that	DT	O	that	pobj	23	SENT_60	[p3l1147t3401r1282b3463],
31	in	IN	O	in	_	0	SENT_60	[p3l1300t3401r1364b3462],
32	the	DT	O	the	det	33	SENT_60	[p3l1384t3401r1487b3463],
33	EMs	NNS	O	em	prep_in	30	SENT_60	[p3l1507t3403r1670b3463],
34	(	VBP	O	(	ccomp	20	SENT_60	[p3l1691t3401r1856b3479],
35	PRI	NNP	ORGANIZATION	PRI	dobj	34	SENT_60	[p3l1691t3401r1856b3479],
36	in	IN	O	in	_	0	SENT_60	[p3l1875t3401r1940b3462],
37	EMs	NNP	O	EMs	prep_in	35	SENT_60	[p3l1960t3403r2139b3463],
38	:	:	O	:	_	0	SENT_60	[p3l1960t3403r2139b3463],
39	50.0	CD	NUMBER	50.0	number	40	SENT_60	[p3l12t3509r147b3569],
40	:1	CD	NUMBER	:1	dep	35	SENT_60	[p3l194t3513r244b3564],
41	:	:	O	:	_	0	SENT_60	[p3l194t3513r244b3564],
42	15.2	CD	PERCENT	15.2	num	43	SENT_60	[p3l297t3508r529b3581],
43	%	NN	PERCENT	%	dep	40	SENT_60	[p3l297t3508r529b3581],
44	,	,	O	,	_	0	SENT_60	[p3l297t3508r529b3581],
45	IMs	NNS	O	im	appos	43	SENT_60	[p3l582t3509r738b3568],
46	:	:	O	:	_	0	SENT_60	[p3l582t3509r738b3568],
47	61.5	CD	PERCENT	61.5	number	48	SENT_60	[p3l794t3509r930b3568],
48	:2	CD	PERCENT	:2	dep	35	SENT_60	[p3l977t3513r1028b3564],
49	12.5	CD	PERCENT	12.5	num	50	SENT_60	[p3l1081t3508r1313b3581],
50	%	NN	PERCENT	%	dep	48	SENT_60	[p3l1081t3508r1313b3581],
51	,	,	O	,	_	0	SENT_60	[p3l1081t3508r1313b3581],
52	PMs	NNS	O	pm	appos	48	SENT_60	[p3l1365t3509r1540b3568],
53	:	:	O	:	_	0	SENT_60	[p3l1365t3509r1540b3568],
54	70.2	CD	NUMBER	70.2	dep	35	SENT_60	[p3l1596t3508r1734b3569],
55	i	FW	O	i	dep	54	SENT_60	[p3l1779t3513r1830b3564],
56	10.4	CD	PERCENT	10.4	number	57	SENT_60	[p3l1883t3507r2140b3585],
57	%	NN	PERCENT	%	amod	35	SENT_60	[p3l1883t3507r2140b3585],
58	)	CD	NUMBER	)	tmod	34	SENT_60	[p3l1883t3507r2140b3585],
59	.	.	O	.	_	0	SENT_60	[p3l1883t3507r2140b3585],

1	There	EX	O	there	expl	2	SENT_61	[p3l9t3613r206b3675],
2	were	VBD	O	be	_	0	SENT_61	[p3l233t3634r392b3675],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_61	[p3l422t3614r766b3692],
4	correlations	NNS	O	correlation	nsubj	2	SENT_61	[p3l794t3614r1194b3675],
5	between	IN	O	between	_	0	SENT_61	[p3l1224t3613r1502b3675],
6	PRI	NNP	ORGANIZATION	PRI	prep_between	4	SENT_61	[p3l1529t3616r1669b3674],
7	and	CC	O	and	_	0	SENT_61	[p3l1700t3613r1826b3675],
8	AUC	NN	O	auc	nsubj	2	SENT_61	[p3l1853t3614r2042b3675],
9	or	CC	O	or	_	0	SENT_61	[p3l2072t3634r2145b3675],
10	Cmax	NN	O	cmax	nn	12	SENT_61	[p3l13t3722r176b3795],
11	(	NN	O	(	nn	12	SENT_61	[p3l233t3719r287b3797],
12	r	NN	O	r	conj_and	4	SENT_61	[p3l233t3719r287b3797],
13	=	JJ	O	=	amod	8	SENT_61	[p3l331t3742r382b3760],
14	0.677	CD	NUMBER	0.677	tmod	13	SENT_61	[p3l427t3721r624b3793],
15	,	,	O	,	_	0	SENT_61	[p3l427t3721r624b3793],
16	P	NN	O	p	appos	8	SENT_61	[p3l684t3723r739b3780],
17	<	VBG	O	<	partmod	16	SENT_61	[p3l783t3731r830b3771],
18	0.0001	CD	NUMBER	0.0001	dobj	17	SENT_61	[p3l877t3721r1089b3781],
19	or	CC	O	or	_	0	SENT_61	[p3l1155t3739r1228b3781],
20	r	NN	O	r	conj_or	18	SENT_61	[p3l1284t3741r1313b3780],
21	=	JJ	O	=	amod	20	SENT_61	[p3l1357t3742r1408b3760],
22	0.571	CD	NUMBER	0.571	tmod	21	SENT_61	[p3l1453t3721r1650b3793],
23	,	,	O	,	_	0	SENT_61	[p3l1453t3721r1650b3793],
24	P	NN	O	p	appos	16	SENT_61	[p3l1710t3723r1765b3780],
25	<	VBG	O	<	partmod	24	SENT_61	[p3l1809t3731r1856b3771],
26	0.0001	CD	NUMBER	0.0001	dobj	25	SENT_61	[p3l1904t3721r2140b3793],
27	,	,	O	,	_	0	SENT_61	[p3l1904t3721r2140b3793],

1	respectively	RB	O	respectively	advmod	13	SENT_62	[p4l9t21r444b99],
2	)	RB	O	)	dep	13	SENT_62	[p4l9t21r444b99],
3	,	,	O	,	_	0	SENT_62	[p4l9t21r444b99],
4	and	CC	O	and	_	0	SENT_62	[p4l510t21r636b82],
5	between	IN	O	between	conj_and	2	SENT_62	[p4l698t21r975b82],
6	the	DT	O	the	det	7	SENT_62	[p4l1037t21r1140b82],
7	IPA	NNP	O	IPA	pobj	5	SENT_62	[p4l1202t21r1343b82],
8	and	CC	O	and	_	0	SENT_62	[p4l1405t21r1532b82],
9	AUC	NN	O	auc	nn	12	SENT_62	[p4l1591t21r1781b83],
10	or	CC	O	or	_	0	SENT_62	[p4l1844t41r1917b82],
11	Cmax	NN	O	cmax	nn	12	SENT_62	[p4l1982t23r2145b96],
12	(	NN	O	(	pobj	5	SENT_62	[p4l10t128r65b206],
13	r	NN	O	r	nsubj	26	SENT_62	[p4l10t128r65b206],
14	=	JJ	O	=	amod	13	SENT_62	[p4l109t150r159b168],
15	0.405	CD	NUMBER	0.405	tmod	14	SENT_62	[p4l204t129r401b202],
16	,	,	O	,	_	0	SENT_62	[p4l204t129r401b202],
17	P	NN	O	p	dep	18	SENT_62	[p4l435t131r490b188],
18	<	JJR	O	<	appos	13	SENT_62	[p4l535t139r581b179],
19	0.005	CD	NUMBER	0.005	dep	18	SENT_62	[p4l629t129r806b189],
20	or	CC	O	or	_	0	SENT_62	[p4l840t148r913b189],
21	r	NN	O	r	nsubj	26	SENT_62	[p4l943t149r972b188],
22	=	JJ	O	=	amod	21	SENT_62	[p4l1016t150r1067b168],
23	0.307	CD	NUMBER	0.307	tmod	22	SENT_62	[p4l1112t129r1309b202],
24	,	,	O	,	_	0	SENT_62	[p4l1112t129r1309b202],
25	P	NN	O	p	appos	21	SENT_62	[p4l1342t131r1397b188],
26	<	JJR	O	<	_	0	SENT_62	[p4l1442t139r1489b179],
27	0.05	CD	NUMBER	0.05	dobj	26	SENT_62	[p4l1536t129r1693b202],
28	,	,	O	,	_	0	SENT_62	[p4l1536t129r1693b202],
29	respectively	RB	O	respectively	advmod	33	SENT_62	[p4l1726t128r2142b206],
30	)	CD	NUMBER	)	number	32	SENT_62	[p4l1726t128r2142b206],
31	at	IN	O	at	quantmod	32	SENT_62	[p4l10t242r74b295],
32	4	CD	NUMBER	4	num	33	SENT_62	[p4l100t235r139b294],
33	h	NN	O	h	rcmod	27	SENT_62	[p4l169t234r212b294],
34	after	IN	O	after	_	0	SENT_62	[p4l240t234r395b295],
35	the	DT	O	the	det	36	SENT_62	[p4l422t234r525b295],
36	dosing	NN	O	dosing	prep_after	26	SENT_62	[p4l553t234r792b312],
37	.	.	O	.	_	0	SENT_62	[p4l553t234r792b312],

1	This	DT	O	this	det	2	SENT_63	[p4l94t340r241b401],
2	study	NN	O	study	nsubj	5	SENT_63	[p4l283t339r466b417],
3	is	VBZ	O	be	cop	5	SENT_63	[p4l504t340r553b401],
4	the	DT	O	the	det	5	SENT_63	[p4l594t339r697b401],
5	ﬁrst	NN	O	ﬁrst	_	0	SENT_63	[p4l737t340r868b401],
6	to	TO	O	to	aux	7	SENT_63	[p4l907t348r973b401],
7	demonstrate	VB	O	demonstrate	infmod	5	SENT_63	[p4l1015t339r1437b401],
8	that	IN	O	that	complm	15	SENT_63	[p4l1478t339r1613b401],
9	the	DT	O	the	det	12	SENT_63	[p4l1653t340r1756b401],
10	CYP2Cl9	NN	O	cyp2cl9	nn	12	SENT_63	[p4l1797t341r2142b401],
11	pharmacogenomic	JJ	O	pharmacogenomic	amod	12	SENT_63	[p4l8t445r643b523],
12	status	NN	O	status	nsubj	15	SENT_63	[p4l667t454r861b507],
13	is	VBZ	O	be	cop	15	SENT_63	[p4l885t445r934b507],
14	a	DT	O	a	det	15	SENT_63	[p4l959t465r997b507],
15	determinant	NN	O	determinant	ccomp	7	SENT_63	[p4l1021t445r1434b507],
16	for	IN	O	for	_	0	SENT_63	[p4l1457t445r1558b507],
17	the	DT	O	the	det	18	SENT_63	[p4l1582t445r1684b507],
18	formation	NN	O	formation	prep_for	15	SENT_63	[p4l1708t445r2052b507],
19	of	IN	O	of	_	0	SENT_63	[p4l2077t445r2152b507],
20	the	DT	O	the	det	22	SENT_63	[p4l9t551r112b612],
21	active	JJ	O	active	amod	22	SENT_63	[p4l149t551r342b612],
22	metabolite	NN	O	metabolite	prep_of	18	SENT_63	[p4l376t551r736b612],
23	in	IN	O	in	_	0	SENT_63	[p4l771t551r835b612],
24	healthy	JJ	O	healthy	amod	25	SENT_63	[p4l870t551r1120b629],
25	subjects	NNS	O	subject	prep_in	22	SENT_63	[p4l1156t551r1419b629],
26	including	VBG	O	include	_	0	SENT_63	[p4l1453t551r1769b629],
27	nine	CD	NUMBER	nine	num	29	SENT_63	[p4l1803t551r1946b612],
28	poor	JJ	O	poor	amod	29	SENT_63	[p4l1980t571r2144b629],
29	metabolizers	NNS	O	metabolizer	prep_including	25	SENT_63	[p4l7t657r453b719],
30	.	.	O	.	_	0	SENT_63	[p4l7t657r453b719],

1	We	PRP	O	we	nsubj	3	SENT_64	[p4l483t660r599b719],
2	also	RB	O	also	advmod	3	SENT_64	[p4l626t658r758b719],
3	demonstrated	VBD	O	demonstrate	_	0	SENT_64	[p4l787t657r1253b719],
4	that	IN	O	that	complm	18	SENT_64	[p4l1280t657r1416b719],
5	the	DT	O	the	det	7	SENT_64	[p4l1442t657r1545b719],
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_64	[p4l1571t657r2144b736],
7	parameters	NNS	O	parameter	nsubjpass	18	SENT_64	[p4l8t772r405b841],
8	,	,	O	,	_	0	SENT_64	[p4l8t772r405b841],
9	AUC	NN	O	auc	appos	7	SENT_64	[p4l433t763r621b825],
10	and	CC	O	and	_	0	SENT_64	[p4l649t763r776b825],
11	Cmax	NN	O	cmax	appos	7	SENT_64	[p4l807t766r969b839],
12	of	IN	O	of	_	0	SENT_64	[p4l996t763r1072b825],
13	the	DT	O	the	det	15	SENT_64	[p4l1090t763r1193b825],
14	active	JJ	O	active	amod	15	SENT_64	[p4l1221t763r1415b825],
15	metabolite	NN	O	metabolite	prep_of	9	SENT_64	[p4l1440t763r1800b825],
16	were	VBD	O	be	auxpass	18	SENT_64	[p4l1825t783r1984b825],
17	well	RB	O	well	advmod	18	SENT_64	[p4l2009t763r2144b825],
18	correlated	VBN	O	correlate	ccomp	3	SENT_64	[p4l8t869r349b930],
19	with	IN	O	with	_	0	SENT_64	[p4l375t869r526b931],
20	PRI	NNP	ORGANIZATION	PRI	prep_with	18	SENT_64	[p4l552t871r693b930],
21	and	CC	O	and	_	0	SENT_64	[p4l722t869r849b930],
22	IPA	NNP	O	IPA	conj_and	20	SENT_64	[p4l877t869r1033b930],
23	.	.	O	.	_	0	SENT_64	[p4l877t869r1033b930],

1	These	DT	O	these	det	2	SENT_65	[p4l1065t869r1262b930],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_65	[p4l1290t869r1557b947],
3	suggest	VBP	O	suggest	_	0	SENT_65	[p4l1588t878r1831b947],
4	that	IN	O	that	complm	13	SENT_65	[p4l1859t869r1994b930],
5	low	JJ	O	low	amod	8	SENT_65	[p4l2021t869r2144b931],
6	or	CC	O	or	_	0	SENT_65	[p4l10t996r83b1037],
7	no	DT	O	no	conj_or	5	SENT_65	[p4l119t996r205b1037],
8	responsiveness	NN	O	responsiveness	nsubjpass	13	SENT_65	[p4l244t976r737b1054],
9	to	TO	O	to	_	0	SENT_65	[p4l776t984r843b1037],
10	clopidogrel	NN	O	clopidogrel	prep_to	8	SENT_65	[p4l881t975r1261b1054],
11	is	VBZ	O	be	auxpass	13	SENT_65	[p4l1298t976r1347b1037],
12	mainly	RB	O	mainly	advmod	13	SENT_65	[p4l1384t976r1618b1053],
13	caused	VBN	O	cause	ccomp	3	SENT_65	[p4l1654t975r1883b1037],
14	by	IN	O	by	prep	13	SENT_65	[p4l1920t975r2004b1053],
15	the	DT	O	the	det	18	SENT_65	[p4l2040t975r2143b1037],
16	lower	JJR	O	lower	amod	18	SENT_65	[p4l8t1082r197b1143],
17	metabolic	JJ	O	metabolic	amod	18	SENT_65	[p4l224t1082r559b1143],
18	formation	NN	O	formation	pobj	14	SENT_65	[p4l587t1082r931b1143],
19	of	IN	O	of	_	0	SENT_65	[p4l961t1082r1037b1143],
20	the	DT	O	the	det	21	SENT_65	[p4l1058t1082r1160b1143],
21	metabolite	NN	O	metabolite	prep_of	18	SENT_65	[p4l1188t1082r1566b1156],
22	,	,	O	,	_	0	SENT_65	[p4l1188t1082r1566b1156],
23	but	CC	O	but	_	0	SENT_65	[p4l1598t1082r1712b1143],
24	not	RB	O	not	conj_but	14	SENT_65	[p4l1739t1090r1854b1143],
25	because	IN	O	because	_	0	SENT_65	[p4l1881t1082r2144b1143],
26	of	IN	O	of	prepc_because_of	14	SENT_65	[p4l10t1188r86b1249],
27	the	DT	O	the	det	29	SENT_65	[p4l121t1188r224b1249],
28	poor	JJ	O	poor	amod	29	SENT_65	[p4l265t1208r430b1266],
29	sensitivity	NN	O	sensitivity	pobj	14	SENT_65	[p4l474t1188r806b1265],
30	of	IN	O	of	_	0	SENT_65	[p4l850t1188r926b1249],
31	the	DT	O	the	det	34	SENT_65	[p4l960t1187r1063b1249],
32	platelet	NN	O	platelet	nn	34	SENT_65	[p4l1105t1188r1353b1266],
33	P2Yl2	NN	O	p2yl2	nn	34	SENT_65	[p4l1395t1189r1626b1248],
34	receptor	NN	O	receptor	prep_of	29	SENT_65	[p4l1669t1196r1964b1266],
35	.	.	O	.	_	0	SENT_65	[p4l1669t1196r1964b1266],

1	The	DT	O	the	det	3	SENT_66	[p4l2011t1187r2143b1249],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_66	[p4l10t1294r355b1355],
3	polymorphism	NN	O	polymorphism	nsubj	5	SENT_66	[p4l405t1293r906b1371],
4	has	VBZ	O	have	aux	5	SENT_66	[p4l954t1293r1067b1355],
5	shown	VBN	O	show	_	0	SENT_66	[p4l1118t1293r1338b1355],
6	a	DT	O	a	det	9	SENT_66	[p4l1387t1313r1425b1355],
7	marked	JJ	O	marked	amod	9	SENT_66	[p4l1472t1293r1734b1355],
8	interethnic	JJ	O	interethnic	amod	9	SENT_66	[p4l1783t1293r2145b1355],
9	difference	NN	O	difference	dobj	5	SENT_66	[p4l9t1399r339b1460],
10	in	IN	O	in	_	0	SENT_66	[p4l361t1399r426b1460],
11	the	DT	O	the	det	12	SENT_66	[p4l449t1399r552b1460],
12	incidence	NN	O	incidence	prep_in	5	SENT_66	[p4l575t1399r889b1460],
13	of	IN	O	of	_	0	SENT_66	[p4l913t1399r989b1460],
14	PMs	NNS	O	pm	prep_of	12	SENT_66	[p4l1003t1401r1178b1460],
15	.	.	O	.	_	0	SENT_66	[p4l1003t1401r1178b1460],

1	The	DT	O	the	det	2	SENT_67	[p4l1206t1399r1337b1460],
2	prevalence	NN	O	prevalence	nsubj	22	SENT_67	[p4l1360t1399r1719b1477],
3	of	IN	O	of	_	0	SENT_67	[p4l1744t1399r1820b1460],
4	PMs	NNS	O	pm	prep_of	2	SENT_67	[p4l1834t1401r1992b1460],
5	and	CC	O	and	_	0	SENT_67	[p4l2017t1399r2144b1460],
6	IMs	NNS	O	im	prep_of	2	SENT_67	[p4l9t1508r149b1567],
7	is	VBZ	O	be	cop	22	SENT_67	[p4l195t1506r244b1567],
8	much	RB	O	much	advmod	22	SENT_67	[p4l289t1506r481b1567],
9	greater	JJR	O	greater	amod	10	SENT_67	[p4l527t1514r763b1584],
10	(	NN	O	(	pobj	8	SENT_67	[p4l809t1506r1029b1584],
11	18-23	CD	PERCENT	18-23	num	12	SENT_67	[p4l809t1506r1029b1584],
12	%	NN	PERCENT	%	dep	10	SENT_67	[p4l1041t1506r1141b1584],
13	)	CD	NUMBER	)	dep	8	SENT_67	[p4l1041t1506r1141b1584],
14	in	IN	O	in	_	0	SENT_67	[p4l1187t1506r1251b1566],
15	Asian	JJ	LOCATION	asian	amod	16	SENT_67	[p4l1296t1506r1495b1567],
16	people	NNS	O	people	prep_in	8	SENT_67	[p4l1540t1506r1763b1584],
17	than	IN	O	than	_	0	SENT_67	[p4l1809t1505r1963b1567],
18	that	DT	O	that	det	19	SENT_67	[p4l2009t1506r2145b1567],
19	(	NN	O	(	prep_than	16	SENT_67	[p4l10t1611r529b1689],
20	approximately	RB	O	approximately	quantmod	21	SENT_67	[p4l10t1611r529b1689],
21	3	CD	PERCENT	3	num	22	SENT_67	[p4l557t1611r699b1689],
22	%	NN	PERCENT	%	_	0	SENT_67	[p4l557t1611r699b1689],
23	)	CD	NUMBER	)	nsubj	27	SENT_67	[p4l557t1611r699b1689],
24	in	IN	O	in	_	0	SENT_67	[p4l726t1611r790b1672],
25	Caucasian	JJ	LOCATION	caucasian	amod	26	SENT_67	[p4l816t1611r1168b1673],
26	populations	NNS	O	population	prep_in	23	SENT_67	[p4l1192t1611r1597b1689],
27	[	VBP	O	[	rcmod	22	SENT_67	[p4l1626t1612r1759b1688],
28	10	CD	NUMBER	10	number	29	SENT_67	[p4l1626t1612r1759b1688],
29	]	CD	NUMBER	]	dobj	27	SENT_67	[p4l1626t1612r1759b1688],
30	.	.	O	.	_	0	SENT_67	[p4l1626t1612r1759b1688],

1	In	IN	O	in	_	0	SENT_68	[p4l1789t1614r1862b1672],
2	a	DT	O	a	det	6	SENT_68	[p4l1888t1631r1926b1673],
3	metaanalysis	NN	O	metaanalysis	nn	6	SENT_68	[p4l1950t1620r2142b1673, p4l10t1717r274b1795],
4	[	NN	O	[	nn	6	SENT_68	[p4l299t1718r434b1794],
5	11	CD	NUMBER	11	num	6	SENT_68	[p4l299t1718r434b1794],
6	]	NN	O	]	prep_in	15	SENT_68	[p4l299t1718r434b1794],
7	,	,	O	,	_	0	SENT_68	[p4l299t1718r434b1794],
8	21	CD	PERCENT	21	num	9	SENT_68	[p4l460t1718r615b1780],
9	%	NN	PERCENT	%	nsubj	15	SENT_68	[p4l460t1718r615b1780],
10	of	IN	O	of	_	0	SENT_68	[p4l645t1717r720b1778],
11	patients	NNS	O	patient	prep_of	9	SENT_68	[p4l733t1717r999b1795],
12	treated	VBN	O	treat	partmod	11	SENT_68	[p4l1022t1717r1257b1778],
13	with	IN	O	with	_	0	SENT_68	[p4l1278t1717r1428b1778],
14	clopidogrel	NN	O	clopidogrel	prep_with	12	SENT_68	[p4l1450t1717r1829b1795],
15	achieved	VBD	O	achieve	_	0	SENT_68	[p4l1851t1717r2143b1778],
16	low	JJ	O	low	amod	21	SENT_68	[p4l9t1824r132b1885],
17	or	CC	O	or	_	0	SENT_68	[p4l168t1844r240b1885],
18	no	DT	O	no	det	20	SENT_68	[p4l274t1844r360b1885],
19	ex	FW	O	ex	nn	20	SENT_68	[p4l397t1845r475b1885],
20	vivo	FW	O	vivo	conj_or	16	SENT_68	[p4l513t1828r638b1885],
21	inhibition	NN	O	inhibition	dobj	15	SENT_68	[p4l673t1823r1005b1885],
22	of	IN	O	of	_	0	SENT_68	[p4l1041t1824r1116b1885],
23	ADP-induced	JJ	O	adp-induced	amod	25	SENT_68	[p4l1143t1823r1617b1885],
24	platelet	NN	O	platelet	nn	25	SENT_68	[p4l1650t1824r1899b1902],
25	aggregation	NN	O	aggregation	prep_of	21	SENT_68	[p4l1935t1844r2142b1902, p4l9t1930r224b2008],
26	in	IN	O	in	_	0	SENT_68	[p4l276t1930r341b1990],
27	American	JJ	MISC	american	amod	30	SENT_68	[p4l393t1930r730b1991],
28	or	CC	O	or	_	0	SENT_68	[p4l784t1950r857b1991],
29	European	JJ	MISC	european	conj_or	27	SENT_68	[p4l911t1932r1247b2008],
30	populations	NNS	O	population	prep_in	15	SENT_68	[p4l1299t1930r1721b2008],
31	.	.	O	.	_	0	SENT_68	[p4l1299t1930r1721b2008],

1	This	DT	O	this	det	3	SENT_69	[p4l1779t1930r1927b1991],
2	poor	JJ	O	poor	amod	3	SENT_69	[p4l1980t1950r2145b2008],
3	responsiveness	NN	O	responsiveness	nsubjpass	7	SENT_69	[p4l9t2036r503b2114],
4	to	TO	O	to	_	0	SENT_69	[p4l540t2044r607b2097],
5	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_69	[p4l644t2035r1024b2114],
6	is	VBZ	O	be	auxpass	7	SENT_69	[p4l1059t2036r1108b2097],
7	associated	VBN	O	associate	dep	16	SENT_69	[p4l1146t2035r1491b2097],
8	with	IN	O	with	_	0	SENT_69	[p4l1525t2035r1676b2097],
9	an	DT	O	a	det	11	SENT_69	[p4l1712t2056r1794b2097],
10	increased	VBN	O	increase	amod	11	SENT_69	[p4l1829t2035r2144b2097],
11	risk	NN	O	risk	prep_with	7	SENT_69	[p4l9t2141r134b2202],
12	of	IN	O	of	_	0	SENT_69	[p4l159t2141r235b2203],
13	recurrent	JJ	O	recurrent	amod	15	SENT_69	[p4l252t2149r561b2203],
14	ischaemic	JJ	O	ischaemic	amod	15	SENT_69	[p4l585t2141r912b2203],
15	events	NNS	O	event	prep_of	11	SENT_69	[p4l937t2150r1145b2203],
16	[	VBP	O	[	_	0	SENT_69	[p4l1173t2142r1427b2218],
17	11	CD	NUMBER	11	num	18	SENT_69	[p4l1173t2142r1427b2218],
18	—	CD	NUMBER	—	dobj	16	SENT_69	[p4l1173t2142r1427b2218],
19	13	CD	NUMBER	13	num	20	SENT_69	[p4l1173t2142r1427b2218],
20	]	NN	O	]	nsubj	16	SENT_69	[p4l1173t2142r1427b2218],
21	.	.	O	.	_	0	SENT_69	[p4l1173t2142r1427b2218],

1	Based	VBN	O	base	_	0	SENT_70	[p4l1459t2141r1660b2203],
2	on	IN	O	on	prepc_based_on	20	SENT_70	[p4l1686t2161r1772b2203],
3	the	DT	O	the	det	4	SENT_70	[p4l1798t2141r1901b2203],
4	results	NNS	O	result	pobj	20	SENT_70	[p4l1926t2141r2142b2203],
5	in	IN	O	in	_	0	SENT_70	[p4l8t2247r73b2308],
6	this	DT	O	this	det	7	SENT_70	[p4l127t2247r246b2308],
7	study	NN	O	study	prep_in	4	SENT_70	[p4l303t2247r503b2325],
8	,	,	O	,	_	0	SENT_70	[p4l303t2247r503b2325],
9	the	DT	O	the	det	10	SENT_70	[p4l560t2247r664b2308],
10	prevalence	NN	O	prevalence	nsubjpass	20	SENT_70	[p4l717t2247r1077b2325],
11	of	IN	O	of	_	0	SENT_70	[p4l1133t2247r1209b2308],
12	Asian	JJ	MISC	asian	amod	13	SENT_70	[p4l1253t2247r1452b2308],
13	patients	NNS	O	patient	prep_of	10	SENT_70	[p4l1505t2247r1772b2325],
14	with	IN	O	with	_	0	SENT_70	[p4l1825t2247r1976b2308],
15	less	JJR	O	less	amod	16	SENT_70	[p4l2029t2247r2143b2308],
16	responsiveness	NN	O	responsiveness	prep_with	13	SENT_70	[p4l9t2354r503b2432],
17	to	TO	O	to	_	0	SENT_70	[p4l524t2362r591b2415],
18	clopidogrel	NN	O	clopidogrel	prep_to	16	SENT_70	[p4l612t2353r992b2432],
19	is	VBZ	O	be	auxpass	20	SENT_70	[p4l1012t2354r1061b2415],
20	estimated	VBN	O	estimate	_	0	SENT_70	[p4l1082t2353r1405b2415],
21	to	TO	O	to	aux	27	SENT_70	[p4l1426t2362r1493b2415],
22	be	VB	O	be	cop	27	SENT_70	[p4l1515t2353r1592b2415],
23	more	JJR	O	more	mwe	24	SENT_70	[p4l1611t2374r1788b2415],
24	than	IN	O	than	quantmod	26	SENT_70	[p4l1809t2353r1963b2415],
25	30	CD	PERCENT	30	number	26	SENT_70	[p4l1985t2355r2137b2416],
26	%	NN	PERCENT	%	num	27	SENT_70	[p4l1985t2355r2137b2416],
27	patients	NNS	O	patient	xcomp	20	SENT_70	[p4l8t2459r291b2537],
28	.	.	O	.	_	0	SENT_70	[p4l8t2459r291b2537],

1	Fifteen	CD	NUMBER	fifteen	npadvmod	17	SENT_71	[p4l340t2459r578b2521],
2	out	IN	O	out	_	0	SENT_71	[p4l623t2468r735b2521],
3	of	IN	O	of	_	0	SENT_71	[p4l779t2459r855b2521],
4	47	CD	NUMBER	47	num	5	SENT_71	[p4l889t2461r967b2521],
5	subjects	NNS	O	subject	npadvmod	6	SENT_71	[p4l1013t2459r1275b2537],
6	(	JJ	O	(	amod	9	SENT_71	[p4l1321t2460r1531b2537],
7	32	CD	PERCENT	32	number	8	SENT_71	[p4l1321t2460r1531b2537],
8	%	NN	PERCENT	%	amod	9	SENT_71	[p4l1321t2460r1531b2537],
9	)	NN	O	)	prep_out_of	17	SENT_71	[p4l1321t2460r1531b2537],
10	who	WP	O	who	nsubjpass	12	SENT_71	[p4l1574t2459r1719b2521],
11	were	VBD	O	be	auxpass	12	SENT_71	[p4l1763t2479r1921b2521],
12	given	VBN	O	give	rcmod	9	SENT_71	[p4l1965t2459r2144b2537],
13	300	CD	NUMBER	300	num	14	SENT_71	[p4l10t2568r126b2628],
14	mg	NN	O	mg	dobj	12	SENT_71	[p4l155t2586r263b2644],
15	of	IN	O	of	_	0	SENT_71	[p4l320t2566r396b2627],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_71	[p4l442t2566r822b2644],
17	had	VBD	O	have	_	0	SENT_71	[p4l877t2566r1005b2627],
18	<	JJR	O	<	dobj	17	SENT_71	[p4l1078t2577r1124b2617],
19	30	CD	PERCENT	30	number	20	SENT_71	[p4l1174t2567r1326b2628],
20	%	NN	PERCENT	%	amod	18	SENT_71	[p4l1174t2567r1326b2628],
21	inhibition	NN	O	inhibition	nsubj	17	SENT_71	[p4l1387t2566r1719b2627],
22	of	IN	O	of	_	0	SENT_71	[p4l1775t2566r1851b2627],
23	platelet	NN	O	platelet	nn	24	SENT_71	[p4l1897t2566r2146b2644],
24	aggregation	NN	O	aggregation	prep_of	21	SENT_71	[p4l9t2672r425b2750],
25	.	.	O	.	_	0	SENT_71	[p4l9t2672r425b2750],

1	In	IN	O	in	_	0	SENT_72	[p4l93t2780r166b2838],
2	conclusion	NN	O	conclusion	prep_in	10	SENT_72	[p4l197t2777r579b2851],
3	,	,	O	,	_	0	SENT_72	[p4l197t2777r579b2851],
4	the	DT	O	the	det	7	SENT_72	[p4l614t2777r718b2839],
5	CYP2C19	NN	O	cyp2c19	nn	7	SENT_72	[p4l751t2778r1097b2839],
6	pharmacogenomic	JJ	O	pharmacogenomic	amod	7	SENT_72	[p4l1130t2777r1766b2855],
7	status	NN	O	status	nsubj	10	SENT_72	[p4l1799t2786r1993b2839],
8	is	VBZ	O	be	cop	10	SENT_72	[p4l2025t2777r2074b2839],
9	a	DT	O	a	det	10	SENT_72	[p4l2109t2797r2146b2839],
10	determinant	NN	O	determinant	_	0	SENT_72	[p4l8t2883r422b2944],
11	for	IN	O	for	_	0	SENT_72	[p4l469t2883r569b2944],
12	the	DT	O	the	det	13	SENT_72	[p4l616t2883r720b2944],
13	formation	NN	O	formation	prep_for	10	SENT_72	[p4l767t2883r1112b2944],
14	of	IN	O	of	_	0	SENT_72	[p4l1160t2883r1236b2944],
15	the	DT	O	the	det	17	SENT_72	[p4l1276t2883r1379b2944],
16	active	JJ	O	active	amod	17	SENT_72	[p4l1428t2883r1622b2944],
17	metabolite	NN	O	metabolite	prep_of	13	SENT_72	[p4l1668t2883r2028b2944],
18	of	IN	O	of	_	0	SENT_72	[p4l2078t2883r2153b2944],
19	clopidogrel	NN	O	clopidogrel	prep_of	17	SENT_72	[p4l7t2989r388b3069],
20	and	CC	O	and	_	0	SENT_72	[p4l419t2989r545b3052],
21	its	PRP$	O	its	poss	23	SENT_72	[p4l574t2990r650b3052],
22	antiplatelet	JJ	O	antiplatelet	amod	23	SENT_72	[p4l681t2990r1059b3069],
23	effects	NNS	O	effect	prep_of	13	SENT_72	[p4l1088t2990r1299b3052],
24	to	TO	O	to	_	0	SENT_72	[p4l1330t2998r1397b3052],
25	the	DT	O	the	det	27	SENT_72	[p4l1428t2989r1532b3052],
26	active	JJ	O	active	amod	27	SENT_72	[p4l1563t2990r1757b3052],
27	metabolite	NN	O	metabolite	prep_to	23	SENT_72	[p4l1785t2989r2146b3052],
28	in	IN	O	in	_	0	SENT_72	[p4l7t3097r72b3157],
29	healthy	JJ	O	healthy	amod	30	SENT_72	[p4l98t3097r349b3175],
30	subjects	NNS	O	subject	prep_in	27	SENT_72	[p4l378t3097r658b3175],
31	.	.	O	.	_	0	SENT_72	[p4l378t3097r658b3175],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_73	[p4l7t3336r693b3421],

1	This	DT	O	this	det	2	SENT_74	[p4l8t3500r156b3561],
2	study	NN	O	study	nsubjpass	4	SENT_74	[p4l177t3500r361b3578],
3	was	VBD	O	be	auxpass	4	SENT_74	[p4l378t3520r506b3561],
4	supported	VBN	O	support	_	0	SENT_74	[p4l527t3500r870b3578],
5	by	IN	O	by	_	0	SENT_74	[p4l889t3500r973b3578],
6	a	DT	O	a	det	9	SENT_74	[p4l992t3520r1030b3561],
7	scientiﬁc	NN	O	scientiﬁc	nn	9	SENT_74	[p4l1050t3500r1339b3561],
8	research	NN	O	research	nn	9	SENT_74	[p4l1358t3500r1638b3561],
9	grant	NN	O	grant	agent	4	SENT_74	[p4l1657t3508r1838b3578],
10	from	IN	O	from	_	0	SENT_74	[p4l1856t3500r2024b3561],
11	the	DT	O	the	det	14	SENT_74	[p4l2043t3500r2146b3561],
12	Hamamatsu	NNP	ORGANIZATION	Hamamatsu	nn	14	SENT_74	[p4l8t3608r432b3667],
13	University	NNP	ORGANIZATION	University	nn	14	SENT_74	[p4l459t3605r813b3683],
14	School	NNP	ORGANIZATION	School	prep_from	4	SENT_74	[p4l843t3605r1073b3667],
15	of	IN	ORGANIZATION	of	_	0	SENT_74	[p4l1102t3605r1178b3667],
16	Medicine	NNP	ORGANIZATION	Medicine	prep_of	14	SENT_74	[p4l1198t3605r1528b3667],
17	.	.	O	.	_	0	SENT_74	[p4l1198t3605r1528b3667],

1	Disclosure	NN	O	disclosure	_	0	SENT_75	[p5l12t92r391b158],
2	of	IN	O	of	_	0	SENT_75	[p5l423t92r495b158],
3	Conflict	NN	O	conflict	prep_of	1	SENT_75	[p5l530t92r817b158],
4	of	IN	O	of	_	0	SENT_75	[p5l847t92r920b158],
5	Interests	NNS	O	interest	prep_of	1	SENT_75	[p5l953t97r1260b158],

1	The	DT	O	the	det	2	SENT_76	[p5l8t256r139b317],
2	authors	NNS	O	author	nsubj	3	SENT_76	[p5l168t256r426b317],
3	state	VBP	O	state	_	0	SENT_76	[p5l456t264r610b317],
4	that	IN	O	that	complm	6	SENT_76	[p5l638t256r774b317],
5	they	PRP	O	they	nsubj	6	SENT_76	[p5l801t256r946b334],
6	have	VBP	O	have	ccomp	3	SENT_76	[p5l972t256r1130b317],
7	no	DT	O	no	det	8	SENT_76	[p5l1157t276r1244b317],
8	conﬂict	NN	O	conﬂict	dobj	6	SENT_76	[p5l1272t256r1522b317],
9	of	IN	O	of	_	0	SENT_76	[p5l1550t256r1626b317],
10	interest	NN	O	interest	prep_of	8	SENT_76	[p5l1644t256r1908b317],
11	.	.	O	.	_	0	SENT_76	[p5l1644t256r1908b317],

1	References	NNS	O	reference	_	0	SENT_77	[p5l12t495r403b561],

1	Chen	NNP	ORGANIZATION	Chen	nn	2	SENT_78	[p5l113t656r265b708],
2	ZM	NNP	ORGANIZATION	ZM	dep	25	SENT_78	[p5l289t657r418b719],
3	,	,	O	,	_	0	SENT_78	[p5l289t657r418b719],
4	Jiang	NNP	PERSON	Jiang	nn	5	SENT_78	[p5l444t656r597b722],
5	LX	NNP	O	LX	appos	2	SENT_78	[p5l621t658r733b719],
6	,	,	O	,	_	0	SENT_78	[p5l621t658r733b719],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_78	[p5l761t656r914b708],
8	YP	NNP	O	YP	appos	2	SENT_78	[p5l937t658r1046b719],
9	,	,	O	,	_	0	SENT_78	[p5l937t658r1046b719],
10	Xie	NNP	O	Xie	nn	11	SENT_78	[p5l1072t656r1172b708],
11	JX	NNP	O	JX	appos	2	SENT_78	[p5l1195t658r1293b719],
12	,	,	O	,	_	0	SENT_78	[p5l1195t658r1293b719],
13	Pan	NNP	O	Pan	nn	14	SENT_78	[p5l1318t658r1432b708],
14	HC	NNP	O	HC	appos	2	SENT_78	[p5l1456t657r1576b719],
15	,	,	O	,	_	0	SENT_78	[p5l1456t657r1576b719],
16	Peto	NNP	PERSON	Peto	nn	17	SENT_78	[p5l1602t658r1731b708],
17	R	NNP	PERSON	R	appos	2	SENT_78	[p5l1758t658r1823b719],
18	,	,	O	,	_	0	SENT_78	[p5l1758t658r1823b719],
19	Collins	NNP	ORGANIZATION	Collins	nn	20	SENT_78	[p5l1851t656r2052b708],
20	R	NNP	ORGANIZATION	R	appos	2	SENT_78	[p5l2078t658r2143b719],
21	,	,	O	,	_	0	SENT_78	[p5l2078t658r2143b719],
22	Liu	NNP	ORGANIZATION	Liu	nn	23	SENT_78	[p5l113t745r212b797],
23	LS	NN	ORGANIZATION	l	appos	2	SENT_78	[p5l257t745r353b808],
24	,	,	O	,	_	0	SENT_78	[p5l257t745r353b808],
25	COMMIT	VBP	O	commit	_	0	SENT_78	[p5l401t745r712b797],
26	(	CD	NUMBER	(	dobj	25	SENT_78	[p5l758t744r1137b811],
27	ClOpidogrel	NNP	O	ClOpidogrel	dep	25	SENT_78	[p5l758t744r1137b811],
28	and	CC	O	and	_	0	SENT_78	[p5l1183t744r1290b797],
29	Metoprolol	NNP	O	Metoprolol	conj_and	27	SENT_78	[p5l1335t745r1667b811],
30	in	IN	O	in	_	0	SENT_78	[p5l1710t745r1765b796],
31	Myocardial	JJ	O	myocardial	amod	33	SENT_78	[p5l1810t744r2147b811],
32	Infarction	NN	O	infarction	nn	33	SENT_78	[p5l112t833r402b886],
33	Trial	NN	O	trial	prep_in	25	SENT_78	[p5l447t834r608b900],
34	)	CD	NUMBER	)	num	36	SENT_78	[p5l447t834r608b900],
35	collaborative	JJ	O	collaborative	amod	36	SENT_78	[p5l654t833r1030b886],
36	group	NN	O	group	nsubj	25	SENT_78	[p5l1076t850r1261b900],
37	.	.	O	.	_	0	SENT_78	[p5l1076t850r1261b900],

1	Addition	NN	O	addition	nsubj	14	SENT_79	[p5l1309t833r1572b886],
2	of	IN	O	of	_	0	SENT_79	[p5l1617t833r1682b886],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_79	[p5l1719t833r2043b900],
4	to	TO	O	to	dep	5	SENT_79	[p5l2088t841r2145b886],
5	aspirin	NN	O	aspirin	dep	14	SENT_79	[p5l112t923r307b989],
6	in	IN	O	in	_	0	SENT_79	[p5l341t923r396b974],
7	45,852	CD	NUMBER	45,852	num	8	SENT_79	[p5l429t924r617b986],
8	patients	NNS	O	patient	prep_in	5	SENT_79	[p5l650t923r877b989],
9	with	IN	O	with	_	0	SENT_79	[p5l911t923r1038b975],
10	acute	JJ	O	acute	amod	12	SENT_79	[p5l1073t930r1223b975],
11	myocardial	JJ	O	myocardial	amod	12	SENT_79	[p5l1257t922r1584b989],
12	infarction	NN	O	infarction	prep_with	8	SENT_79	[p5l1617t923r1913b975],
13	:	:	O	:	_	0	SENT_79	[p5l1617t923r1913b975],
14	randomised	VBN	O	randomise	_	0	SENT_79	[p5l1952t922r2145b975, p5l110t1011r278b1063],
15	placebo-controlled	JJ	O	placebo-controlled	amod	16	SENT_79	[p5l300t1011r842b1077],
16	trial	NN	O	trial	dobj	14	SENT_79	[p5l866t1011r996b1063],
17	.	.	O	.	_	0	SENT_79	[p5l866t1011r996b1063],

1	Lancet	NNP	O	Lancet	_	0	SENT_80	[p5l1023t1014r1218b1063],
2	2005	CD	DATE	2005	num	1	SENT_80	[p5l1241t1012r1390b1074],
3	;	:	O	;	_	0	SENT_80	[p5l1241t1012r1390b1074],
4	366	CD	NUMBER	366	num	6	SENT_80	[p5l1416t1012r1531b1063],
5	:	:	O	:	_	0	SENT_80	[p5l1416t1012r1531b1063],
6	1607-21	CD	NUMBER	1607-21	dep	1	SENT_80	[p5l1565t1012r1810b1064],
7	.	.	O	.	_	0	SENT_80	[p5l1565t1012r1810b1064],

1	Sabatine	NNP	PERSON	Sabatine	nn	2	SENT_81	[p5l114t1100r361b1153],
2	MS	NN	O	m	nsubj	22	SENT_81	[p5l428t1102r548b1164],
3	,	,	O	,	_	0	SENT_81	[p5l428t1102r548b1164],
4	Cannon	NNP	ORGANIZATION	Cannon	nn	5	SENT_81	[p5l617t1101r850b1153],
5	CP	NNP	ORGANIZATION	CP	appos	2	SENT_81	[p5l916t1101r1020b1164],
6	,	,	O	,	_	0	SENT_81	[p5l916t1101r1020b1164],
7	Gibson	NNP	PERSON	Gibson	nn	8	SENT_81	[p5l1090t1100r1302b1153],
8	CM	NN	O	cm	appos	2	SENT_81	[p5l1368t1101r1500b1164],
9	,	,	O	,	_	0	SENT_81	[p5l1368t1101r1500b1164],
10	Lopez-Sendon	NNP	O	Lopez-Sendon	nn	11	SENT_81	[p5l1569t1100r1989b1167],
11	JL	NNP	O	JL	appos	2	SENT_81	[p5l2054t1102r2144b1164],
12	,	,	O	,	_	0	SENT_81	[p5l2054t1102r2144b1164],
13	Montalescot	NNP	O	Montalescot	nn	14	SENT_81	[p5l112t1190r475b1242],
14	G	NNP	O	G	appos	2	SENT_81	[p5l511t1191r580b1253],
15	,	,	O	,	_	0	SENT_81	[p5l511t1191r580b1253],
16	Theroux	NNP	PERSON	Theroux	nn	17	SENT_81	[p5l618t1190r866b1242],
17	P	NN	O	p	appos	2	SENT_81	[p5l901t1192r956b1253],
18	,	,	O	,	_	0	SENT_81	[p5l901t1192r956b1253],
19	Claeys	NNP	PERSON	Claeys	nn	20	SENT_81	[p5l995t1190r1184b1256],
20	MJ	NNP	PERSON	MJ	appos	2	SENT_81	[p5l1221t1191r1332b1253],
21	,	,	O	,	_	0	SENT_81	[p5l1221t1191r1332b1253],
22	Cools	VBZ	O	cool	_	0	SENT_81	[p5l1371t1190r1536b1242],
23	F	NN	O	f	dobj	22	SENT_81	[p5l1573t1192r1632b1253],
24	,	,	O	,	_	0	SENT_81	[p5l1573t1192r1632b1253],
25	Hill	NNP	LOCATION	Hill	nn	26	SENT_81	[p5l1670t1190r1779b1241],
26	KA	NN	LOCATION	ka	appos	23	SENT_81	[p5l1814t1190r1938b1253],
27	,	,	O	,	_	0	SENT_81	[p5l1814t1190r1938b1253],
28	Skene	NNP	ORGANIZATION	Skene	nn	29	SENT_81	[p5l1978t1190r2147b1242],
29	AM	NNP	ORGANIZATION	AM	appos	23	SENT_81	[p5l111t1278r247b1341],
30	,	,	O	,	_	0	SENT_81	[p5l111t1278r247b1341],
31	McCabe	NNP	PERSON	McCabe	nn	32	SENT_81	[p5l290t1278r538b1330],
32	CH	NN	O	ch	appos	23	SENT_81	[p5l579t1279r698b1341],
33	,	,	O	,	_	0	SENT_81	[p5l579t1279r698b1341],
34	Braunwald	NNP	PERSON	Braunwald	nn	35	SENT_81	[p5l742t1278r1061b1330],
35	E	NNP	O	E	appos	23	SENT_81	[p5l1101t1280r1160b1341],
36	,	,	O	,	_	0	SENT_81	[p5l1101t1280r1160b1341],
37	CLARITY-TIMI	NNP	O	CLARITY-TIMI	nn	39	SENT_81	[p5l1203t1278r1716b1330],
38	28	CD	NUMBER	28	num	39	SENT_81	[p5l1757t1279r1821b1330],
39	Investigators	NNS	O	investigator	appos	23	SENT_81	[p5l1864t1278r2144b1344, p5l112t1374r236b1419],
40	.	.	O	.	_	0	SENT_81	[p5l1864t1278r2144b1344, p5l112t1374r236b1419],

1	Addition	NN	O	addition	_	0	SENT_82	[p5l278t1367r540b1419],
2	of	IN	O	of	_	0	SENT_82	[p5l572t1367r636b1419],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_82	[p5l658t1367r982b1433],
4	to	TO	O	to	_	0	SENT_82	[p5l1012t1374r1069b1419],
5	aspirin	NN	O	aspirin	prep_to	3	SENT_82	[p5l1102t1367r1298b1433],
6	and	CC	O	and	_	0	SENT_82	[p5l1328t1367r1436b1419],
7	ﬁbrinolytic	JJ	O	ﬁbrinolytic	amod	8	SENT_82	[p5l1466t1367r1782b1433],
8	therapy	NN	O	therapy	prep_of	1	SENT_82	[p5l1812t1367r2033b1433],
9	for	IN	O	for	_	0	SENT_82	[p5l2063t1367r2148b1419],
10	myocardial	JJ	O	myocardial	amod	11	SENT_82	[p5l110t1457r437b1523],
11	infarction	NN	O	infarction	prep_for	8	SENT_82	[p5l456t1457r739b1509],
12	with	IN	O	with	_	0	SENT_82	[p5l759t1457r887b1509],
13	ST-segment	NN	O	st-segment	nn	14	SENT_82	[p5l909t1458r1248b1523],
14	elevation	NN	O	elevation	prep_with	1	SENT_82	[p5l1268t1457r1541b1509],
15	.	.	O	.	_	0	SENT_82	[p5l1268t1457r1541b1509],

1	N	NN	O	n	nn	3	SENT_83	[p5l1566t1460r1624b1509],
2	Engl	NNP	O	Engl	nn	3	SENT_83	[p5l1638t1457r1773b1523],
3	J	NNP	O	J	nsubj	4	SENT_83	[p5l1788t1460r1828b1509],
4	Med	VBD	O	med	_	0	SENT_83	[p5l1842t1457r1980b1509],
5	2005	CD	DATE	2005	dobj	4	SENT_83	[p5l1994t1458r2143b1520],
6	;	:	O	;	_	0	SENT_83	[p5l1994t1458r2143b1520],
7	352	CD	NUMBER	352	num	9	SENT_83	[p5l111t1546r226b1597],
8	:	:	O	:	_	0	SENT_83	[p5l111t1546r226b1597],
9	1179-89	CD	NUMBER	1179-89	dep	5	SENT_83	[p5l260t1546r505b1597],
10	.	.	O	.	_	0	SENT_83	[p5l260t1546r505b1597],

1	Pereillo	JJ	O	pereillo	amod	3	SENT_84	[p5l111t1634r326b1686],
2	J	NN	O	j	nn	3	SENT_84	[p5l347t1636r375b1686],
3	M	NN	O	m	dep	32	SENT_84	[p5l378t1636r459b1697],
4	,	,	O	,	_	0	SENT_84	[p5l378t1636r459b1697],
5	Maftouh	NN	O	maftouh	nn	6	SENT_84	[p5l482t1634r742b1686],
6	M	NN	O	m	appos	3	SENT_84	[p5l762t1636r843b1697],
7	,	,	O	,	_	0	SENT_84	[p5l762t1636r843b1697],
8	Andrieu	NNP	PERSON	Andrieu	nn	9	SENT_84	[p5l865t1634r1105b1686],
9	A	NNP	O	A	appos	3	SENT_84	[p5l1123t1634r1191b1697],
10	,	,	O	,	_	0	SENT_84	[p5l1123t1634r1191b1697],
11	Uzabiaga	NNP	O	Uzabiaga	nn	12	SENT_84	[p5l1213t1634r1490b1700],
12	MF	NN	O	mf	appos	3	SENT_84	[p5l1511t1636r1638b1697],
13	,	,	O	,	_	0	SENT_84	[p5l1511t1636r1638b1697],
14	Fedeli	NNP	PERSON	Fedeli	nn	15	SENT_84	[p5l1662t1634r1838b1686],
15	O	NNP	PERSON	O	appos	3	SENT_84	[p5l1858t1635r1924b1697],
16	,	,	O	,	_	0	SENT_84	[p5l1858t1635r1924b1697],
17	Savi	NNP	PERSON	Savi	nn	18	SENT_84	[p5l1949t1634r2068b1687],
18	P	NN	O	p	appos	3	SENT_84	[p5l2088t1636r2143b1697],
19	,	,	O	,	_	0	SENT_84	[p5l2088t1636r2143b1697],
20	Pascal	NNP	PERSON	Pascal	nn	21	SENT_84	[p5l111t1724r294b1776],
21	M	NNP	PERSON	M	appos	3	SENT_84	[p5l318t1725r400b1786],
22	,	,	O	,	_	0	SENT_84	[p5l318t1725r400b1786],
23	Herbert	NNP	PERSON	Herbert	nn	25	SENT_84	[p5l427t1723r654b1775],
24	J	NNP	PERSON	J	nn	25	SENT_84	[p5l678t1726r706b1776],
25	M	NN	PERSON	m	appos	3	SENT_84	[p5l708t1726r790b1786],
26	,	,	O	,	_	0	SENT_84	[p5l708t1726r790b1786],
27	Maffrand	NNP	O	Maffrand	nn	28	SENT_84	[p5l817t1724r1096b1776],
28	JP	NNP	O	JP	appos	3	SENT_84	[p5l1120t1726r1205b1786],
29	,	,	O	,	_	0	SENT_84	[p5l1120t1726r1205b1786],
30	Picard	NNP	PERSON	Picard	nn	31	SENT_84	[p5l1231t1724r1417b1775],
31	C.	NNP	O	C.	appos	3	SENT_84	[p5l1441t1725r1503b1776],
32	Structure	NN	O	structure	_	0	SENT_84	[p5l1532t1725r1798b1776],
33	and	CC	O	and	_	0	SENT_84	[p5l1823t1723r1930b1775],
34	stereochemistry	NN	O	stereochemistry	conj_and	32	SENT_84	[p5l1955t1731r2145b1775, p5l111t1812r391b1878],
35	of	IN	O	of	_	0	SENT_84	[p5l420t1812r484b1864],
36	the	DT	O	the	det	38	SENT_84	[p5l505t1812r593b1864],
37	active	JJ	O	active	amod	38	SENT_84	[p5l621t1812r787b1864],
38	metabolite	NN	O	metabolite	prep_of	32	SENT_84	[p5l814t1812r1120b1864],
39	of	IN	O	of	_	0	SENT_84	[p5l1149t1812r1213b1864],
40	clopidogrel	NN	O	clopidogrel	prep_of	38	SENT_84	[p5l1234t1812r1570b1878],
41	.	.	O	.	_	0	SENT_84	[p5l1234t1812r1570b1878],

1	Drug	NNP	O	Drug	nn	3	SENT_85	[p5l1600t1815r1750b1878],
2	Meta	NNP	O	Meta	nn	3	SENT_85	[p5l1775t1815r1930b1864],
3	Dispos	NNP	O	Dispos	_	0	SENT_85	[p5l1955t1815r2147b1878],
4	2002	CD	DATE	2002	num	3	SENT_85	[p5l112t1901r262b1963],
5	;	:	O	;	_	0	SENT_85	[p5l112t1901r262b1963],
6	30	CD	NUMBER	30	num	8	SENT_85	[p5l287t1901r368b1952],
7	:	:	O	:	_	0	SENT_85	[p5l287t1901r368b1952],
8	1288-95	CD	NUMBER	1288-95	dep	3	SENT_85	[p5l402t1901r647b1952],
9	.	.	O	.	_	0	SENT_85	[p5l402t1901r647b1952],

1	Savi	NNP	PERSON	Savi	_	0	SENT_86	[p5l114t1988r234b2041],
2	P	NN	PERSON	p	dep	1	SENT_86	[p5l285t1990r341b2051],
3	,	,	O	,	_	0	SENT_86	[p5l285t1990r341b2051],
4	Pereillo	NNP	O	Pereillo	nn	6	SENT_86	[p5l395t1988r611b2040],
5	J	NNP	O	J	nn	6	SENT_86	[p5l664t1990r692b2041],
6	M	NN	O	m	conj_and	2	SENT_86	[p5l695t1990r777b2051],
7	,	,	O	,	_	0	SENT_86	[p5l695t1990r777b2051],
8	Uzabiaga	NNP	O	Uzabiaga	nn	9	SENT_86	[p5l832t1988r1109b2055],
9	MF	NN	O	mf	conj_and	2	SENT_86	[p5l1162t1990r1289b2051],
10	,	,	O	,	_	0	SENT_86	[p5l1162t1990r1289b2051],
11	Combalbert	NNP	PERSON	Combalbert	nn	12	SENT_86	[p5l1345t1988r1694b2041],
12	J	NNP	PERSON	J	conj_and	2	SENT_86	[p5l1744t1990r1773b2041],
13	,	,	O	,	_	0	SENT_86	[p5l1777t2032r1788b2051],
14	Picard	NNP	PERSON	Picard	nn	15	SENT_86	[p5l1843t1988r2029b2040],
15	C	NNP	O	C	conj_and	2	SENT_86	[p5l2082t1989r2144b2051],
16	,	,	O	,	_	0	SENT_86	[p5l2082t1989r2144b2051],
17	Maffrand	NNP	O	Maffrand	nn	18	SENT_86	[p5l112t2078r390b2130],
18	JP	NNP	O	JP	dep	1	SENT_86	[p5l427t2080r512b2141],
19	,	,	O	,	_	0	SENT_86	[p5l427t2080r512b2141],
20	Pascal	NNP	PERSON	Pascal	nn	21	SENT_86	[p5l552t2078r735b2130],
21	M	NNP	PERSON	M	dep	1	SENT_86	[p5l773t2080r855b2141],
22	,	,	O	,	_	0	SENT_86	[p5l773t2080r855b2141],
23	Herbert	NNP	PERSON	Herbert	nn	26	SENT_86	[p5l896t2078r1123b2130],
24	J	NNP	PERSON	J	nn	26	SENT_86	[p5l1159t2080r1188b2130],
25	M.	NNP	PERSON	M.	nn	26	SENT_86	[p5l1190t2080r1271b2130],
26	Identiﬁcation	NNP	PERSON	Identiﬁcation	conj_and	2	SENT_86	[p5l1313t2078r1700b2130],
27	and	CC	O	and	_	0	SENT_86	[p5l1729t2078r1836b2130],
28	biological	JJ	O	biological	amod	29	SENT_86	[p5l1865t2078r2146b2144],
29	activity	NN	O	activity	conj_and	2	SENT_86	[p5l112t2166r323b2232],
30	of	IN	O	of	_	0	SENT_86	[p5l343t2166r407b2218],
31	the	DT	O	the	det	33	SENT_86	[p5l420t2166r507b2218],
32	active	JJ	O	active	amod	33	SENT_86	[p5l527t2166r693b2218],
33	metabolite	NN	O	metabolite	prep_of	1	SENT_86	[p5l711t2166r1017b2218],
34	of	IN	O	of	_	0	SENT_86	[p5l1038t2166r1102b2218],
35	clopidogrel	NN	O	clopidogrel	prep_of	33	SENT_86	[p5l1114t2166r1451b2232],
36	.	.	O	.	_	0	SENT_86	[p5l1114t2166r1451b2232],

1	T	NN	O	t	nn	2	SENT_87	[p5l1479t2169r1525b2218],
2	hromb	NN	O	hromb	_	0	SENT_87	[p5l1519t2166r1699b2218],
3	Haemost	NNP	O	Haemost	dep	2	SENT_87	[p5l1719t2169r1976b2218],
4	2000	CD	DATE	2000	num	3	SENT_87	[p5l1994t2167r2143b2229],
5	;	:	O	;	_	0	SENT_87	[p5l1994t2167r2143b2229],
6	84	CD	NUMBER	84	num	8	SENT_87	[p5l111t2256r192b2308],
7	:	:	O	:	_	0	SENT_87	[p5l111t2256r192b2308],
8	891-6	CD	NUMBER	891-6	dep	2	SENT_87	[p5l221t2256r402b2308],
9	.	.	O	.	_	0	SENT_87	[p5l221t2256r402b2308],

1	Hulot	NNP	PERSON	Hulot	nn	3	SENT_88	[p5l112t2344r283b2397],
2	J	NNP	PERSON	J	nn	3	SENT_88	[p5l313t2346r342b2397],
3	S	NN	PERSON	s	nsubj	36	SENT_88	[p5l346t2345r395b2407],
4	,	,	O	,	_	0	SENT_88	[p5l346t2345r395b2407],
5	Bura	NNP	O	Bura	nn	6	SENT_88	[p5l431t2346r572b2397],
6	A	NNP	O	A	appos	3	SENT_88	[p5l602t2344r670b2407],
7	,	,	O	,	_	0	SENT_88	[p5l602t2344r670b2407],
8	Villard	NNP	ORGANIZATION	Villard	nn	9	SENT_88	[p5l703t2344r903b2397],
9	E	NNP	ORGANIZATION	E	appos	3	SENT_88	[p5l935t2346r993b2408],
10	,	,	O	,	_	0	SENT_88	[p5l935t2346r993b2408],
11	Azizi	NNP	O	Azizi	nn	12	SENT_88	[p5l1026t2344r1174b2396],
12	M	NNP	O	M	appos	3	SENT_88	[p5l1207t2346r1288b2408],
13	,	,	O	,	_	0	SENT_88	[p5l1207t2346r1288b2408],
14	Remones	NNP	O	Remones	nn	15	SENT_88	[p5l1324t2346r1591b2397],
15	V	NNP	O	V	appos	3	SENT_88	[p5l1622t2346r1686b2408],
16	,	,	O	,	_	0	SENT_88	[p5l1622t2346r1686b2408],
17	Goyenvalle	NNP	O	Goyenvalle	nn	18	SENT_88	[p5l1722t2344r2049b2411],
18	C	NNP	O	C	appos	3	SENT_88	[p5l2082t2345r2144b2407],
19	,	,	O	,	_	0	SENT_88	[p5l2082t2345r2144b2407],
20	Aiach	NNP	O	Aiach	nn	21	SENT_88	[p5l111t2433r283b2485],
21	M	NNP	O	M	appos	3	SENT_88	[p5l321t2435r402b2496],
22	,	,	O	,	_	0	SENT_88	[p5l321t2435r402b2496],
23	Lechat	NNP	PERSON	Lechat	nn	24	SENT_88	[p5l443t2433r640b2485],
24	P	NN	PERSON	p	appos	3	SENT_88	[p5l677t2435r732b2496],
25	,	,	O	,	_	0	SENT_88	[p5l677t2435r732b2496],
26	Gaussem	NNP	O	Gaussem	nn	32	SENT_88	[p5l773t2434r1039b2485],
27	P.	NNP	O	P.	nn	32	SENT_88	[p5l1075t2435r1129b2485],
28	Cytochrome	NNP	O	Cytochrome	nn	32	SENT_88	[p5l1171t2433r1531b2499],
29	P450	NN	O	p450	nn	32	SENT_88	[p5l1568t2434r1710b2486],
30	2C19	NN	O	2c19	nn	32	SENT_88	[p5l1748t2434r1897b2485],
31	lossoffunction	NN	O	lossoffunction	nn	32	SENT_88	[p5l1936t2433r2144b2485, p5l112t2522r353b2574],
32	polymorphism	NN	O	polymorphism	appos	3	SENT_88	[p5l408t2522r834b2589],
33	is	VBZ	O	be	cop	36	SENT_88	[p5l889t2522r931b2574],
34	a	DT	O	a	det	36	SENT_88	[p5l988t2539r1020b2574],
35	major	JJ	O	major	amod	36	SENT_88	[p5l1075t2522r1248b2589],
36	determinant	NN	O	determinant	_	0	SENT_88	[p5l1303t2522r1655b2574],
37	of	IN	O	of	_	0	SENT_88	[p5l1711t2522r1776b2574],
38	clopidogrel	NN	O	clopidogrel	nn	39	SENT_88	[p5l1824t2522r2147b2589],
39	responsiveness	NN	O	responsiveness	prep_of	36	SENT_88	[p5l112t2611r532b2678],
40	in	IN	O	in	_	0	SENT_88	[p5l555t2611r609b2663],
41	healthy	JJ	O	healthy	amod	42	SENT_88	[p5l633t2611r846b2677],
42	subjects	NNS	O	subject	prep_in	39	SENT_88	[p5l870t2611r1107b2678],
43	.	.	O	.	_	0	SENT_88	[p5l870t2611r1107b2678],

1	Blood	NN	O	blood	_	0	SENT_89	[p5l1135t2611r1306b2664],
2	2006	CD	DATE	2006	num	1	SENT_89	[p5l1323t2612r1473b2675],
3	;	:	O	;	_	0	SENT_89	[p5l1323t2612r1473b2675],
4	108	CD	NUMBER	108	num	6	SENT_89	[p5l1502t2612r1613b2664],
5	:	:	O	:	_	0	SENT_89	[p5l1502t2612r1613b2664],
6	2244-7	CD	NUMBER	2244-7	dep	1	SENT_89	[p5l1641t2612r1858b2664],
7	.	.	O	.	_	0	SENT_89	[p5l1641t2612r1858b2664],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_90	[p5l113t2700r315b2752],
2	J	NNP	PERSON	J	_	0	SENT_90	[p5l332t2702r361b2752],
3	T	NN	PERSON	t	dep	2	SENT_90	[p5l363t2702r422b2763],
4	,	,	O	,	_	0	SENT_90	[p5l363t2702r422b2763],
5	Close	NNP	O	Close	nn	6	SENT_90	[p5l445t2700r603b2752],
6	SL	NNP	O	SL	appos	3	SENT_90	[p5l624t2701r719b2763],
7	,	,	O	,	_	0	SENT_90	[p5l624t2701r719b2763],
8	Iturria	NNP	ORGANIZATION	Iturria	nn	9	SENT_90	[p5l741t2700r929b2752],
9	SJ	NNP	ORGANIZATION	SJ	appos	3	SENT_90	[p5l950t2701r1029b2763],
10	,	,	O	,	_	0	SENT_90	[p5l950t2701r1029b2763],
11	Payne	NNP	PERSON	Payne	nn	12	SENT_90	[p5l1049t2702r1225b2766],
12	CD	NNP	O	CD	appos	3	SENT_90	[p5l1245t2701r1365b2763],
13	,	,	O	,	_	0	SENT_90	[p5l1245t2701r1365b2763],
14	Farid	NNP	ORGANIZATION	Farid	nn	18	SENT_90	[p5l1387t2700r1547b2752],
15	NA	NNP	ORGANIZATION	NA	nn	18	SENT_90	[p5l1565t2700r1690b2763],
16	,	,	O	,	_	0	SENT_90	[p5l1565t2700r1690b2763],
17	Ernest	NNP	PERSON	Ernest	appos	18	SENT_90	[p5l1712t2702r1897b2752],
18	CS	NNP	O	CS	appos	3	SENT_90	[p5l1917t2701r2000b2753],
19	2nd	JJ	ORDINAL	2nd	amod	18	SENT_90	[p5l2021t2700r2144b2763],
20	,	,	O	,	_	0	SENT_90	[p5l2021t2700r2144b2763],
21	Lachno	NNP	O	Lachno	nn	22	SENT_90	[p5l113t2789r332b2841],
22	DR	NN	O	dr	appos	3	SENT_90	[p5l370t2791r493b2852],
23	,	,	O	,	_	0	SENT_90	[p5l370t2791r493b2852],
24	Salazar	NN	PERSON	salazar	nn	25	SENT_90	[p5l534t2789r745b2842],
25	D	NN	O	d	appos	3	SENT_90	[p5l780t2791r850b2852],
26	,	,	O	,	_	0	SENT_90	[p5l780t2791r850b2852],
27	Winters	NNP	ORGANIZATION	Winters	nn	28	SENT_90	[p5l887t2789r1115b2842],
28	KJ	NNP	ORGANIZATION	KJ	appos	3	SENT_90	[p5l1152t2791r1251b2842],
29	.	.	O	.	_	0	SENT_90	[p5l1152t2791r1251b2842],

1	Common	JJ	O	common	amod	2	SENT_91	[p5l1292t2790r1567b2842],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_91	[p5l1601t2789r2052b2856],
3	of	IN	O	of	_	0	SENT_91	[p5l2089t2789r2153b2841],
4	CYP	NN	O	cyp	nn	5	SENT_91	[p5l113t2879r255b2931],
5	2C19	NN	O	2c19	prep_of	2	SENT_91	[p5l282t2879r431b2931],
6	and	CC	O	and	_	0	SENT_91	[p5l461t2878r567b2930],
7	CYP	NN	O	cyp	nn	8	SENT_91	[p5l596t2879r738b2931],
8	2C9	NN	O	2c9	prep_of	2	SENT_91	[p5l766t2879r880b2931],
9	after	IN	O	after	_	0	SENT_91	[p5l909t2878r1042b2930],
10	the	DT	O	the	det	14	SENT_91	[p5l1068t2878r1156b2930],
11	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_91	[p5l1182t2878r1669b2945],
12	and	CC	O	and	_	0	SENT_91	[p5l1697t2878r1805b2930],
13	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	11	SENT_91	[p5l1830t2878r2146b2945, p5l112t2967r359b3034],
14	response	NN	O	response	prep_after	5	SENT_91	[p5l377t2984r626b3034],
15	to	TO	O	to	_	0	SENT_91	[p5l645t2975r702b3020],
16	clopidogrel	NN	O	clopidogrel	prep_to	14	SENT_91	[p5l721t2967r1045b3034],
17	but	CC	O	but	_	0	SENT_91	[p5l1063t2967r1160b3020],
18	not	RB	O	not	_	0	SENT_91	[p5l1178t2975r1274b3020],
19	prasugrel	NN	O	prasugrel	prep_after	5	SENT_91	[p5l1291t2967r1574b3034],
20	.	.	O	.	_	0	SENT_91	[p5l1291t2967r1574b3034],

1	J	NN	O	j	nn	3	SENT_92	[p5l1595t2970r1635b3020],
2	T	NN	O	t	nn	3	SENT_92	[p5l1652t2970r1698b3019],
3	hromb	NN	O	hromb	_	0	SENT_92	[p5l1692t2968r1872b3020],
4	Haemost	NNP	O	Haemost	dep	3	SENT_92	[p5l1891t2970r2147b3020],
5	2007	CD	DATE	2007	num	4	SENT_92	[p5l112t3057r262b3119],
6	;	:	O	;	_	0	SENT_92	[p5l112t3057r262b3119],
7	5	CD	NUMBER	5	num	9	SENT_92	[p5l287t3058r333b3108],
8	:	:	O	:	_	0	SENT_92	[p5l287t3058r333b3108],
9	2429-36	CD	NUMBER	2429-36	dep	3	SENT_92	[p5l362t3057r612b3108],
10	.	.	O	.	_	0	SENT_92	[p5l362t3057r612b3108],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_93	[p5l112t3144r242b3196],
2	K	NNP	PERSON	K	_	0	SENT_93	[p5l266t3146r337b3207],
3	,	,	O	,	_	0	SENT_93	[p5l266t3146r337b3207],
4	Park	NNP	O	Park	nn	5	SENT_93	[p5l364t3144r503b3196],
5	P	NN	O	p	appos	2	SENT_93	[p5l526t3146r581b3207],
6	,	,	O	,	_	0	SENT_93	[p5l526t3146r581b3207],
7	Hong	NNP	LOCATION	Hong	nn	8	SENT_93	[p5l609t3146r775b3211],
8	S	NNP	LOCATION	S	appos	2	SENT_93	[p5l800t3145r850b3207],
9	,	,	O	,	_	0	SENT_93	[p5l800t3145r850b3207],
10	Park	NNP	O	Park	nn	11	SENT_93	[p5l877t3144r1015b3197],
11	JY	NN	O	jy	appos	2	SENT_93	[p5l1039t3146r1135b3197],
12	.	.	O	.	_	0	SENT_93	[p5l1039t3146r1135b3197],

1	The	DT	O	the	det	2	SENT_94	[p5l1163t3144r1275b3196],
2	effect	NN	O	effect	_	0	SENT_94	[p5l1299t3144r1451b3196],
3	of	IN	O	of	_	0	SENT_94	[p5l1476t3144r1540b3196],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_94	[p5l1558t3145r1852b3197],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_94	[p5l1877t3144r2146b3211, p5l111t3233r287b3300],
6	on	IN	O	on	_	0	SENT_94	[p5l318t3250r391b3286],
7	the	DT	O	the	det	8	SENT_94	[p5l422t3233r509b3286],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	2	SENT_94	[p5l539t3233r1051b3300],
9	and	CC	O	and	_	0	SENT_94	[p5l1084t3233r1191b3286],
10	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	2	SENT_94	[p5l1221t3233r1789b3300],
11	of	IN	O	of	_	0	SENT_94	[p5l1821t3233r1885b3286],
12	clopido	NN	O	clopido	nn	13	SENT_94	[p5l1909t3233r2145b3300, p5l224t3453r274b3503],
13	©	NN	O	©	prep_of	8	SENT_94	[p5l1909t3233r2145b3300, p5l224t3453r274b3503],

1	2008	CD	DATE	2008	num	3	SENT_95	[p5l302t3452r439b3503],
2	International	NNP	ORGANIZATION	International	nn	3	SENT_95	[p5l469t3451r866b3503],
3	Society	NNP	ORGANIZATION	Society	_	0	SENT_95	[p5l895t3451r1110b3516],
4	on	IN	O	on	_	0	SENT_95	[p5l1137t3468r1212b3503],
5	Thrombosis	NNP	O	Thrombosis	prep_on	3	SENT_95	[p5l1239t3450r1599b3503],
6	and	CC	O	and	_	0	SENT_95	[p5l1628t3450r1738b3503],
7	Haemostasis	NNP	PERSON	Haemostasis	nn	8	SENT_95	[p5l1766t3451r2146b3503],
8	grel	NN	O	grel	conj_and	5	SENT_95	[p5l117t3539r236b3604],
9	:	:	O	:	_	0	SENT_95	[p5l117t3539r236b3604],
10	a	DT	O	a	det	12	SENT_95	[p5l266t3556r298b3590],
11	possible	JJ	O	possible	amod	12	SENT_95	[p5l320t3539r550b3604],
12	mechanism	NN	O	mechanism	dep	3	SENT_95	[p5l573t3539r899b3590],
13	for	IN	O	for	_	0	SENT_95	[p5l922t3539r1007b3590],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_95	[p5l1031t3538r1354b3604],
15	resistance	NN	O	resistance	prep_for	12	SENT_95	[p5l1378t3539r1669b3590],
16	.	.	O	.	_	0	SENT_95	[p5l1378t3539r1669b3590],

1	Clin	NNP	PERSON	Clin	nn	2	SENT_96	[p5l1701t3539r1814b3591],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_96	[p5l1839t3539r2150b3590],
3	T	NN	O	t	dep	2	SENT_96	[p5l123t3628r169b3676],
4	her	PRP$	O	she	poss	11	SENT_96	[p5l163t3625r252b3676],
5	2008	CD	DATE	2008	nn	11	SENT_96	[p5l274t3626r424b3687],
6	;	:	O	;	_	0	SENT_96	[p5l274t3626r424b3687],
7	DOI	NNP	O	DOI	dep	5	SENT_96	[p5l450t3625r1208b3691],
8	:10.1038	CD	NUMBER	:10.1038	num	7	SENT_96	[p5l450t3625r1208b3691],
9	/	:	O	/	punct	7	SENT_96	[p5l450t3625r1208b3691],
10	clpt	JJ	O	clpt	amod	11	SENT_96	[p5l450t3625r1208b3691],
11	.2008.20	NN	O	.2008.20	dep	3	SENT_96	[p5l450t3625r1208b3691],
12	.	.	O	.	_	0	SENT_96	[p5l450t3625r1208b3691],

1	8	CD	NUMBER	8	_	0	SENT_97	[p5l36t3714r63b3764],
2	Brandt	NNP	ORGANIZATION	Brandt	nn	3	SENT_97	[p5l118t3712r320b3764],
3	JT	NNP	ORGANIZATION	JT	dep	1	SENT_97	[p5l340t3714r430b3774],
4	,	,	O	,	_	0	SENT_97	[p5l340t3714r430b3774],
5	Payne	NNP	PERSON	Payne	nn	6	SENT_97	[p5l453t3714r629b3777],
6	CD	NNP	O	CD	appos	3	SENT_97	[p5l652t3713r770b3774],
7	,	,	O	,	_	0	SENT_97	[p5l652t3713r770b3774],
8	Wiviott	NNP	PERSON	Wiviott	nn	9	SENT_97	[p5l793t3712r1014b3764],
9	SD	NN	O	sd	appos	3	SENT_97	[p5l1037t3713r1143b3774],
10	,	,	O	,	_	0	SENT_97	[p5l1037t3713r1143b3774],
11	Weerakkody	NNP	PERSON	Weerakkody	nn	12	SENT_97	[p5l1166t3712r1539b3777],
12	G	NNP	PERSON	G	appos	3	SENT_97	[p5l1561t3713r1630b3774],
13	,	,	O	,	_	0	SENT_97	[p5l1561t3713r1630b3774],
14	Farid	NNP	PERSON	Farid	nn	15	SENT_97	[p5l1655t3712r1814b3764],
15	NA	NNP	O	NA	appos	3	SENT_97	[p5l1835t3712r1959b3774],
16	,	,	O	,	_	0	SENT_97	[p5l1835t3712r1959b3774],
17	Small	NNP	O	Small	appos	3	SENT_97	[p5l1986t3712r2146b3764],

1	DS	NN	O	d	_	0	SENT_98	[p6l117t19r225b81],
2	,	,	O	,	_	0	SENT_98	[p6l117t19r225b81],
3	Jakubowski	NNP	PERSON	Jakubowski	nn	4	SENT_98	[p6l260t18r605b70],
4	JA	NNP	O	JA	appos	1	SENT_98	[p6l638t18r735b81],
5	,	,	O	,	_	0	SENT_98	[p6l638t18r735b81],
6	Naganuma	NNP	PERSON	Naganuma	nn	7	SENT_98	[p6l770t20r1095b84],
7	H	NNP	O	H	appos	1	SENT_98	[p6l1128t20r1199b81],
8	,	,	O	,	_	0	SENT_98	[p6l1128t20r1199b81],
9	Winters	NNP	ORGANIZATION	Winters	nn	10	SENT_98	[p6l1233t18r1460b70],
10	KJ	NNP	ORGANIZATION	KJ	appos	1	SENT_98	[p6l1494t20r1593b70],
11	.	.	O	.	_	0	SENT_98	[p6l1494t20r1593b70],

1	A	DT	O	a	det	2	SENT_99	[p6l1629t18r1682b69],
2	comparison	NN	O	comparison	nsubjpass	18	SENT_99	[p6l1714t18r2054b84],
3	of	IN	O	of	_	0	SENT_99	[p6l2089t18r2153b70],
4	prasugrel	NN	O	prasugrel	prep_of	2	SENT_99	[p6l116t105r384b170],
5	and	CC	O	and	_	0	SENT_99	[p6l412t105r519b156],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_99	[p6l546t105r868b170],
7	loading	NN	O	loading	nn	8	SENT_99	[p6l896t105r1111b170],
8	doses	NNS	O	dose	conj_and	2	SENT_99	[p6l1138t105r1292b156],
9	on	IN	O	on	_	0	SENT_99	[p6l1322t122r1394b156],
10	platelet	NN	O	platelet	nn	11	SENT_99	[p6l1421t105r1632b170],
11	function	NN	O	function	prep_on	8	SENT_99	[p6l1659t105r1913b156],
12	:	:	O	:	_	0	SENT_99	[p6l1659t105r1913b156],
13	magnitude	NN	O	magnitude	dep	8	SENT_99	[p6l1944t105r2145b170, p6l117t192r242b244],
14	of	IN	O	of	_	0	SENT_99	[p6l262t192r326b244],
15	platelet	NN	O	platelet	nn	16	SENT_99	[p6l336t192r547b258],
16	inhibition	NN	O	inhibition	prep_of	13	SENT_99	[p6l564t192r845b244],
17	is	VBZ	O	be	auxpass	18	SENT_99	[p6l863t192r904b243],
18	related	VBN	O	relate	_	0	SENT_99	[p6l923t192r1119b244],
19	to	TO	O	to	_	0	SENT_99	[p6l1137t199r1194b244],
20	active	JJ	O	active	amod	22	SENT_99	[p6l1214t192r1378b244],
21	metabolite	NN	O	metabolite	nn	22	SENT_99	[p6l1395t192r1700b244],
22	formation	NN	O	formation	prep_to	18	SENT_99	[p6l1719t192r2023b244],
23	.	.	O	.	_	0	SENT_99	[p6l1719t192r2023b244],

1	Am	VBP	O	be	dep	3	SENT_100	[p6l2044t194r2145b243],
2	Heart	NNP	O	Heart	nn	3	SENT_100	[p6l117t283r286b332],
3	J	NNP	O	J	_	0	SENT_100	[p6l307t283r346b332],
4	2007	CD	DATE	2007	num	3	SENT_100	[p6l363t282r512b343],
5	;	:	O	;	_	0	SENT_100	[p6l363t282r512b343],
6	153	CD	NUMBER	153	dep	3	SENT_100	[p6l542t281r652b332],
7	:	:	O	:	_	0	SENT_100	[p6l542t281r652b332],
8	66	CD	NUMBER	66	dep	6	SENT_100	[p6l681t282r760b332],
9	.	.	O	.	_	0	SENT_100	[p6l681t282r760b332],

1	Schwarz	NNP	PERSON	Schwarz	nn	2	SENT_101	[p6l119t367r360b419],
2	UR	NNP	O	UR	_	0	SENT_101	[p6l396t369r520b429],
3	,	,	O	,	_	0	SENT_101	[p6l396t369r520b429],
4	Geiger	NNP	PERSON	Geiger	nn	5	SENT_101	[p6l559t367r751b432],
5	J	NNP	PERSON	J	appos	2	SENT_101	[p6l785t369r813b418],
6	,	,	O	,	_	0	SENT_101	[p6l818t410r829b429],
7	Walter	NNP	PERSON	Walter	nn	8	SENT_101	[p6l866t367r1065b418],
8	U	NNP	PERSON	U	appos	2	SENT_101	[p6l1100t369r1170b429],
9	,	,	O	,	_	0	SENT_101	[p6l1100t369r1170b429],
10	Eigenthale	NNP	PERSON	Eigenthale	nn	14	SENT_101	[p6l1209t367r1513b432],
11	M.	NNP	PERSON	M.	nn	14	SENT_101	[p6l1550t369r1630b418],
12	Flow	NN	PERSON	flow	nn	14	SENT_101	[p6l1671t367r1820b418],
13	cytometry	NN	O	cytometry	nn	14	SENT_101	[p6l1855t374r2146b432],
14	analysis	NN	O	analysis	dep	2	SENT_101	[p6l118t454r342b519],
15	of	IN	O	of	_	0	SENT_101	[p6l369t454r433b506],
16	intracellular	JJ	O	intracellular	amod	18	SENT_101	[p6l450t454r797b506],
17	VASP	NN	ORGANIZATION	vasp	nn	18	SENT_101	[p6l821t454r1003b506],
18	phosphorylation	NN	O	phosphorylation	prep_of	2	SENT_101	[p6l1026t454r1505b520],
19	for	IN	O	for	_	0	SENT_101	[p6l1529t454r1614b506],
20	the	DT	O	the	det	21	SENT_101	[p6l1638t454r1725b505],
21	assessment	NN	O	assessment	prep_for	2	SENT_101	[p6l1751t461r2064b506],
22	of	IN	O	of	_	0	SENT_101	[p6l2090t454r2154b506],
23	activating	VBG	O	activate	nn	28	SENT_101	[p6l118t541r399b607],
24	and	CC	O	and	_	0	SENT_101	[p6l442t541r549b593],
25	inhibitory	JJ	O	inhibitory	nn	28	SENT_101	[p6l590t541r876b606],
26	signal	NN	O	signal	nn	28	SENT_101	[p6l919t541r1083b607],
27	transduction	NN	O	transduction	nn	28	SENT_101	[p6l1125t541r1489b593],
28	pathways	NNS	O	pathway	prep_of	2	SENT_101	[p6l1530t541r1805b607],
29	in	IN	O	in	_	0	SENT_101	[p6l1847t541r1901b592],
30	human	JJ	O	human	amod	32	SENT_101	[p6l1943t541r2146b593],
31	platelets	NNS	O	platelet	nn	32	SENT_101	[p6l116t628r351b694],
32	deﬁnition	NN	O	deﬁnition	prep_in	2	SENT_101	[p6l394t628r669b680],
33	and	CC	O	and	_	0	SENT_101	[p6l711t628r818b680],
34	detection	NN	O	detection	prep_in	2	SENT_101	[p6l859t628r1122b680],
35	of	IN	O	of	_	0	SENT_101	[p6l1163t628r1228b680],
36	ticlopidine/clopidogrel	JJ	O	ticlopidine/clopidogrel	amod	37	SENT_101	[p6l1262t628r1910b694],
37	effects	NNS	O	effect	prep_of	2	SENT_101	[p6l1951t628r2141b680],
38	.	.	O	.	_	0	SENT_101	[p6l1951t628r2141b680],

1	T	NN	O	t	nn	3	SENT_102	[p6l123t719r169b767],
2	hromb	NN	O	hromb	nn	3	SENT_102	[p6l163t716r343b768],
3	Haemost	NN	O	haemost	_	0	SENT_102	[p6l366t719r621b768],
4	1999	CD	DATE	1999	dep	3	SENT_102	[p6l650t717r793b779],
5	;	:	O	;	_	0	SENT_102	[p6l650t717r793b779],
6	82	CD	NUMBER	82	num	8	SENT_102	[p6l819t717r899b768],
7	:	:	O	:	_	0	SENT_102	[p6l819t717r899b768],
8	1145-52	CD	NUMBER	1145-52	dep	3	SENT_102	[p6l933t717r1177b768],
9	.	.	O	.	_	0	SENT_102	[p6l933t717r1177b768],

1	Ishizaki	NNP	PERSON	Ishizaki	nn	2	SENT_103	[p6l117t803r341b855],
2	T	NN	O	t	_	0	SENT_103	[p6l374t805r434b865],
3	,	,	O	,	_	0	SENT_103	[p6l374t805r434b865],
4	Sohn	NNP	PERSON	Sohn	nn	5	SENT_103	[p6l471t803r618b855],
5	DR	NN	O	dr	appos	2	SENT_103	[p6l651t805r775b865],
6	,	,	O	,	_	0	SENT_103	[p6l651t805r775b865],
7	Kobayashi	NNP	LOCATION	Kobayashi	nn	8	SENT_103	[p6l810t803r1124b868],
8	K	NNP	LOCATION	K	appos	5	SENT_103	[p6l1157t805r1227b865],
9	,	,	O	,	_	0	SENT_103	[p6l1157t805r1227b865],
10	Chiba	NNP	ORGANIZATION	Chiba	nn	11	SENT_103	[p6l1263t803r1438b855],
11	K	NNP	ORGANIZATION	K	appos	5	SENT_103	[p6l1470t805r1540b865],
12	,	,	O	,	_	0	SENT_103	[p6l1470t805r1540b865],
13	Lee	NNP	PERSON	Lee	nn	14	SENT_103	[p6l1576t805r1678b855],
14	KH	NNP	PERSON	KH	appos	5	SENT_103	[p6l1711t805r1838b865],
15	,	,	O	,	_	0	SENT_103	[p6l1711t805r1838b865],
16	Shin	NNP	PERSON	Shin	nn	17	SENT_103	[p6l1876t803r2003b855],
17	SG	NNP	PERSON	SG	appos	5	SENT_103	[p6l2037t804r2142b855],
18	.	.	O	.	_	0	SENT_103	[p6l2037t804r2142b855],

1	Interethnic	JJ	O	interethnic	amod	2	SENT_104	[p6l117t890r432b942],
2	differences	NNS	O	difference	_	0	SENT_104	[p6l494t890r797b942],
3	in	IN	O	in	_	0	SENT_104	[p6l859t890r914b941],
4	omeprazole	NN	O	omeprazole	nn	5	SENT_104	[p6l978t890r1311b956],
5	metabolism	NN	O	metabolism	prep_in	2	SENT_104	[p6l1373t890r1710b942],
6	in	IN	O	in	dep	2	SENT_104	[p6l1771t890r1826b941],
7	the	DT	O	the	det	9	SENT_104	[p6l1888t890r1975b942],
8	two	CD	NUMBER	two	num	9	SENT_104	[p6l2038t897r2144b942],
9	Letters	NNS	O	letter	pobj	6	SENT_104	[p6l1254t988r1491b1043],
10	to	TO	O	to	dep	2	SENT_104	[p6l1525t997r1583b1043],
11	the	DT	O	the	det	12	SENT_104	[p6l1618t985r1713b1043],
12	editor	NN	O	editor	pobj	10	SENT_104	[p6l1743t985r1935b1043],
13	1441	CD	DATE	1441	num	12	SENT_104	[p6l1980t987r2141b1042],

1	S-mephenytoin	NN	O	s-mephenytoin	nn	3	SENT_105	[p6l119t1195r560b1261],
2	hydroxylation	NN	O	hydroxylation	nn	3	SENT_105	[p6l586t1195r995b1261],
3	phenotypes	NNS	O	phenotype	nsubj	4	SENT_105	[p6l1020t1195r1350b1261],
4	studied	VBN	O	study	_	0	SENT_105	[p6l1379t1194r1585b1247],
5	in	IN	O	in	_	0	SENT_105	[p6l1611t1195r1666b1246],
6	Caucasians	NNPS	MISC	Caucasians	prep_in	4	SENT_105	[p6l1693t1195r2017b1247],
7	and	CC	O	and	_	0	SENT_105	[p6l2045t1195r2152b1247],
8	Orientals	NNPS	O	Orientals	prep_in	4	SENT_105	[p6l118t1283r395b1335],
9	.	.	O	.	_	0	SENT_105	[p6l118t1283r395b1335],

1	T	NN	O	t	nn	3	SENT_106	[p6l428t1286r474b1335],
2	her	PRP$	O	she	poss	3	SENT_106	[p6l468t1283r557b1335],
3	Drug	NN	O	drug	_	0	SENT_106	[p6l578t1286r727b1349],
4	Monit	NNP	O	Monit	dep	3	SENT_106	[p6l749t1286r925b1335],
5	1994	CD	DATE	1994	num	4	SENT_106	[p6l954t1284r1097b1346],
6	;	:	O	;	_	0	SENT_106	[p6l954t1284r1097b1346],
7	16	CD	NUMBER	16	num	9	SENT_106	[p6l1127t1284r1204b1335],
8	:	:	O	:	_	0	SENT_106	[p6l1127t1284r1204b1335],
9	214-5	CD	NUMBER	214-5	dep	3	SENT_106	[p6l1231t1284r1414b1335],
10	.	.	O	.	_	0	SENT_106	[p6l1231t1284r1414b1335],

1	Snoep	NNP	PERSON	Snoep	nn	2	SENT_107	[p6l120t1373r296b1439],
2	JD	NNP	O	JD	_	0	SENT_107	[p6l316t1374r417b1435],
3	,	,	O	,	_	0	SENT_107	[p6l316t1374r417b1435],
4	Hovens	NNP	ORGANIZATION	Hovens	nn	5	SENT_107	[p6l440t1374r660b1425],
5	MMC	NNP	ORGANIZATION	MMC	appos	2	SENT_107	[p6l681t1373r883b1435],
6	,	,	O	,	_	0	SENT_107	[p6l681t1373r883b1435],
7	Eikenboom	NNP	PERSON	Eikenboom	nn	9	SENT_107	[p6l906t1372r1245b1424],
8	J	NNP	PERSON	J	nn	9	SENT_107	[p6l1263t1374r1292b1425],
9	CJ	NNP	PERSON	CJ	appos	5	SENT_107	[p6l1295t1373r1372b1425],
10	,	,	O	,	_	0	SENT_107	[p6l1376t1416r1387b1435],
11	van	NNP	O	van	nn	14	SENT_107	[p6l1408t1389r1514b1424],
12	der	NNP	O	der	nn	14	SENT_107	[p6l1534t1372r1626b1424],
13	Bom	NNP	O	Bom	nn	14	SENT_107	[p6l1647t1374r1786b1425],
14	JG	NNP	O	JG	appos	5	SENT_107	[p6l1804t1373r1905b1435],
15	,	,	O	,	_	0	SENT_107	[p6l1804t1373r1905b1435],
16	Jukema	NNP	O	Jukema	nn	17	SENT_107	[p6l1927t1372r2153b1425],
17	JW	NNP	O	JW	appos	5	SENT_107	[p6l117t1463r230b1525],
18	,	,	O	,	_	0	SENT_107	[p6l117t1463r230b1525],
19	Huisman	NNP	PERSON	Huisman	nn	20	SENT_107	[p6l257t1461r523b1514],
20	MV	NNP	O	MV	appos	5	SENT_107	[p6l548t1463r678b1514],
21	.	.	O	.	_	0	SENT_107	[p6l548t1463r678b1514],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_108	[p6l708t1461r1050b1528],
2	nonresponsiveness	NN	O	nonresponsiveness	_	0	SENT_108	[p6l1073t1461r1608b1528],
3	in	IN	O	in	_	0	SENT_108	[p6l1633t1461r1687b1513],
4	patients	NNS	O	patient	prep_in	2	SENT_108	[p6l1710t1461r1937b1528],
5	undergoing	VBG	O	undergo	partmod	4	SENT_108	[p6l1962t1461r2151b1514, p6l118t1550r278b1616],
6	percutaneous	JJ	O	percutaneous	amod	8	SENT_108	[p6l302t1557r688b1616],
7	coronary	JJ	O	coronary	amod	8	SENT_108	[p6l713t1567r976b1616],
8	intervention	NN	O	intervention	dobj	5	SENT_108	[p6l1001t1550r1351b1602],
9	with	IN	O	with	_	0	SENT_108	[p6l1376t1550r1503b1602],
10	stenting	NN	O	stenting	prep_with	5	SENT_108	[p6l1529t1550r1767b1616],
11	:	:	O	:	_	0	SENT_108	[p6l1529t1550r1767b1616],
12	a	DT	O	a	det	14	SENT_108	[p6l1797t1567r1829b1602],
13	systematic	JJ	O	systematic	amod	14	SENT_108	[p6l1856t1550r2153b1616],
14	review	NN	O	review	dep	2	SENT_108	[p6l118t1639r303b1692],
15	and	CC	O	and	_	0	SENT_108	[p6l327t1639r434b1692],
16	meta-analysis	NN	O	meta-analysis	conj_and	14	SENT_108	[p6l457t1639r864b1705],
17	.	.	O	.	_	0	SENT_108	[p6l457t1639r864b1705],

1	Am	VBP	O	be	dep	3	SENT_109	[p6l890t1641r992b1691],
2	Heart	NNP	O	Heart	nn	3	SENT_109	[p6l1015t1642r1184b1692],
3	J	NNP	O	J	_	0	SENT_109	[p6l1205t1642r1245b1692],
4	2007	CD	DATE	2007	num	3	SENT_109	[p6l1262t1640r1411b1703],
5	;	:	O	;	_	0	SENT_109	[p6l1262t1640r1411b1703],
6	154	CD	NUMBER	154	dep	3	SENT_109	[p6l1441t1640r1552b1692],
7	:	:	O	:	_	0	SENT_109	[p6l1441t1640r1552b1692],
8	221-31	CD	NUMBER	221-31	dep	6	SENT_109	[p6l1580t1640r1797b1692],
9	.	.	O	.	_	0	SENT_109	[p6l1580t1640r1797b1692],

1	Matetzky	NNP	O	Matetzky	nn	2	SENT_110	[p6l118t1728r395b1795],
2	S	NNP	O	S	nsubjpass	36	SENT_110	[p6l425t1729r474b1792],
3	,	,	O	,	_	0	SENT_110	[p6l425t1729r474b1792],
4	Shenkman	NNP	PERSON	Shenkman	nn	5	SENT_110	[p6l507t1728r813b1781],
5	B	NNP	O	B	appos	2	SENT_110	[p6l842t1730r900b1792],
6	,	,	O	,	_	0	SENT_110	[p6l842t1730r900b1792],
7	Guetta	NNP	PERSON	Guetta	nn	8	SENT_110	[p6l932t1729r1133b1781],
8	V	NNP	O	V	appos	2	SENT_110	[p6l1159t1730r1223b1791],
9	,	,	O	,	_	0	SENT_110	[p6l1159t1730r1223b1791],
10	Shechter	NNP	PERSON	Shechter	nn	11	SENT_110	[p6l1256t1728r1503b1781],
11	M	NNP	O	M	appos	2	SENT_110	[p6l1532t1730r1613b1791],
12	,	,	O	,	_	0	SENT_110	[p6l1532t1730r1613b1791],
13	Bienart	NNP	PERSON	Bienart	nn	14	SENT_110	[p6l1645t1728r1856b1781],
14	R	NNP	PERSON	R	appos	2	SENT_110	[p6l1885t1730r1950b1792],
15	,	,	O	,	_	0	SENT_110	[p6l1885t1730r1950b1792],
16	Goldenberg	NNP	PERSON	Goldenberg	nn	20	SENT_110	[p6l1982t1728r2151b1781, p6l118t1817r311b1883],
17	I	PRP	O	I	dep	20	SENT_110	[p6l331t1819r370b1880],
18	,	,	O	,	_	0	SENT_110	[p6l331t1819r370b1880],
19	Novikov	NNP	PERSON	Novikov	dep	20	SENT_110	[p6l391t1817r647b1869],
20	I	NNP	O	I	appos	2	SENT_110	[p6l666t1819r705b1880],
21	,	,	O	,	_	0	SENT_110	[p6l666t1819r705b1880],
22	Pres	NNP	O	Pres	nn	23	SENT_110	[p6l726t1819r848b1869],
23	H	NNP	O	H	appos	2	SENT_110	[p6l868t1819r938b1880],
24	,	,	O	,	_	0	SENT_110	[p6l868t1819r938b1880],
25	Savion	NNP	PERSON	Savion	nn	26	SENT_110	[p6l962t1817r1159b1869],
26	N	NNP	PERSON	N	appos	2	SENT_110	[p6l1177t1819r1249b1880],
27	,	,	O	,	_	0	SENT_110	[p6l1177t1819r1249b1880],
28	Varon	NNP	PERSON	Varon	nn	29	SENT_110	[p6l1269t1819r1454b1869],
29	D	NNP	PERSON	D	appos	2	SENT_110	[p6l1474t1819r1544b1880],
30	,	,	O	,	_	0	SENT_110	[p6l1474t1819r1544b1880],
31	Hod	NNP	O	Hod	nn	33	SENT_110	[p6l1566t1817r1697b1869],
32	H.	NNP	O	H.	nn	33	SENT_110	[p6l1717t1819r1786b1869],
33	Clopidogrel	NNP	O	Clopidogrel	appos	2	SENT_110	[p6l1810t1817r2152b1883],
34	resistance	NN	O	resistance	dep	2	SENT_110	[p6l118t1906r394b1958],
35	is	VBZ	O	be	auxpass	36	SENT_110	[p6l421t1906r462b1958],
36	associated	VBN	O	associate	_	0	SENT_110	[p6l491t1906r783b1959],
37	with	IN	O	with	_	0	SENT_110	[p6l808t1906r935b1959],
38	increased	VBN	O	increase	amod	39	SENT_110	[p6l961t1906r1229b1959],
39	risk	NN	O	risk	prep_with	36	SENT_110	[p6l1256t1906r1363b1958],
40	of	IN	O	of	_	0	SENT_110	[p6l1389t1906r1453b1959],
41	recurrent	JJ	O	recurrent	amod	43	SENT_110	[p6l1473t1914r1737b1958],
42	atherothrombotic	JJ	O	atherothrombotic	amod	43	SENT_110	[p6l1764t1906r2151b1959, p6l118t1995r262b2047],
43	events	NNS	O	event	prep_of	39	SENT_110	[p6l288t2002r465b2048],
44	in	IN	O	in	_	0	SENT_110	[p6l492t1995r547b2047],
45	patients	NNS	O	patient	prep_in	43	SENT_110	[p6l572t1995r799b2062],
46	with	IN	O	with	_	0	SENT_110	[p6l825t1995r953b2047],
47	acute	JJ	O	acute	amod	49	SENT_110	[p6l980t2002r1131b2047],
48	myocardial	JJ	O	myocardial	amod	49	SENT_110	[p6l1157t1995r1483b2061],
49	infarction	NN	O	infarction	prep_with	45	SENT_110	[p6l1509t1995r1805b2048],
50	.	.	O	.	_	0	SENT_110	[p6l1509t1995r1805b2048],

1	Circulation	NN	O	circulation	_	0	SENT_111	[p6l1840t1996r2151b2048],
2	2004	CD	DATE	2004	num	1	SENT_111	[p6l118t2085r267b2147],
3	;	:	O	;	_	0	SENT_111	[p6l118t2085r267b2147],
4	109	CD	NUMBER	109	num	6	SENT_111	[p6l296t2086r408b2136],
5	:	:	O	:	_	0	SENT_111	[p6l296t2086r408b2136],
6	3171-5	CD	NUMBER	3171-5	dep	1	SENT_111	[p6l437t2086r652b2136],
7	.	.	O	.	_	0	SENT_111	[p6l437t2086r652b2136],

1	Gurbel	NNP	ORGANIZATION	Gurbel	nn	2	SENT_112	[p6l119t2172r322b2225],
2	PA	NN	ORGANIZATION	pa	_	0	SENT_112	[p6l355t2172r464b2235],
3	,	,	O	,	_	0	SENT_112	[p6l355t2172r464b2235],
4	Bliden	NNP	PERSON	Bliden	nn	5	SENT_112	[p6l502t2172r686b2224],
5	KP	NNP	O	KP	appos	2	SENT_112	[p6l721t2174r832b2235],
6	,	,	O	,	_	0	SENT_112	[p6l721t2174r832b2235],
7	Hiatt	NNP	PERSON	Hiatt	nn	8	SENT_112	[p6l869t2172r1021b2224],
8	BL	NN	O	bl	appos	2	SENT_112	[p6l1055t2174r1160b2235],
9	,	,	O	,	_	0	SENT_112	[p6l1055t2174r1160b2235],
10	O’Connor	NN	O	o’connor	nn	11	SENT_112	[p6l1197t2173r1490b2225],
11	CM	NN	O	cm	appos	2	SENT_112	[p6l1524t2173r1653b2225],
12	.	.	O	.	_	0	SENT_112	[p6l1524t2173r1653b2225],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_113	[p6l1692t2172r2034b2239],
2	for	IN	O	for	_	0	SENT_113	[p6l2068t2172r2153b2224],
3	coronary	JJ	O	coronary	amod	4	SENT_113	[p6l117t2278r380b2327],
4	stenting	NN	O	stenting	prep_for	1	SENT_113	[p6l405t2261r643b2328],
5	:	:	O	:	_	0	SENT_113	[p6l405t2261r643b2328],
6	response	NN	O	response	nn	7	SENT_113	[p6l671t2278r921b2328],
7	variability	NN	O	variability	conj_and	1	SENT_113	[p6l944t2261r1253b2327],
8	,	,	O	,	_	0	SENT_113	[p6l944t2261r1253b2327],
9	drug	NN	O	drug	nn	10	SENT_113	[p6l1280t2261r1415b2328],
10	resistance	NN	O	resistance	appos	7	SENT_113	[p6l1438t2261r1732b2324],
11	,	,	O	,	_	0	SENT_113	[p6l1438t2261r1732b2324],
12	and	CC	O	and	_	0	SENT_113	[p6l1758t2261r1866b2314],
13	the	DT	O	the	det	14	SENT_113	[p6l1890t2261r1978b2313],
14	effect	NN	O	effect	conj_and	1	SENT_113	[p6l2002t2261r2153b2313],
15	of	IN	O	of	_	0	SENT_113	[p6l119t2350r183b2403],
16	pretreatment	NN	O	pretreatment	nn	18	SENT_113	[p6l198t2357r573b2417],
17	platelet	NN	O	platelet	nn	18	SENT_113	[p6l595t2350r806b2417],
18	reactivity	NN	O	reactivity	prep_of	14	SENT_113	[p6l829t2350r1109b2417],
19	.	.	O	.	_	0	SENT_113	[p6l829t2350r1109b2417],

1	Circulation	NN	O	circulation	_	0	SENT_114	[p6l1140t2351r1452b2403],
2	2003	CD	DATE	2003	num	1	SENT_114	[p6l1476t2352r1626b2414],
3	;	:	O	;	_	0	SENT_114	[p6l1476t2352r1626b2414],
4	107	CD	NUMBER	107	num	6	SENT_114	[p6l1655t2352r1766b2403],
5	:	:	O	:	_	0	SENT_114	[p6l1655t2352r1766b2403],
6	2908-13	CD	NUMBER	2908-13	dep	1	SENT_114	[p6l1794t2352r2045b2403],
7	.	.	O	.	_	0	SENT_114	[p6l1794t2352r2045b2403],

1	More	RBR	O	more	_	0	SENT_115	[p6l50t2570r219b2624],
2	on	IN	O	on	prep	1	SENT_115	[p6l248t2584r344b2624],
3	:	:	O	:	_	0	SENT_115	[p6l248t2584r344b2624],
4	vitamin	NN	O	vitamin	nn	6	SENT_115	[p6l375t2570r615b2624],
5	K	NN	O	k	nn	6	SENT_115	[p6l649t2570r688b2624],
6	antagonists	NNS	O	antagonist	dep	1	SENT_115	[p6l717t2570r1089b2641],
7	and	CC	O	and	_	0	SENT_115	[p6l1119t2566r1233b2624],
8	cancer	NN	O	cancer	dep	1	SENT_115	[p6l1265t2584r1471b2624],

1	G.	NNP	PERSON	G.	nn	7	SENT_116	[p6l48t2697r85b2724],
2	AGNELLl	NNP	PERSON	AGNELLl	nn	7	SENT_116	[p6l107t2697r321b2729],
3	,	,	O	,	_	0	SENT_116	[p6l107t2697r321b2729],
4	*	NNP	O	*	appos	7	SENT_116	[p6l107t2697r321b2729],
5	M.	NNP	PERSON	M.	nn	7	SENT_116	[p6l343t2697r390b2724],
6	R.	NNP	PERSON	R.	nn	7	SENT_116	[p6l413t2697r446b2724],
7	TAL	NNP	PERSON	TAL	nsubj	8	SENT_116	[p6l467t2697r673b2729],
8	|	VBD	O	|	_	0	SENT_116	[p6l467t2697r673b2729],
9	AN	DT	O	a	det	10	SENT_116	[p6l467t2697r673b2729],
10	|	NN	O	|	dobj	8	SENT_116	[p6l467t2697r673b2729],
11	,	,	O	,	_	0	SENT_116	[p6l467t2697r673b2729],
12	*	NN	O	*	conj_and	10	SENT_116	[p6l467t2697r673b2729],
13	and	CC	O	and	_	0	SENT_116	[p6l696t2695r752b2724],
14	P.	NNP	PERSON	P.	nn	53	SENT_116	[p6l770t2697r800b2724],
15	PRANDONIT	NNP	PERSON	PRANDONIT	nn	53	SENT_116	[p6l823t2697r1084b2731],
16	,	,	O	,	_	0	SENT_116	[p6l823t2697r1084b2731],
17	FOR	IN	O	for	dep	53	SENT_116	[p6l1108t2697r1187b2724],
18	THE	DT	O	the	det	20	SENT_116	[p6l1206t2697r1280b2724],
19	WODIT	NNP	O	WODIT	nn	20	SENT_116	[p6l1300t2697r1447b2724],
20	INVESTIGATORS	NNPS	O	INVESTIGATORS	pobj	17	SENT_116	[p6l1468t2697r1802b2724],
21	*	CD	NUMBER	*	num	22	SENT_116	[p6l48t2745r179b2770],
22	Division	NN	O	division	dep	20	SENT_116	[p6l48t2745r179b2770],
23	of	IN	O	of	_	0	SENT_116	[p6l192t2744r223b2770],
24	Internal	JJ	O	internal	prep_of	22	SENT_116	[p6l233t2744r342b2770],
25	and	CC	O	and	_	0	SENT_116	[p6l353t2744r407b2770],
26	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	27	SENT_116	[p6l419t2744r630b2770],
27	Medicine	NNP	ORGANIZATION	Medicine	prep_of	22	SENT_116	[p6l640t2744r779b2774],
28	,	,	O	,	_	0	SENT_116	[p6l640t2744r779b2774],
29	Internal	NNP	ORGANIZATION	Internal	nn	30	SENT_116	[p6l796t2744r905b2770],
30	Medicine	NNP	ORGANIZATION	Medicine	conj_and	20	SENT_116	[p6l916t2744r1056b2774],
31	,	,	O	,	_	0	SENT_116	[p6l916t2744r1056b2774],
32	University	NNP	ORGANIZATION	University	appos	30	SENT_116	[p6l1074t2745r1217b2777],
33	of	IN	ORGANIZATION	of	_	0	SENT_116	[p6l1229t2744r1259b2770],
34	Perugia	NNP	ORGANIZATION	Perugia	prep_of	32	SENT_116	[p6l1269t2745r1380b2777],
35	,	,	O	,	_	0	SENT_116	[p6l1269t2745r1380b2777],
36	Via	NNP	PERSON	Via	nn	39	SENT_116	[p6l1398t2745r1441b2770],
37	Enrico	NNP	PERSON	Enrico	nn	39	SENT_116	[p6l1455t2745r1541b2770],
38	dal	NN	PERSON	dal	nn	39	SENT_116	[p6l1554t2744r1598b2770],
39	Pozzo	NNP	PERSON	Pozzo	conj_and	20	SENT_116	[p6l1610t2745r1698b2774],
40	,	,	O	,	_	0	SENT_116	[p6l1610t2745r1698b2774],
41	Perugia	NNP	ORGANIZATION	Perugia	appos	39	SENT_116	[p6l1715t2745r1828b2777],
42	;	:	O	;	_	0	SENT_116	[p6l1715t2745r1828b2777],
43	and	CC	O	and	_	0	SENT_116	[p6l1841t2744r1895b2770],
44	tlnternal	JJ	O	tlnternal	amod	45	SENT_116	[p6l1907t2744r2032b2776],
45	Medicine	NN	O	medicine	conj_and	20	SENT_116	[p6l46t2791r185b2821],
46	,	,	O	,	_	0	SENT_116	[p6l46t2791r185b2821],
47	University	NNP	ORGANIZATION	University	appos	45	SENT_116	[p6l203t2793r346b2824],
48	of	IN	ORGANIZATION	of	_	0	SENT_116	[p6l358t2791r389b2817],
49	Padova	NNP	ORGANIZATION	Padova	nn	51	SENT_116	[p6l398t2791r507b2821],
50	,	,	O	,	_	0	SENT_116	[p6l398t2791r507b2821],
51	Padova	NNP	ORGANIZATION	Padova	prep_of	47	SENT_116	[p6l523t2791r632b2821],
52	,	,	O	,	_	0	SENT_116	[p6l523t2791r632b2821],
53	Italy	NNP	LOCATION	Italy	dobj	8	SENT_116	[p6l648t2791r711b2824],

1	To	TO	O	to	aux	2	SENT_117	[p6l47t2927r82b2951],
2	cite	VB	O	cite	dep	7	SENT_117	[p6l94t2927r144b2951],
3	this	DT	O	this	det	4	SENT_117	[p6l156t2925r207b2951],
4	article	NN	O	article	dobj	2	SENT_117	[p6l220t2925r315b2951],
5	:	:	O	:	_	0	SENT_117	[p6l220t2925r315b2951],
6	Agnelli	NNP	PERSON	Agnelli	nn	7	SENT_117	[p6l327t2925r423b2958],
7	G	NNP	PERSON	G	_	0	SENT_117	[p6l436t2926r465b2955],
8	,	,	O	,	_	0	SENT_117	[p6l436t2926r465b2955],
9	Taliani	NNP	PERSON	Taliani	nn	10	SENT_117	[p6l478t2925r568b2951],
10	MR	NN	PERSON	mr	appos	7	SENT_117	[p6l581t2927r639b2955],
11	,	,	O	,	_	0	SENT_117	[p6l581t2927r639b2955],
12	Prandoni	NNP	PERSON	Prandoni	nn	13	SENT_117	[p6l654t2925r775b2951],
13	P	NN	PERSON	p	appos	7	SENT_117	[p6l790t2927r813b2955],
14	,	,	O	,	_	0	SENT_117	[p6l790t2927r813b2955],
15	the	DT	O	the	det	17	SENT_117	[p6l826t2925r870b2951],
16	WODIT	NNP	O	WODIT	nn	17	SENT_117	[p6l882t2926r994b2951],
17	Investigators	NNS	O	investigator	appos	13	SENT_117	[p6l1007t2927r1191b2958],
18	.	.	O	.	_	0	SENT_117	[p6l1007t2927r1191b2958],

1	More	RBR	O	more	_	0	SENT_118	[p6l1205t2927r1280b2951],
2	on	IN	O	on	prep	1	SENT_118	[p6l1293t2933r1335b2951],
3	:	:	O	:	_	0	SENT_118	[p6l1293t2933r1335b2951],
4	vitamin	NN	O	vitamin	nn	6	SENT_118	[p6l1348t2927r1450b2951],
5	K	NN	O	k	nn	6	SENT_118	[p6l1465t2927r1482b2951],
6	antagonists	NNS	O	antagonist	dep	1	SENT_118	[p6l1494t2927r1653b2958],
7	and	CC	O	and	_	0	SENT_118	[p6l1666t2925r1716b2951],
8	cancer	NN	O	cancer	dep	1	SENT_118	[p6l1729t2933r1827b2951],
9	.	.	O	.	_	0	SENT_118	[p6l1729t2933r1827b2951],

1	J	NNP	O	J	nn	3	SENT_119	[p6l1839t2927r1852b2951],
2	Thromb	NNP	O	Thromb	nn	3	SENT_119	[p6l1866t2925r1974b2951],
3	Haemost	NNP	O	Haemost	_	0	SENT_119	[p6l1986t2927r2113b2951],
4	2008	CD	DATE	2008	num	3	SENT_119	[p6l9t2998r179b3058],
5	;	:	O	;	_	0	SENT_119	[p6l9t2998r179b3058],
6	6	CD	NUMBER	6	num	8	SENT_119	[p6l211t2998r261b3049],
7	:	:	O	:	_	0	SENT_119	[p6l211t2998r261b3049],
8	1441-2	CD	NUMBER	1441-2	dep	3	SENT_119	[p6l296t2998r537b3048],
9	.	.	O	.	_	0	SENT_119	[p6l296t2998r537b3048],

1	In	IN	O	in	_	0	SENT_120	[p6l10t3272r83b3330],
2	2003	CD	DATE	2003	prep_in	5	SENT_120	[p6l111t3271r287b3343],
3	,	,	O	,	_	0	SENT_120	[p6l111t3271r287b3343],
4	we	PRP	O	we	nsubj	5	SENT_120	[p6l317t3289r410b3331],
5	published	VBD	O	publish	_	0	SENT_120	[p6l437t3269r766b3347],
6	a	DT	O	a	det	7	SENT_120	[p6l796t3289r833b3331],
7	paper	NN	O	paper	dobj	5	SENT_120	[p6l859t3289r1055b3347],
8	in	IN	O	in	_	0	SENT_120	[p6l1081t3269r1146b3330],
9	the	DT	O	the	det	10	SENT_120	[p6l1174t3269r1277b3331],
10	Journal	NNP	O	Journal	prep_in	7	SENT_120	[p6l1305t3270r1561b3331],
11	on	IN	O	on	_	0	SENT_120	[p6l1586t3289r1672b3331],
12	the	DT	O	the	det	13	SENT_120	[p6l1700t3269r1802b3331],
13	incidence	NN	O	incidence	prep_on	5	SENT_120	[p6l1830t3269r2143b3331],
14	of	IN	O	of	_	0	SENT_120	[p6l11t3376r87b3437],
15	newly	RB	O	newly	advmod	16	SENT_120	[p6l113t3376r312b3454],
16	diagnosed	VBN	O	diagnose	amod	17	SENT_120	[p6l347t3376r690b3454],
17	cancer	NN	O	cancer	prep_of	13	SENT_120	[p6l725t3396r945b3437],
18	after	IN	O	after	_	0	SENT_120	[p6l981t3376r1136b3437],
19	a	DT	O	a	det	21	SENT_120	[p6l1172t3396r1210b3437],
20	ﬁrst	JJ	O	ﬁrst	amod	21	SENT_120	[p6l1245t3376r1376b3437],
21	episode	NN	O	episode	prep_after	5	SENT_120	[p6l1411t3376r1664b3454],
22	of	IN	O	of	_	0	SENT_120	[p6l1701t3376r1777b3437],
23	idiopathic	JJ	O	idiopathic	amod	25	SENT_120	[p6l1803t3376r2145b3454],
24	venous	JJ	O	venous	amod	25	SENT_120	[p6l8t3502r246b3543],
25	thromboembolism	NN	O	thromboembolism	prep_of	21	SENT_120	[p6l280t3481r912b3543],
26	in	IN	O	in	_	0	SENT_120	[p6l943t3482r1008b3542],
27	patients	NNS	O	patient	prep_in	25	SENT_120	[p6l1039t3482r1305b3560],
28	treated	VBN	O	treat	partmod	27	SENT_120	[p6l1339t3481r1574b3543],
29	with	IN	O	with	_	0	SENT_120	[p6l1606t3482r1756b3543],
30	vitamin	NN	O	vitamin	nn	32	SENT_120	[p6l1787t3482r2047b3543],
31	K	NN	O	k	nn	32	SENT_120	[p6l2079t3484r2145b3542],
32	antagonists	NNS	O	antagonist	prep_with	28	SENT_120	[p6l10t3587r395b3665],
33	for	IN	O	for	_	0	SENT_120	[p6l425t3587r525b3649],
34	either	CC	O	either	preconj	36	SENT_120	[p6l553t3587r744b3649],
35	3	CD	DURATION	3	num	36	SENT_120	[p6l775t3589r807b3649],
36	months	NNS	NUMBER	month	prep_for	32	SENT_120	[p6l839t3587r1096b3649],
37	or	CC	O	or	_	0	SENT_120	[p6l1128t3607r1200b3649],
38	1	CD	DURATION	1	num	40	SENT_120	[p6l1237t3589r1259b3648],
39	year	NN	NUMBER	year	nn	40	SENT_120	[p6l1296t3607r1441b3665],
40	[	NN	O	[	prep_for	32	SENT_120	[p6l1473t3588r1566b3664],
41	1	CD	NUMBER	1	num	42	SENT_120	[p6l1473t3588r1566b3664],
42	]	NN	O	]	dep	32	SENT_120	[p6l1473t3588r1566b3664],
43	.	.	O	.	_	0	SENT_120	[p6l1473t3588r1566b3664],

1	In	IN	O	in	_	0	SENT_121	[p6l1601t3590r1674b3648],
2	contrast	NN	O	contrast	prep_in	17	SENT_121	[p6l1703t3596r1979b3649],
3	to	TO	O	to	_	0	SENT_121	[p6l2008t3595r2075b3649],
4	a	DT	O	a	det	5	SENT_121	[p6l2107t3607r2145b3649],
5	report	NN	O	report	prep_to	2	SENT_121	[p6l9t3702r219b3771],
6	from	IN	O	from	_	0	SENT_121	[p6l241t3693r410b3754],
7	Schulman	NNP	PERSON	Schulman	prep_from	5	SENT_121	[p6l434t3693r772b3755],
8	and	CC	O	and	_	0	SENT_121	[p6l796t3693r923b3754],
9	Lindmarker	NNP	O	Lindmarker	nn	10	SENT_121	[p6l947t3693r1357b3754],
10	[	NN	O	[	prep_to	2	SENT_121	[p6l1382t3694r1477b3770],
11	2	CD	NUMBER	2	num	12	SENT_121	[p6l1382t3694r1477b3770],
12	]	NN	O	]	dep	10	SENT_121	[p6l1382t3694r1477b3770],
13	,	,	O	,	_	0	SENT_121	[p6l1382t3694r1477b3770],
14	we	PRP	O	we	nsubj	17	SENT_121	[p6l1502t3713r1594b3754],
15	did	VBD	O	do	aux	17	SENT_121	[p6l1618t3693r1726b3754],
16	not	RB	O	not	neg	17	SENT_121	[p6l1749t3701r1863b3754],
17	observe	VB	O	observe	_	0	SENT_121	[p6l1887t3693r2144b3754],
18	any	DT	O	any	det	19	SENT_121	[p7l10t42r133b99],
19	reduction	NN	O	reduction	dobj	17	SENT_121	[p7l168t21r491b83],
20	in	IN	O	in	_	0	SENT_121	[p7l526t22r591b82],
21	the	DT	O	the	det	22	SENT_121	[p7l625t21r729b83],
22	incidence	NN	O	incidence	prep_in	19	SENT_121	[p7l763t21r1076b83],
23	of	IN	O	of	_	0	SENT_121	[p7l1113t22r1189b83],
24	newly	RB	O	newly	advmod	25	SENT_121	[p7l1216t22r1414b99],
25	diagnosed	VBN	O	diagnose	amod	26	SENT_121	[p7l1449t21r1791b100],
26	cancer	NN	O	cancer	prep_of	22	SENT_121	[p7l1827t42r2046b83],
27	in	IN	O	in	_	0	SENT_121	[p7l2080t22r2144b82],
28	patients	NNS	O	patient	prep_in	17	SENT_121	[p7l8t127r274b205],
29	treated	VBN	O	treat	partmod	28	SENT_121	[p7l312t127r547b189],
30	with	IN	O	with	_	0	SENT_121	[p7l582t127r733b189],
31	vitamin	NN	O	vitamin	nn	33	SENT_121	[p7l768t127r1028b189],
32	K	NN	O	k	nn	33	SENT_121	[p7l1064t130r1131b188],
33	antagonists	NNS	O	antagonist	prep_with	29	SENT_121	[p7l1167t127r1552b205],
34	for	IN	O	for	_	0	SENT_121	[p7l1590t127r1690b189],
35	1	CD	DURATION	1	num	36	SENT_121	[p7l1734t129r1756b188],
36	year	NN	NUMBER	year	prep_for	33	SENT_121	[p7l1793t147r1954b205],
37	.	.	O	.	_	0	SENT_121	[p7l1793t147r1954b205],

1	In	IN	O	in	_	0	SENT_122	[p7l1996t130r2069b188],
2	a	DT	O	a	det	4	SENT_122	[p7l2107t147r2144b189],
3	scientiﬁc	JJ	O	scientiﬁc	amod	4	SENT_122	[p7l11t233r300b294],
4	letter	NN	O	letter	prep_in	17	SENT_122	[p7l320t233r493b294],
5	later	RB	O	later	advmod	6	SENT_122	[p7l513t233r664b294],
6	published	VBN	O	publish	partmod	4	SENT_122	[p7l684t233r1013b311],
7	by	IN	O	by	_	0	SENT_122	[p7l1034t233r1118b311],
8	the	DT	O	the	det	12	SENT_122	[p7l1138t233r1241b294],
9	Journal	NNP	O	Journal	nn	12	SENT_122	[p7l1262t234r1518b295],
10	[	NN	O	[	nn	12	SENT_122	[p7l1537t234r1631b310],
11	3	CD	NUMBER	3	num	12	SENT_122	[p7l1537t234r1631b310],
12	]	NN	O	]	agent	6	SENT_122	[p7l1537t234r1631b310],
13	,	,	O	,	_	0	SENT_122	[p7l1537t234r1631b310],
14	Schulman	NNP	PERSON	Schulman	nsubj	17	SENT_122	[p7l1658t233r1996b295],
15	and	CC	O	and	_	0	SENT_122	[p7l2018t233r2144b294],
16	Lindmarker	NNP	PERSON	Lindmarker	conj_and	14	SENT_122	[p7l10t339r421b401],
17	argued	VBD	O	argue	_	0	SENT_122	[p7l444t339r676b417],
18	that	IN	O	that	complm	30	SENT_122	[p7l699t339r835b401],
19	the	DT	O	the	det	20	SENT_122	[p7l857t339r960b401],
20	discordance	NN	O	discordance	nsubjpass	30	SENT_122	[p7l984t339r1386b401],
21	between	IN	O	between	_	0	SENT_122	[p7l1410t339r1686b401],
22	the	DT	O	the	det	23	SENT_122	[p7l1710t339r1813b401],
23	results	NNS	O	result	prep_between	20	SENT_122	[p7l1836t339r2051b401],
24	of	IN	O	of	_	0	SENT_122	[p7l2077t339r2152b401],
25	the	DT	O	the	det	27	SENT_122	[p7l9t445r113b506],
26	two	CD	NUMBER	two	num	27	SENT_122	[p7l134t454r259b506],
27	studies	NNS	O	study	prep_of	23	SENT_122	[p7l284t445r511b506],
28	might	MD	O	might	aux	30	SENT_122	[p7l531t445r731b523],
29	be	VB	O	be	auxpass	30	SENT_122	[p7l750t445r827b506],
30	explained	VBN	O	explain	ccomp	17	SENT_122	[p7l848t445r1172b523],
31	by	IN	O	by	_	0	SENT_122	[p7l1192t445r1276b523],
32	differences	NNS	O	difference	agent	30	SENT_122	[p7l1296t445r1655b506],
33	in	IN	O	in	_	0	SENT_122	[p7l1676t445r1741b506],
34	duration	NN	O	duration	prep_in	32	SENT_122	[p7l1761t445r2056b506],
35	of	IN	O	of	_	0	SENT_122	[p7l2078t445r2153b506],
36	the	DT	O	the	det	37	SENT_122	[p7l9t552r113b613],
37	follow-up	NN	O	follow-up	prep_of	34	SENT_122	[p7l152t552r479b630],
38	(	CD	NUMBER	(	number	39	SENT_122	[p7l520t552r683b630],
39	43.7	CD	DURATION	43.7	num	40	SENT_122	[p7l520t552r683b630],
40	months	NNS	NUMBER	month	tmod	37	SENT_122	[p7l713t551r970b613],
41	in	IN	O	in	_	0	SENT_122	[p7l1008t552r1073b612],
42	our	PRP$	O	we	poss	44	SENT_122	[p7l1112t572r1229b613],
43	Italian	JJ	MISC	italian	amod	44	SENT_122	[p7l1267t552r1488b613],
44	study	NN	O	study	prep_in	30	SENT_122	[p7l1528t551r1710b629],
45	vs.	IN	O	vs.	_	0	SENT_122	[p7l1746t572r1832b613],
46	approximately	RB	O	approximately	quantmod	47	SENT_122	[p7l1876t572r2143b630, p7l9t657r258b735],
47	8	CD	DURATION	8	num	48	SENT_122	[p7l287t659r320b719],
48	years	NNS	NUMBER	year	prep_vs.	44	SENT_122	[p7l353t677r527b735],
49	in	IN	O	in	_	0	SENT_122	[p7l555t657r619b718],
50	their	PRP$	O	they	poss	53	SENT_122	[p7l647t657r802b719],
51	Swedish	JJ	MISC	swedish	amod	53	SENT_122	[p7l831t657r1106b719],
52	study	NN	O	study	nn	53	SENT_122	[p7l1135t657r1359b735],
53	)	NN	O	)	prep_in	48	SENT_122	[p7l1135t657r1359b735],
54	.	.	O	.	_	0	SENT_122	[p7l1135t657r1359b735],

1	It	PRP	O	it	nsubjpass	4	SENT_123	[p7l1392t660r1447b718],
2	was	VBD	O	be	auxpass	4	SENT_123	[p7l1471t677r1599b719],
3	also	RB	O	also	advmod	4	SENT_123	[p7l1629t657r1760b719],
4	noted	VBN	O	note	_	0	SENT_123	[p7l1789t657r1982b719],
5	that	IN	O	that	complm	30	SENT_123	[p7l2010t657r2145b719],
6	although	IN	O	although	mark	17	SENT_123	[p7l10t763r314b841],
7	the	DT	O	the	det	8	SENT_123	[p7l352t763r455b824],
8	difference	NN	O	difference	nsubj	17	SENT_123	[p7l494t763r824b824],
9	in	IN	O	in	_	0	SENT_123	[p7l862t763r926b824],
10	the	DT	O	the	det	11	SENT_123	[p7l965t763r1068b824],
11	incidence	NN	O	incidence	prep_in	8	SENT_123	[p7l1105t763r1419b824],
12	of	IN	O	of	_	0	SENT_123	[p7l1459t763r1535b824],
13	newly	RB	O	newly	advmod	14	SENT_123	[p7l1565t763r1762b841],
14	diagnosed	VBN	O	diagnose	amod	15	SENT_123	[p7l1801t763r2143b841],
15	cancer	NN	O	cancer	prep_of	11	SENT_123	[p7l9t890r228b931],
16	was	VBD	O	be	cop	17	SENT_123	[p7l251t890r379b931],
17	evident	JJ	O	evident	advcl	30	SENT_123	[p7l405t869r650b931],
18	after	IN	O	after	_	0	SENT_123	[p7l675t869r831b931],
19	2	CD	DURATION	2	num	20	SENT_123	[p7l855t871r893b930],
20	years	NNS	NUMBER	year	prep_after	17	SENT_123	[p7l922t890r1097b947],
21	in	IN	O	in	_	0	SENT_123	[p7l1121t870r1186b930],
22	the	DT	O	the	det	24	SENT_123	[p7l1211t870r1314b931],
23	Swedish	JJ	MISC	swedish	amod	24	SENT_123	[p7l1342t869r1617b931],
24	study	NN	O	study	prep_in	20	SENT_123	[p7l1644t869r1844b947],
25	,	,	O	,	_	0	SENT_123	[p7l1644t869r1844b947],
26	this	DT	O	this	nsubj	30	SENT_123	[p7l1872t870r1990b931],
27	was	VBD	O	be	cop	30	SENT_123	[p7l2015t890r2143b931],
28	only	RB	O	only	advmod	30	SENT_123	[p7l11t975r158b1053],
29	statistically	RB	O	statistically	advmod	30	SENT_123	[p7l180t975r555b1053],
30	signiﬁcant	JJ	O	signiﬁcant	ccomp	4	SENT_123	[p7l576t975r921b1053],
31	at	IN	O	at	_	0	SENT_123	[p7l941t984r1005b1037],
32	6	CD	DURATION	6	num	34	SENT_123	[p7l1027t977r1062b1037],
33	years	NNS	NUMBER	year	nn	34	SENT_123	[p7l1092t995r1267b1053],
34	follow-up	NN	O	follow-up	prep_at	30	SENT_123	[p7l1288t975r1633b1053],
35	.	.	O	.	_	0	SENT_123	[p7l1288t975r1633b1053],

1	We	PRP	O	we	nsubj	3	SENT_124	[p7l1657t978r1773b1037],
2	would	MD	O	would	aux	3	SENT_124	[p7l1792t975r2005b1037],
3	like	VB	O	like	_	0	SENT_124	[p7l2025t975r2144b1037],
4	to	TO	O	to	aux	5	SENT_124	[p7l9t1089r76b1142],
5	report	VB	O	report	xcomp	3	SENT_124	[p7l103t1089r313b1159],
6	an	DT	O	a	det	8	SENT_124	[p7l337t1101r419b1142],
7	updated	VBN	O	update	amod	8	SENT_124	[p7l443t1081r721b1159],
8	analysis	NN	O	analysis	dobj	5	SENT_124	[p7l747t1081r1011b1159],
9	of	IN	O	of	_	0	SENT_124	[p7l1037t1081r1113b1142],
10	our	PRP$	O	we	poss	11	SENT_124	[p7l1130t1101r1247b1142],
11	study	NN	O	study	prep_of	8	SENT_124	[p7l1273t1081r1456b1159],
12	after	IN	O	after	_	0	SENT_124	[p7l1481t1081r1636b1142],
13	a	DT	O	a	det	14	SENT_124	[p7l1661t1101r1699b1142],
14	follow-up	NN	O	follow-up	prep_after	3	SENT_124	[p7l1722t1081r2050b1159],
15	of	IN	O	of	_	0	SENT_124	[p7l2077t1081r2153b1142],
16	approximately	RB	O	approximately	quantmod	17	SENT_124	[p7l10t1187r503b1265],
17	7	CD	DURATION	7	num	18	SENT_124	[p7l532t1190r568b1249],
18	years	NNS	NUMBER	year	prep_of	14	SENT_124	[p7l598t1207r789b1265],
19	.	.	O	.	_	0	SENT_124	[p7l598t1207r789b1265],

1	We	PRP	O	we	_	0	SENT_125	[p7l93t1295r208b1354],
2	followed-up	JJ	O	followed-up	dep	1	SENT_125	[p7l240t1293r648b1371],
3	and	CC	O	and	_	0	SENT_125	[p7l682t1293r809b1354],
4	report	NN	O	report	npadvmod	10	SENT_125	[p7l841t1302r1051b1371],
5	on	IN	O	on	_	0	SENT_125	[p7l1085t1313r1171b1354],
6	441	CD	NUMBER	441	num	7	SENT_125	[p7l1202t1294r1313b1354],
7	patients	NNS	O	patient	prep_on	4	SENT_125	[p7l1352t1293r1637b1371],
8	,	,	O	,	_	0	SENT_125	[p7l1352t1293r1637b1371],
9	12	CD	NUMBER	12	appos	7	SENT_125	[p7l1681t1294r1750b1354],
10	more	JJR	O	more	conj_and	2	SENT_125	[p7l1781t1313r1958b1354],
11	than	IN	O	than	dep	1	SENT_125	[p7l1991t1293r2145b1354],
12	in	IN	O	in	_	0	SENT_125	[p7l8t1400r73b1460],
13	the	DT	O	the	det	15	SENT_125	[p7l105t1399r209b1461],
14	original	JJ	O	original	amod	15	SENT_125	[p7l242t1400r502b1478],
15	publication	NN	O	publication	prep_in	11	SENT_125	[p7l533t1399r935b1478],
16	.	.	O	.	_	0	SENT_125	[p7l533t1399r935b1478],

1	These	DT	O	these	det	4	SENT_126	[p7l971t1400r1169b1461],
2	additional	JJ	O	additional	amod	4	SENT_126	[p7l1202t1399r1547b1461],
3	12	CD	NUMBER	12	num	4	SENT_126	[p7l1587t1401r1656b1460],
4	patients	NNS	O	patient	nsubjpass	8	SENT_126	[p7l1688t1400r1954b1478],
5	were	VBD	O	be	auxpass	8	SENT_126	[p7l1986t1420r2144b1461],
6	not	RB	O	not	neg	8	SENT_126	[p7l9t1514r123b1567],
7	originally	RB	O	originally	advmod	8	SENT_126	[p7l184t1505r505b1583],
8	included	VBN	O	include	_	0	SENT_126	[p7l563t1505r852b1567],
9	in	IN	O	in	_	0	SENT_126	[p7l911t1505r975b1566],
10	the	DT	O	the	det	11	SENT_126	[p7l1035t1505r1139b1567],
11	report	NN	O	report	prep_in	8	SENT_126	[p7l1199t1514r1408b1583],
12	as	IN	O	as	mark	16	SENT_126	[p7l1468t1525r1535b1567],
13	they	PRP	O	they	nsubjpass	16	SENT_126	[p7l1597t1505r1741b1583],
14	had	VBD	O	have	aux	16	SENT_126	[p7l1800t1505r1928b1567],
15	been	VBN	O	be	auxpass	16	SENT_126	[p7l1987t1505r2145b1567],
16	followed	VBN	O	follow	advcl	8	SENT_126	[p7l9t1611r302b1672],
17	for	IN	O	for	_	0	SENT_126	[p7l337t1611r438b1672],
18	<	JJR	O	<	prep_for	16	SENT_126	[p7l489t1622r535b1663],
19	1	CD	DURATION	1	num	20	SENT_126	[p7l563t1613r585b1672],
20	year	NN	NUMBER	year	tmod	18	SENT_126	[p7l622t1631r768b1689],
21	at	IN	O	at	_	0	SENT_126	[p7l803t1619r867b1672],
22	the	DT	O	the	det	23	SENT_126	[p7l901t1611r1004b1672],
23	time	NN	O	time	prep_at	16	SENT_126	[p7l1040t1611r1187b1672],
24	of	IN	O	of	_	0	SENT_126	[p7l1224t1611r1300b1672],
25	the	DT	O	the	det	26	SENT_126	[p7l1326t1611r1429b1672],
26	submission	NN	O	submission	prep_of	23	SENT_126	[p7l1467t1611r1858b1672],
27	.	.	O	.	_	0	SENT_126	[p7l1467t1611r1858b1672],

1	During	IN	O	during	_	0	SENT_127	[p7l1898t1611r2145b1689],

1	Correspondence	NN	O	correspondence	_	0	SENT_128	[p7l10t1850r514b1917],
2	:	:	O	:	_	0	SENT_128	[p7l10t1850r514b1917],
3	Giancarlo	NNP	PERSON	Giancarlo	nn	4	SENT_128	[p7l591t1850r890b1903],
4	Agnelli	NNP	PERSON	Agnelli	dep	1	SENT_128	[p7l961t1850r1194b1917],
5	,	,	O	,	_	0	SENT_128	[p7l961t1850r1194b1917],
6	Division	NNP	O	Division	appos	1	SENT_128	[p7l1268t1850r1522b1903],
7	of	IN	O	of	_	0	SENT_128	[p7l1594t1850r1659b1903],
8	Internal	NNP	O	Internal	nn	11	SENT_128	[p7l1724t1850r1964b1903],
9	and	CC	O	and	_	0	SENT_128	[p7l2035t1850r2145b1903],
10	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	11	SENT_128	[p7l10t1942r469b1995],
11	Medicine	NNP	ORGANIZATION	Medicine	prep_of	6	SENT_128	[p7l506t1942r800b2006],
12	,	,	O	,	_	0	SENT_128	[p7l506t1942r800b2006],
13	Internal	NNP	ORGANIZATION	Internal	nn	14	SENT_128	[p7l840t1942r1080b1995],
14	Medicine	NNP	ORGANIZATION	Medicine	appos	1	SENT_128	[p7l1117t1942r1411b2006],
15	,	,	O	,	_	0	SENT_128	[p7l1117t1942r1411b2006],
16	University	NNP	ORGANIZATION	University	appos	1	SENT_128	[p7l1451t1942r1764b2009],
17	of	IN	ORGANIZATION	of	_	0	SENT_128	[p7l1802t1942r1868b1995],
18	Perugia	NNP	ORGANIZATION	Perugia	prep_of	16	SENT_128	[p7l1897t1943r2143b2009],
19	,	,	O	,	_	0	SENT_128	[p7l1897t1943r2143b2009],
20	Via	NNP	PERSON	Via	nn	25	SENT_128	[p7l8t2034r112b2086],
21	Enrico	NNP	PERSON	Enrico	nn	25	SENT_128	[p7l140t2034r338b2086],
22	dal	NN	PERSON	dal	nn	25	SENT_128	[p7l366t2034r457b2086],
23	Pozzo	NNP	PERSON	Pozzo	nn	25	SENT_128	[p7l483t2036r681b2097],
24	,	,	O	,	_	0	SENT_128	[p7l483t2036r681b2097],
25	Perugia	NNP	ORGANIZATION	Perugia	appos	1	SENT_128	[p7l710t2034r955b2101],
26	,	,	O	,	_	0	SENT_128	[p7l710t2034r955b2101],
27	Italy	NNP	LOCATION	Italy	appos	1	SENT_128	[p7l985t2034r1139b2100],
28	.	.	O	.	_	0	SENT_128	[p7l985t2034r1139b2100],

1	Tel.	NNP	O	Tel.	_	0	SENT_129	[p7l9t2126r138b2178],
2	:	:	O	:	_	0	SENT_129	[p7l9t2126r138b2178],
3	+39 075 578 2266	CD	NUMBER	+39 075 578 2266	dep	1	SENT_129	[p7l596t2128r751b2189],[p7l181t2128r307b2178],
4	;	:	O	;	_	0	SENT_129	[p7l596t2128r751b2189],
5	fax	NN	O	fax	dep	1	SENT_129	[p7l781t2126r888b2178],
6	:	:	O	:	_	0	SENT_129	[p7l781t2126r888b2178],
7	+39 075 578 2436	CD	NUMBER	+39 075 578 2436	dep	5	SENT_129	[p7l1346t2127r1500b2178],[p7l931t2128r1057b2178],
8	.	.	O	.	_	0	SENT_129	[p7l1346t2127r1500b2178],

1	E-mail	NN	O	e-mail	_	0	SENT_130	[p7l10t2218r225b2270],
2	:	:	O	:	_	0	SENT_130	[p7l10t2218r225b2270],
3	agnellig@unipg.it	NN	O	agnellig@unipg.it	dep	1	SENT_130	[p7l256t2218r794b2284],

1	DOI	NNP	O	DOI	_	0	SENT_131	[p7l9t2414r162b2466],
2	:	:	O	:	_	0	SENT_131	[p7l9t2414r162b2466],
3	10.1111	CD	NUMBER	10.1111	dep	1	SENT_131	[p7l199t2413r1206b2480],
4	/	:	O	/	punct	3	SENT_131	[p7l199t2413r1206b2480],
5	j.1538-7836	CD	DURATION	j.1538-7836	num	6	SENT_131	[p7l199t2413r1206b2480],
6	.2008.03044	CD	NUMBER	.2008.03044	dep	3	SENT_131	[p7l199t2413r1206b2480],
7	.	.	O	.	_	0	SENT_131	[p7l199t2413r1206b2480],

1	x	CC	O	x	_	0	SENT_132	[p7l199t2413r1206b2480],

1	Received	VBN	O	receive	_	0	SENT_133	[p7l11t2609r269b2660],
2	13	CD	DATE	13	dobj	1	SENT_133	[p7l299t2610r356b2660],
3	May	NNP	DATE	May	tmod	1	SENT_133	[p7l382t2610r517b2674],
4	2008	CD	DATE	2008	num	3	SENT_133	[p7l540t2610r691b2671],
5	,	,	O	,	_	0	SENT_133	[p7l540t2610r691b2671],
6	accepted	VBD	O	accept	dep	1	SENT_133	[p7l717t2609r965b2674],
7	16	CD	DATE	16	dobj	6	SENT_133	[p7l995t2610r1054b2660],
8	May	NNP	DATE	May	tmod	6	SENT_133	[p7l1078t2611r1214b2674],
9	2008	CD	DATE	2008	num	8	SENT_133	[p7l1236t2610r1368b2660],

1	©	RB	O	©	dep	4	SENT_134	[p7l10t2825r60b2874],
2	2008	CD	DATE	2008	num	4	SENT_134	[p7l89t2824r226b2874],
3	International	NNP	ORGANIZATION	International	nn	4	SENT_134	[p7l255t2823r652b2874],
4	Society	NNP	ORGANIZATION	Society	_	0	SENT_134	[p7l681t2823r895b2887],
5	on	IN	O	on	_	0	SENT_134	[p7l923t2839r997b2874],
6	Thrombosis	NNP	O	Thrombosis	prep_on	4	SENT_134	[p7l1024t2822r1384b2874],
7	and	CC	O	and	_	0	SENT_134	[p7l1413t2822r1523b2874],
8	Haemostasis	NNP	PERSON	Haemostasis	prep_on	4	SENT_134	[p7l1550t2823r1929b2874],
9	an	DT	O	a	det	11	SENT_134	[p7l8t3069r90b3111],
10	average	JJ	O	average	amod	11	SENT_134	[p7l128t3069r387b3127],
11	follow-up	NN	O	follow-up	dep	4	SENT_134	[p7l423t3048r753b3127],
12	of	IN	O	of	_	0	SENT_134	[p7l792t3048r868b3111],
13	7.1	CD	DURATION	7.1	num	14	SENT_134	[p7l898t3050r988b3111],
14	years	NNS	NUMBER	year	prep_of	11	SENT_134	[p7l1025t3069r1219b3127],
15	,	,	O	,	_	0	SENT_134	[p7l1025t3069r1219b3127],
16	42	CD	NUMBER	42	num	17	SENT_134	[p7l1258t3050r1337b3110],
17	patients	NNS	O	patient	appos	4	SENT_134	[p7l1372t3048r1640b3127],
18	(	IN	O	(	_	0	SENT_134	[p7l1679t3049r1911b3128],
19	9.5	CD	PERCENT	9.5	num	20	SENT_134	[p7l1679t3049r1911b3128],
20	%	NN	PERCENT	%	prep_(	22	SENT_134	[p7l1679t3049r1911b3128],
21	)	CD	NUMBER	)	nsubj	22	SENT_134	[p7l1679t3049r1911b3128],
22	had	VBD	O	have	rcmod	17	SENT_134	[p7l1948t3048r2077b3111],
23	a	DT	O	a	det	25	SENT_134	[p7l2114t3069r2152b3111],
24	new	JJ	O	new	amod	25	SENT_134	[p7l7t3176r145b3218],
25	diagnosis	NN	O	diagnosis	dobj	22	SENT_134	[p7l188t3155r503b3235],
26	of	IN	O	of	_	0	SENT_134	[p7l549t3156r625b3218],
27	cancer	NN	O	cancer	prep_of	25	SENT_134	[p7l660t3176r898b3231],
28	,	,	O	,	_	0	SENT_134	[p7l660t3176r898b3231],
29	23	CD	NUMBER	23	appos	27	SENT_134	[p7l945t3157r1020b3218],
30	of	IN	O	of	_	0	SENT_134	[p7l1068t3156r1144b3218],
31	these	DT	O	these	det	32	SENT_134	[p7l1180t3155r1349b3218],
32	patients	NNS	O	patient	prep_of	29	SENT_134	[p7l1392t3156r1659b3235],
33	(	IN	O	(	_	0	SENT_134	[p7l1705t3156r1977b3235],
34	10.3	CD	PERCENT	10.3	num	35	SENT_134	[p7l1705t3156r1977b3235],
35	%	NN	PERCENT	%	prep_(	39	SENT_134	[p7l1705t3156r1977b3235],
36	)	CD	NUMBER	)	nsubjpass	39	SENT_134	[p7l1705t3156r1977b3235],
37	had	VBD	O	have	aux	39	SENT_134	[p7l2022t3155r2151b3218],
38	been	VBN	O	be	auxpass	39	SENT_134	[p7l7t3262r165b3325],
39	treated	VBN	O	treat	rcmod	25	SENT_134	[p7l200t3262r436b3325],
40	for	IN	O	for	_	0	SENT_134	[p7l472t3262r572b3325],
41	1	CD	DURATION	1	prep_for	39	SENT_134	[p7l614t3264r637b3324],
42	year	NN	NUMBER	year	tmod	22	SENT_134	[p7l674t3283r820b3341],
43	with	IN	O	with	_	0	SENT_134	[p7l853t3262r1004b3325],
44	vitamin	NN	O	vitamin	nn	46	SENT_134	[p7l1038t3262r1298b3325],
45	K	NN	O	k	nn	46	SENT_134	[p7l1333t3265r1399b3324],
46	antagonists	NNS	O	antagonist	prep_with	22	SENT_134	[p7l1435t3262r1840b3341],
47	,	,	O	,	_	0	SENT_134	[p7l1435t3262r1840b3341],
48	whereas	IN	O	whereas	mark	56	SENT_134	[p7l1877t3262r2151b3325],
49	19	CD	NUMBER	19	num	50	SENT_134	[p7l15t3370r84b3431],
50	patients	NNS	O	patient	nsubjpass	56	SENT_134	[p7l126t3369r393b3448],
51	(	IN	O	(	_	0	SENT_134	[p7l436t3369r668b3448],
52	8.7	CD	PERCENT	8.7	num	53	SENT_134	[p7l436t3369r668b3448],
53	%	NN	PERCENT	%	prep_(	50	SENT_134	[p7l436t3369r668b3448],
54	)	CD	NUMBER	)	dep	53	SENT_134	[p7l436t3369r668b3448],
55	were	VBD	O	be	auxpass	56	SENT_134	[p7l709t3389r868b3431],
56	treated	VBN	O	treat	advcl	22	SENT_134	[p7l909t3369r1145b3431],
57	for	IN	O	for	_	0	SENT_134	[p7l1187t3369r1287b3431],
58	3	CD	DURATION	3	num	59	SENT_134	[p7l1330t3371r1362b3431],
59	months	NNS	NUMBER	month	prep_for	56	SENT_134	[p7l1394t3369r1652b3431],
60	(	CD	NUMBER	(	num	61	SENT_134	[p7l1695t3369r1850b3448],
61	HR	NN	DURATION	hr	dep	59	SENT_134	[p7l1695t3369r1850b3448],
62	=	JJ	O	=	amod	17	SENT_134	[p7l1894t3392r1945b3410],
63	1.19	CD	NUMBER	1.19	tmod	62	SENT_134	[p7l1999t3370r2149b3444],
64	,	,	O	,	_	0	SENT_134	[p7l1999t3370r2149b3444],
65	95	CD	PERCENT	95	number	66	SENT_134	[p7l8t3478r163b3540],
66	%	NN	PERCENT	%	amod	67	SENT_134	[p7l8t3478r163b3540],
67	CI	NN	O	ci	appos	17	SENT_134	[p7l226t3478r311b3539],
68	0.65-2	CD	NUMBER	0.65-2	num	69	SENT_134	[p7l368t3478r707b3552],
69	.20	CD	NUMBER	.20	dep	67	SENT_134	[p7l368t3478r707b3552],
70	;	:	O	;	_	0	SENT_134	[p7l368t3478r707b3552],
71	Fig	NN	O	fig	dep	17	SENT_134	[p7l767t3477r1012b3556],
72	.1	CD	NUMBER	.1	num	73	SENT_134	[p7l767t3477r1012b3556],
73	)	NN	O	)	dep	71	SENT_134	[p7l767t3477r1012b3556],
74	.	.	O	.	_	0	SENT_134	[p7l767t3477r1012b3556],

1	Cancer	NN	O	cancer	nsubjpass	3	SENT_135	[p7l1073t3478r1316b3539],
2	was	VBD	O	be	auxpass	3	SENT_135	[p7l1369t3497r1498b3539],
3	diagnosed	VBN	O	diagnose	_	0	SENT_135	[p7l1554t3477r1899b3556],
4	in	IN	O	in	_	0	SENT_135	[p7l1953t3477r2018b3538],
5	23	CD	NUMBER	23	num	6	SENT_135	[p7l2073t3478r2148b3539],
6	patients	NNS	O	patient	prep_in	3	SENT_135	[p7l6t3583r274b3662],
7	presenting	VBG	O	present	partmod	6	SENT_135	[p7l307t3583r660b3662],
8	with	IN	O	with	_	0	SENT_135	[p7l692t3583r843b3646],
9	deep	JJ	O	deep	amod	11	SENT_135	[p7l876t3583r1033b3662],
10	vein	NN	O	vein	nn	11	SENT_135	[p7l1066t3583r1206b3646],
11	thrombosis	NN	O	thrombosis	prep_with	7	SENT_135	[p7l1240t3583r1623b3646],
12	(	CD	PERCENT	(	number	13	SENT_135	[p7l1659t3584r1891b3662],
13	9.1	CD	PERCENT	9.1	num	14	SENT_135	[p7l1659t3584r1891b3662],
14	%	NN	PERCENT	%	dep	11	SENT_135	[p7l1659t3584r1891b3662],
15	)	CD	NUMBER	)	dep	14	SENT_135	[p7l1659t3584r1891b3662],
16	and	CC	O	and	_	0	SENT_135	[p7l1927t3583r2055b3646],
17	in	IN	O	in	_	0	SENT_135	[p7l2087t3583r2152b3645],
18	19	CD	NUMBER	19	num	19	SENT_135	[p7l15t3692r85b3752],
19	patients	NNS	O	patient	conj_and	6	SENT_135	[p7l134t3690r401b3769],
20	presenting	VBG	O	present	partmod	19	SENT_135	[p7l450t3690r803b3769],
21	with	IN	O	with	_	0	SENT_135	[p7l850t3690r1001b3753],
22	pulmonary	JJ	O	pulmonary	amod	23	SENT_135	[p7l1048t3690r1427b3769],
23	embolism	NN	O	embolism	prep_with	20	SENT_135	[p7l1476t3690r1807b3753],
24	(	CD	PERCENT	(	number	25	SENT_135	[p7l1857t3690r2147b3769],
25	10.1	CD	PERCENT	10.1	num	26	SENT_135	[p7l1857t3690r2147b3769],
26	%	NN	PERCENT	%	dep	23	SENT_135	[p7l1857t3690r2147b3769],
27	)	CD	NUMBER	)	dep	26	SENT_135	[p7l1857t3690r2147b3769],
28	.	.	O	.	_	0	SENT_135	[p7l1857t3690r2147b3769],

1	The	DT	O	the	det	3	SENT_136	[p8l7t21r139b83],
2	average	JJ	O	average	amod	3	SENT_136	[p8l170t41r429b100],
3	age	NN	O	age	nsubj	12	SENT_136	[p8l460t41r572b100],
4	of	IN	O	of	_	0	SENT_136	[p8l603t21r679b83],
5	patients	NNS	O	patient	prep_of	3	SENT_136	[p8l698t21r966b100],
6	with	IN	O	with	_	0	SENT_136	[p8l995t21r1146b83],
7	newly	RB	O	newly	advmod	8	SENT_136	[p8l1174t21r1373b100],
8	diagnosed	VBN	O	diagnose	amod	9	SENT_136	[p8l1402t21r1746b100],
9	cancer	NN	O	cancer	prep_with	5	SENT_136	[p8l1775t41r1995b83],
10	was	VBD	O	be	cop	12	SENT_136	[p8l2022t41r2151b83],
11	69.3	CD	DURATION	69.3	num	12	SENT_136	[p8l9t129r144b190],
12	years	NNS	NUMBER	year	_	0	SENT_136	[p8l177t148r352b206],
13	compared	VBN	O	compare	_	0	SENT_136	[p8l407t127r749b206],
14	with	IN	O	with	prepc_compared_with	12	SENT_136	[p8l803t127r953b190],
15	65.1	CD	DURATION	65.1	num	16	SENT_136	[p8l1010t129r1141b190],
16	years	NNS	NUMBER	year	pobj	12	SENT_136	[p8l1178t148r1353b206],
17	for	IN	O	for	_	0	SENT_136	[p8l1410t127r1510b190],
18	patients	NNS	O	patient	prep_for	16	SENT_136	[p8l1563t127r1831b206],
19	without	IN	O	without	_	0	SENT_136	[p8l1886t127r2153b190],
20	cancer	NN	O	cancer	prep_without	18	SENT_136	[p8l7t255r244b310],
21	;	:	O	;	_	0	SENT_136	[p8l7t255r244b310],
22	this	DT	O	this	det	23	SENT_136	[p8l284t235r403b297],
23	difference	NN	O	difference	nsubj	27	SENT_136	[p8l440t235r771b297],
24	was	VBD	O	be	cop	27	SENT_136	[p8l806t255r935b297],
25	not	RB	O	not	neg	27	SENT_136	[p8l972t244r1087b297],
26	statistically	RB	O	statistically	advmod	27	SENT_136	[p8l1124t235r1501b314],
27	signiﬁcant	JJ	O	signiﬁcant	parataxis	12	SENT_136	[p8l1538t235r1899b314],
28	.	.	O	.	_	0	SENT_136	[p8l1538t235r1899b314],

1	Death	NN	O	death	nsubj	2	SENT_137	[p8l1939t235r2152b297],
2	occurred	VBD	O	occur	_	0	SENT_137	[p8l9t341r307b404],
3	in	IN	O	in	_	0	SENT_137	[p8l335t341r399b403],
4	71	CD	NUMBER	71	num	5	SENT_137	[p8l429t343r498b404],
5	patients	NNS	O	patient	prep_in	2	SENT_137	[p8l533t341r801b420],
6	(	IN	O	(	_	0	SENT_137	[p8l832t342r1121b420],
7	16.1	CD	PERCENT	16.1	num	8	SENT_137	[p8l832t342r1121b420],
8	%	NN	PERCENT	%	prep_(	5	SENT_137	[p8l832t342r1121b420],
9	)	CD	NUMBER	)	num	11	SENT_137	[p8l832t342r1121b420],
10	:	:	O	:	_	0	SENT_137	[p8l832t342r1121b420],
11	34	CD	NUMBER	34	dobj	2	SENT_137	[p8l1157t343r1234b404],
12	of	IN	O	of	_	0	SENT_137	[p8l1263t341r1340b404],
13	the	DT	O	the	det	14	SENT_137	[p8l1359t341r1463b404],
14	patients	NNS	O	patient	prep_of	11	SENT_137	[p8l1491t341r1758b420],
15	treated	VBN	O	treat	partmod	14	SENT_137	[p8l1788t341r2024b404],
16	for	IN	O	for	_	0	SENT_137	[p8l2052t341r2153b404],
17	3	CD	DURATION	3	num	18	SENT_137	[p8l10t450r42b510],
18	months	NNS	NUMBER	month	prep_for	15	SENT_137	[p8l75t448r332b510],
19	and	CC	O	and	_	0	SENT_137	[p8l374t448r501b510],
20	37	CD	NUMBER	37	prep_for	15	SENT_137	[p8l544t450r618b510],
21	of	IN	O	of	_	0	SENT_137	[p8l661t448r737b510],
22	the	DT	O	the	det	23	SENT_137	[p8l769t448r872b510],
23	patients	NNS	O	patient	prep_of	20	SENT_137	[p8l911t448r1178b527],
24	treated	VBN	O	treat	partmod	23	SENT_137	[p8l1219t448r1456b510],
25	for	IN	O	for	_	0	SENT_137	[p8l1496t448r1596b510],
26	1	CD	DURATION	1	num	27	SENT_137	[p8l1643t450r1666b509],
27	year	NN	NUMBER	year	prep_for	24	SENT_137	[p8l1703t468r1864b527],
28	.	.	O	.	_	0	SENT_137	[p8l1703t468r1864b527],

1	Cancer	NN	O	cancer	nsubj	4	SENT_138	[p8l1910t449r2153b511],
2	was	VBD	O	be	cop	4	SENT_138	[p8l6t576r134b618],
3	the	DT	O	the	det	4	SENT_138	[p8l172t556r275b618],
4	cause	NN	O	cause	_	0	SENT_138	[p8l311t576r495b618],
5	of	IN	O	of	_	0	SENT_138	[p8l533t556r609b618],
6	death	NN	O	death	prep_of	4	SENT_138	[p8l637t556r827b618],
7	in	IN	O	in	_	0	SENT_138	[p8l861t556r926b617],
8	22	CD	NUMBER	22	num	9	SENT_138	[p8l962t557r1040b617],
9	patients	NNS	O	patient	prep_in	6	SENT_138	[p8l1075t556r1360b635],
10	.	.	O	.	_	0	SENT_138	[p8l1075t556r1360b635],

1	.	.	O	.	_	0	SENT_139	[p8l857t1083r1011b1090],

1	—	NN	O	—	_	0	SENT_140	[p8l857t1083r1011b1090],
2	.	.	O	.	_	0	SENT_140	[p8l857t1083r1011b1090],

1	-	:	O	-	_	0	SENT_141	[p8l857t1083r1011b1090],
2	.	.	O	.	_	0	SENT_141	[p8l857t1083r1011b1090],

1	—	NN	O	—	_	0	SENT_142	[p8l857t1083r1011b1090],
2	.	.	O	.	_	0	SENT_142	[p8l857t1083r1011b1090],

1	-	:	O	-	_	0	SENT_143	[p8l857t1083r1011b1090],
2	Three	CD	DURATION	three	num	4	SENT_143	[p8l1048t1050r1232b1104],
3	months	NNS	NUMBER	month	nn	4	SENT_143	[p8l1259t1050r1488b1103],
4	treatment	NN	O	treatment	dep	5	SENT_143	[p8l1511t1054r1813b1104],
5	i	FW	O	i	_	0	SENT_143	[p8l857t1181r1011b1188],
6	One	CD	DURATION	one	num	8	SENT_143	[p8l1050t1147r1180b1202],
7	year	NN	NUMBER	year	nn	8	SENT_143	[p8l1204t1162r1343b1216],
8	treatment	NN	O	treatment	dep	5	SENT_143	[p8l1363t1152r1666b1202],

1	.	.	O	.	_	0	SENT_144	[p8l380t1108r431b1161],

1	o	NN	O	o	nsubj	2	SENT_145	[p8l380t1108r431b1161],
2	ca	MD	O	can	_	0	SENT_145	[p8l439t1108r475b1161],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_146	[p8l197t1547r251b1901],
2	hazard	NN	O	hazard	_	0	SENT_146	[p8l198t1308r251b1520],
3	of	IN	O	of	_	0	SENT_146	[p8l197t1225r251b1282],
4	newly	RB	O	newly	advmod	5	SENT_146	[p8l198t1021r265b1200],
5	diagnosed	VBN	O	diagnose	amod	6	SENT_146	[p8l284t1418r352b1744],
6	cancer	NN	O	cancer	prep_of	2	SENT_146	[p8l297t1178r337b1392],

1	Follow	VB	O	follow	_	0	SENT_147	[p8l912t2310r1113b2363],
2	up	RP	O	up	prt	1	SENT_147	[p8l1138t2323r1212b2377],
3	(	CD	NUMBER	(	num	4	SENT_147	[p8l1239t2309r1453b2378],
4	years	NNS	NUMBER	year	tmod	1	SENT_147	[p8l1239t2309r1453b2378],
5	)	IN	O	)	prep	1	SENT_147	[p8l1239t2309r1453b2378],

1	Fig	NN	O	fig	_	0	SENT_148	[p8l6t2470r115b2536],
2	.	.	O	.	_	0	SENT_148	[p8l6t2470r115b2536],

1	1	LS	NUMBER	1	_	0	SENT_149	[p8l146t2470r190b2522],
2	.	.	O	.	_	0	SENT_149	[p8l146t2470r190b2522],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_150	[p8l231t2469r568b2522],
2	hazard	NN	O	hazard	_	0	SENT_150	[p8l591t2469r790b2522],
3	of	IN	O	of	_	0	SENT_150	[p8l815t2469r880b2522],
4	newly	RB	O	newly	advmod	5	SENT_150	[p8l896t2469r1064b2535],
5	diagnosed	VBN	O	diagnose	amod	6	SENT_150	[p8l1087t2469r1379b2536],
6	cancer	NN	O	cancer	prep_of	2	SENT_150	[p8l1402t2486r1589b2521],
7	in	IN	O	in	_	0	SENT_150	[p8l1611t2469r1666b2521],
8	patients	NNS	O	patient	prep_in	2	SENT_150	[p8l1688t2469r1916b2536],
9	treated	VBN	O	treat	partmod	2	SENT_150	[p8l1940t2469r2141b2521],
10	for	IN	O	for	_	0	SENT_150	[p8l7t2558r92b2611],
11	3	CD	DURATION	3	num	12	SENT_150	[p8l117t2560r144b2611],
12	months	NNS	NUMBER	month	prep_for	9	SENT_150	[p8l171t2558r390b2611],
13	or	CC	O	or	_	0	SENT_150	[p8l415t2575r477b2611],
14	1	CD	DURATION	1	num	15	SENT_150	[p8l506t2560r525b2610],
15	year	NN	NUMBER	year	prep_for	9	SENT_150	[p8l557t2575r681b2624],
16	with	IN	O	with	_	0	SENT_150	[p8l703t2558r830b2611],
17	warfarin	NN	O	warfarin	prep_with	9	SENT_150	[p8l852t2558r1115b2611],
18	.	.	O	.	_	0	SENT_150	[p8l852t2558r1115b2611],

